US20230321647A1 - Liquid transfer system - Google Patents
Liquid transfer system Download PDFInfo
- Publication number
- US20230321647A1 US20230321647A1 US18/333,495 US202318333495A US2023321647A1 US 20230321647 A1 US20230321647 A1 US 20230321647A1 US 202318333495 A US202318333495 A US 202318333495A US 2023321647 A1 US2023321647 A1 US 2023321647A1
- Authority
- US
- United States
- Prior art keywords
- bladder
- pipette
- pipette tip
- volume
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 202
- 238000012546 transfer Methods 0.000 title claims abstract description 127
- 230000004044 response Effects 0.000 claims abstract description 38
- 239000000463 material Substances 0.000 claims description 35
- 238000004113 cell culture Methods 0.000 abstract description 206
- 239000012528 membrane Substances 0.000 abstract description 55
- 239000012530 fluid Substances 0.000 abstract description 35
- 238000004891 communication Methods 0.000 abstract description 19
- 210000004027 cell Anatomy 0.000 description 223
- 238000000034 method Methods 0.000 description 58
- 238000003860 storage Methods 0.000 description 53
- 238000003384 imaging method Methods 0.000 description 48
- 238000003556 assay Methods 0.000 description 41
- 239000003570 air Substances 0.000 description 40
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 26
- 239000000523 sample Substances 0.000 description 25
- 239000007789 gas Substances 0.000 description 24
- 239000001569 carbon dioxide Substances 0.000 description 19
- 229910002092 carbon dioxide Inorganic materials 0.000 description 19
- 239000001963 growth medium Substances 0.000 description 16
- 239000006143 cell culture medium Substances 0.000 description 14
- 230000008569 process Effects 0.000 description 14
- 239000000356 contaminant Substances 0.000 description 13
- 238000012544 monitoring process Methods 0.000 description 13
- 239000002609 medium Substances 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- 238000011109 contamination Methods 0.000 description 11
- 230000007246 mechanism Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
- 230000010261 cell growth Effects 0.000 description 10
- 230000033001 locomotion Effects 0.000 description 10
- 230000032258 transport Effects 0.000 description 10
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 9
- 230000004069 differentiation Effects 0.000 description 9
- 230000007613 environmental effect Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- -1 valves Substances 0.000 description 9
- 238000012258 culturing Methods 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- 108020004414 DNA Proteins 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 239000004033 plastic Substances 0.000 description 7
- 229920003023 plastic Polymers 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
- 238000012864 cross contamination Methods 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 210000004962 mammalian cell Anatomy 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 239000013589 supplement Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 238000005138 cryopreservation Methods 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 238000013537 high throughput screening Methods 0.000 description 5
- 230000000284 resting effect Effects 0.000 description 5
- 210000000130 stem cell Anatomy 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000005260 human cell Anatomy 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000004115 adherent culture Methods 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 238000013467 fragmentation Methods 0.000 description 3
- 238000006062 fragmentation reaction Methods 0.000 description 3
- 239000012737 fresh medium Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 230000024042 response to gravity Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 2
- 108010092160 Dactinomycin Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 241000282324 Felis Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000204031 Mycoplasma Species 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 229960000640 dactinomycin Drugs 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 230000005670 electromagnetic radiation Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000002991 molded plastic Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001084 poly(chloroprene) Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000565 sealant Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003104 tissue culture media Substances 0.000 description 2
- 239000012780 transparent material Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 238000009333 weeding Methods 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 238000012605 2D cell culture Methods 0.000 description 1
- 238000012604 3D cell culture Methods 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
- YXHLJMWYDTXDHS-IRFLANFNSA-N 7-aminoactinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=C(N)C=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 YXHLJMWYDTXDHS-IRFLANFNSA-N 0.000 description 1
- 108700012813 7-aminoactinomycin D Proteins 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108090000672 Annexin A5 Proteins 0.000 description 1
- 102000004121 Annexin A5 Human genes 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 206010005949 Bone cancer Diseases 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 238000010453 CRISPR/Cas method Methods 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000011727 Caspases Human genes 0.000 description 1
- 108010076667 Caspases Proteins 0.000 description 1
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 description 1
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical class [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 102100031547 HLA class II histocompatibility antigen, DO alpha chain Human genes 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 101000866278 Homo sapiens HLA class II histocompatibility antigen, DO alpha chain Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- 241001138401 Kluyveromyces lactis Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 229920000459 Nitrile rubber Polymers 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 229920000776 Poly(Adenosine diphosphate-ribose) polymerase Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 108010093965 Polymyxin B Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 239000012979 RPMI medium Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- PLXBWHJQWKZRKG-UHFFFAOYSA-N Resazurin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3[N+]([O-])=C21 PLXBWHJQWKZRKG-UHFFFAOYSA-N 0.000 description 1
- 102220497176 Small vasohibin-binding protein_T47D_mutation Human genes 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000269370 Xenopus <genus> Species 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Chemical class 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 238000011130 autologous cell therapy Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 1
- 238000000423 cell based assay Methods 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- 239000010960 cold rolled steel Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011124 ex vivo culture Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229950006501 fosmidomycin Drugs 0.000 description 1
- GJXWDTUCERCKIX-UHFFFAOYSA-N fosmidomycin Chemical compound O=CN(O)CCCP(O)(O)=O GJXWDTUCERCKIX-UHFFFAOYSA-N 0.000 description 1
- 208000005017 glioblastoma Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000012203 high throughput assay Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000012774 insulation material Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000004925 microvascular endothelial cell Anatomy 0.000 description 1
- 239000007758 minimum essential medium Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 210000003098 myoblast Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 210000003061 neural cell Anatomy 0.000 description 1
- 239000010955 niobium Substances 0.000 description 1
- 229910052758 niobium Inorganic materials 0.000 description 1
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000052 poly(p-xylylene) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000005023 polychlorotrifluoroethylene (PCTFE) polymer Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000024 polymyxin B Polymers 0.000 description 1
- 229960005266 polymyxin b Drugs 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000012587 primary cell supplement Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052709 silver Chemical class 0.000 description 1
- 239000004332 silver Chemical class 0.000 description 1
- 210000004683 skeletal myoblast Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 150000004579 taxol derivatives Chemical class 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000013042 tunel staining Methods 0.000 description 1
- 210000003954 umbilical cord Anatomy 0.000 description 1
- 231100000747 viability assay Toxicity 0.000 description 1
- 238000003026 viability measurement method Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/02—Burettes; Pipettes
- B01L3/0275—Interchangeable or disposable dispensing tips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L9/00—Supporting devices; Holding devices
- B01L9/54—Supports specially adapted for pipettes and burettes
- B01L9/543—Supports specially adapted for pipettes and burettes for disposable pipette tips, e.g. racks or cassettes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
- C12M33/04—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus by injection or suction, e.g. using pipettes, syringes, needles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/12—Means for regulation, monitoring, measurement or control, e.g. flow regulation of temperature
- C12M41/14—Incubators; Climatic chambers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/40—Means for regulation, monitoring, measurement or control, e.g. flow regulation of pressure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0689—Sealing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/14—Process control and prevention of errors
- B01L2200/141—Preventing contamination, tampering
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/12—Specific details about materials
- B01L2300/123—Flexible; Elastomeric
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0481—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure squeezing of channels or chambers
Definitions
- aspects relate to a liquid transfer system and methods for using the system to transfer a volume of liquid into and out of a pipette tip. Some aspects relate to using such a liquid transfer system in cell culture incubators and to methods for using such incubators.
- Pipettes are used to transfer a volume of liquid, such as transferring media containing cells between cell culture vessels.
- Cell culture is a useful technique in both research and clinical contexts. For example, culture of mammalian cells is often performed in order to establish clonal cell lines, tissue preparations, in vitro fertilization preparations, or to expand populations of stem cells.
- pipette tips may introduce contaminants into a sample in the pipette tip.
- the pipette tip is open at an end adjacent a pipette, which is used to transfer many different samples into and out of numerous pipette tips, cross-contamination may occur. In embodiments using such pipette tips in a cell cultures, this may lower culture efficiency and repeatability.
- traditional pipette tips are designed for a single use only, a large volume of waste (e.g., a large pile of used tips) may result during an experiment such as a cell culture being performed in an incubator.
- Single-use pipette tips also may need a large area for storage.
- the instant document provides a liquid transfer system having a pipette tip arranged to minimize or even eliminate cross contamination and to also reduce waste and/or storage space.
- the instant document provides a pipette tip with a body defining an inner volume and having first and second ends, the first end arranged to pass a liquid into and out of the pipette tip and the second end arranged for attachment to a pipette, and a bladder sealingly attached to the body.
- the bladder is disposable in the inner volume of the body.
- a first side of the bladder is exposed to a volume of accommodated liquid.
- a second, opposite side may be exposed to a pipette.
- the bladder may be attached to the second end of the body.
- the bladder also may be attached to the first end or at a location between the first and second ends.
- the bladder is arranged to accommodate a volume of liquid or a volume of air above the liquid in the pipette tip (e.g., the air used to displace a volume of liquid).
- the bladder is manipulated (e.g., moved, retracted, expanded, contracted, and/or stretched) to transfer a volume of liquid into or out of the pipette tip.
- a pressure may be applied to the bladder to manipulate the bladder.
- the bladder is arranged to move back and forth in response to an applied pressure.
- the bladder may be at least partially retracted outside of the pipette tip body to draw a volume of liquid into the pipette tip in response to a negative pressure.
- the bladder may be retracted into the pipette tip (e.g., into the inner volume of the pipette tip body) to expel at least a portion of the volume of liquid from the pipette tip.
- the bladder is configured to expand and contract in response to the applied pressure.
- the bladder also may be arranged stretch in response to the applied pressure.
- the negative pressure creates a vacuum that is applied to the bladder.
- a negative pressure differential may be created between the air pressure in a container (e.g., the air pressure in the tip) and the air pressure of the environment.
- the pressure differential or pressure gradient may be applied across the bladder.
- the bladder includes a membranous sac that is arranged to accommodate the volume of liquid.
- the bladder is disposable in the body of the pipette tip, with the formed, membranous sac folded into the tip.
- the bladder may be disposed in the pipette tip such that the membranous sac extends from a location at the second end, or between the first and second ends, toward the first end.
- the bladder includes a planar membrane.
- the planar membrane may include an unformed state of a membranous sac.
- an elastomeric membrane may be disposed in the tip, with the membrane having a planar configuration in a resting state.
- a pressure e.g., a negative pressure
- the membrane may be stretched and/or expanded such that the membrane forms the membranous sac, which may accommodate the volume of liquid.
- the planar membrane may simple move back and forth in response to the applied pressure, without expanding and contracting.
- a least a part of the membrane may fall below the plane extending through the membrane (e.g., slightly towards the first end of the pipette tip) in response to gravity, forming a concave arrangement.
- the pipette tip is arranged to accommodate a volume liquid that is less than or equal to a sum of a volume of the bladder and a volume of an inner volume of the body of the pipette tip.
- the volume of accommodated liquid may be limited by the volume of the bladder.
- the volume of the bladder includes a volume defined by the membranous sac.
- the bladder is formed of a material that allows the bladder to expand beyond the volume of the membranous sac.
- the volume of the bladder also may include the volume of the expanded bladder (e.g., the bladder after an applied pressure greater than that needed to simply draw a liquid into the bladder).
- the bladder is permanently attached to the pipette tip body (e.g., to the second end of the body). In other embodiments, the bladder may be removably attached to the pipette tip body.
- the second end of the pipette tip is adjacent a pipette.
- the bladder e.g., the formed membranous sac or planar membrane
- the membranous sac extends from the second end of the body towards the first end of the body.
- the pipette tip is reusable.
- the pipette tip also may be disposable such that the tip is only used for a single liquid transfer. In these situations, the pipette tip may be removably attached to the pipette.
- this document provides a liquid transfer system that includes a pipette tip having a body defining an inner volume and having first and second ends, the first end arranged to pass a liquid into and out of the pipette tip and the second end arranged for attachment to a pipette, and a bladder sealingly attached to the body.
- the bladder is disposable in the inner volume.
- the system also may include a pipette attached to the pipette tip, the pipette arranged to generate pressure gradients across the bladder to transfer a volume of liquid into and out of the pipette tip.
- the volume of liquid drawn into (or expelled from) the pipette tip is dependent on the first applied pressure.
- the volume of liquid drawn into (or dispensed out of) the pipette tip may be based upon the amplitude of the pressure differential (e.g., between air in the container and the environment) and the duration of the applied pressure.
- the volume of liquid accommodated by the pipette tip is limited by the total volume of the pipette tip body and the volume of the bladder.
- the bladder may be retracted (e.g., partially retracted), expanded or stretched into the body of the pipette in response to the applied pressure.
- the volume of the pipette body may be greater than or equal to the volume of membrane (e.g., the volume of the bladder and/or diaphragm).
- the pipette body includes a pump which applies the pressure (e.g., via a fluid such as a liquid or air) to the pipette tip.
- the pipette is connected to a fluid conduit which applies the pressure (e.g., the negative pressure) to the pipette tip via a valve and pump.
- the fluid conduit may be connected to a fluid supply (e.g., an air or liquid supply).
- the pipette includes a pipette shell disposed inside the pipette body to separate the pipette body from the pipette tip.
- the pipette shell may further minimize cross contamination between the pipette and the liquid being drawn into the pipette tip.
- the pipette shell is disposable. In other embodiments, the pipette shell may be reusable.
- this document provides a pipette tip including a body defining an inner volume and having first and second ends, the first end arranged to pass a liquid into and out of the pipette tip and the second end arranged for attachment to a pipette, and a bladder sealingly attached to the body.
- the bladder is disposable in the inner volume of the body. The bladder and at least a portion of the inner volume are arranged to accommodate a volume of fluid.
- the volume of liquid is less than or equal to a sum of the volume of the bladder and a volume of the body.
- the bladder divides the body into first and second compartments.
- the first compartment may be in fluid communication with the first end and the second compartment may be in fluid communication with the second end.
- the second compartment may be arranged to receive at last one of a first applied pressure to draw a volume of liquid into the body and a second applied pressure to expel the volume of liquid from the pipette tip.
- the bladder includes a membrane (e.g., an elastomeric membrane) that has been stretched in response to an applied pressure to form a sac for accommodating a volume of liquid.
- a membrane e.g., an elastomeric membrane
- this document provides a liquid transfer system including a pipette tip having a body defining an inner volume and having first and second ends, the first end arranged to pass a liquid into and out of the pipette tip and the second end arranged for attachment to a pipette, and a bladder sealingly attached to the body.
- the bladder is disposable in the inner volume of the body.
- the system also includes a manipulator arranged to generate pressure gradients across the bladder to transfer a first volume of liquid into or out of the pipette tip.
- the bladder in response to the applied pressure, is at least partially retracted into an interior volume of the manipulator.
- the pressure is a negative pressure and the bladder retracts to draw a volume of the liquid into the body of the pipette.
- the manipulator is arranged to apply a pressure of air to the bladder to transfer a portion of the volume of liquid out of the pipette tip. In such embodiments, the bladder is moved into the body.
- the pipette tip may be removably attachable to the manipulator.
- the manipulator may include a multi-tipped pipette.
- the pipette shell may be attached to the manipulator prior to attaching the pipette tip.
- the system includes a second pipette tip defining an inner volume and having a second body with third and fourth ends, the third end arranged to transfer fluid in and out of the body and the fourth end arranged for attachment to a manipulator, and a second bladder sealingly attached to the inner volume of the second body.
- the bladder is disposable in the second body.
- the manipulator also may be arranged to apply a pressure to the second bladder to transfer a second volume of liquid into or out of the third end of the pipette tip.
- first and second pipette tips are configured to transfer first and second volumes, respectively, from the same cell culture vessel. In other embodiments, the first and second pipette tips transfer first and second volumes from first and second cell culture vessels, respectively.
- a system includes more than two pipettes (e.g., 3, 4, 5, 6, 7, 8, 9, 10, or more) having pipette tips as described in this document.
- this document provides a cell incubator having an internal chamber for incubation of cells in one or more cell culture vessels, a door opening from an external environment to said internal chamber, an imager arranged to imaging the cells within the internal chamber, a manipulator for manipulating the cells in the one or more cell culture vessels within the internal chamber, wherein the manipulator comprises at least one pipette configured to transfer a first volume of media comprising the cells into or out of the one or more cell culture vessels within the internal chamber, a pipette tip in fluid communication with the pipette, the pipette tip having a body defining an inner volume and having first and second ends, the first end arranged to transfer a volume of liquid into and out of the pipette tip and the second end arranged for attachment to a manipulator, and a bladder sealingly attached to the pipette tip, and a cell culture vessel transfer device for moving the one or more cell culture vessels between locations within the internal chamber.
- the manipulator comprises at least one pipette configured to transfer a first volume of media comprising
- the manipulator applies a pressure to the bladder to transfer a first volume of media comprising the cells into or out of the pipette tip.
- the first volume of media is proportional to the applied pressure.
- the bladder is disposable within the inner volume of the pipette tip.
- the pipette applies a pressure to the bladder of the pipette tip to draw the first volume of media into the pipette tip.
- the applied pressure is a negative pressure that applies a vacuum to the bladder.
- the incubator includes a second pipette for transferring a second volume of media containing cells into or out of one or more cell culture vessels within the internal chamber.
- a second pipette tip may be used with the second pipette.
- the second tip may have a body defining an inner volume and having third and fourth ends, the third end arranged to transfer liquid into and out of the pipette tip and the fourth end arranged for attachment to a manipulator, such as a pipette.
- the second bladder is disposable in the inner volume of the second body.
- the bladder includes a membranous sac extending from the fourth end, or a location between the third and fourth ends, toward the third end.
- an incubator includes more than two pipettes (e.g., 3, 4, 5, 6, 7 8, 9, 10 or more), each of which can be used with a pipette tip as described in this document.
- first and second pipette tips may be configured to transfer first and second volumes, respectively, out of the same cell culture vessel.
- the first and second tips are configured to transfer first and second volumes out of first and second cell culture vessels, respectively.
- this document provides a pipette tip that may be nestable with other pipette tips.
- the nested pipette tips may be compactly stored in a cartridge.
- the pipette tips may be loaded directly onto the pipette via the cartridge.
- the cartridge includes a housing and two or more pipette tips.
- Each pipette tip includes a body defining an inner volume and having first and second ends, the first end arranged to pass a liquid into and out of the pipette tip and the second end arranged for attachment to a pipette, and a bladder sealingly attached to the body.
- the two or more pipette tips are nestable.
- the bladder is disposable within the inner volume.
- this document provides a method of transferring a volume of liquid into or out of a pipette tip having a body defining an inner volume and having first and second ends, the first end arranged to pass a liquid into and out of the pipette tip and a second end arranged for attachment to a pipette, and a bladder sealingly attached to the body.
- the method includes applying a first pressure gradient across the bladder of the pipette tip to cause a volume of liquid to be drawn into the pipette tip via the first end of the body.
- FIGS. 1 and 2 are schematic cross-sectional side views of pipette tips according to some embodiments
- FIG. 3 A is a schematic cross-sectional side view of a pipette tip according to one embodiment
- FIG. 3 B is a schematic illustration of the pipette tip of FIG. 3 A , with a bladder in an extended configuration;
- FIG. 4 A is a schematic cross-sectional side view of a pipette tip according to another embodiment
- FIG. 4 B is a schematic cross-sectional side view of the pipette tip of FIG. 4 A , with a bladder in an extended configuration;
- FIG. 5 A - FIG. 5 E are schematic illustrations of a volume of liquid being transferred into and out of a pipette tip attached to a pipette;
- FIGS. 6 A and 6 B are schematic illustrations of a volume of liquid being transferred into a pipette tip attached to a pipette with a pipette shell;
- FIG. 7 is a schematic of an illustrative embodiment of a cell culture incubator having an imager, a manipulator, and a pipette tip;
- FIGS. 8 - 9 are schematics of illustrative embodiments of cell culture incubators, with FIG. 8 showing a schematic of a cell culture incubator having a second imager and FIG. 6 showing a schematic of a cell culture incubator, wherein the imaging location and the manipulating location are the same location;
- FIG. 10 is a schematic depicting further components of cell culture incubators
- FIGS. 11 A and 11 B are schematic representations of a pipette arranged to apply a pressure to a pipette tip
- FIG. 12 is a schematic representation of nested pipette tips
- FIG. 13 is a schematic representation of a cartridge of pipette tips.
- a pipette may draw a sample of a media containing cells from a first culture vessel and thereafter dispense the sample into a second culture vessel.
- Pipettes may be hand-held, with a user grasping and manipulating the pipette to transfer the measured volume of liquid.
- a user may depress a plunger to create a vacuum and draw a sample of liquid into a pipette tip.
- the pipette may be automated.
- the automated pipette may be used with a controller (e.g., a computer in an incubator) that controls the strength and duration of the applied pressure.
- Applicant has recognized that by providing a pipette tip that may separate a volume of liquid being transferred into the pipette tip from the pipette, various advantages may be Applicant has further recognized that advantages may be realized by providing a pipette tip that may be reusable.
- this document relates to a pipette tip having a body defining an inner volume and having first and second ends, the first end arranged to pass liquid into and out of the pipette tip and the second end arranged for attachment to a pipette, and a bladder sealingly attached to the body.
- the bladder is disposable within the inner volume.
- the bladder is not disposable within the inner volume.
- the bladder may be placed between the transferred liquid and the pipette.
- the bladder may extends from a position between the first and second ends of the body toward the first end of the body.
- the bladder may be attached at the second end and may extend toward the first end of the body, such as when the bladder is in a compressed configuration.
- the inner volume is arranged to accommodate a volume of liquid.
- the bladder may be arranged to accommodate a volume of liquid.
- the bladder may be expandable to accommodate the volume of liquid.
- being sealingly attached to the body means that the bladder is attached to the body such that a seal is formed at the location where the bladder is attached to the body.
- the bladder may be heat sealed, glued, bonded, or otherwise suitably attached to the body to create the seal.
- the bladder may be attached to the body at a periphery of the bladder.
- a volume of transferred liquid may not pass outside of the inner volume at the location where the bladder is attached to the body. In such embodiments, contaminants also may not pass into the inner volume at this attachment location.
- the term “bladder” refers to flexible membrane that is arranged to move (e.g., in response to an applied pressure) to transfer a volume of fluid into and out of the body of the pipette tip body.
- the bladder is arranged to accommodate a volume of liquid that is transferred into the inner volume of the pipette tip body.
- the bladder may include a membranous sac.
- the bladder also may include a substantially planar membrane. As will be appreciated, the bladder may have other suitable arrangements in other embodiments.
- the bladder is arranged to move back and forth when pressure is applied to the pipette tip to transfer the volume of liquid.
- the bladder may be moved in a direction away from the first end of the pipette tip when pressure is applied to the pipette tip to draw a volume of liquid into the inner volume.
- the bladder may be moved toward the first end of the body to expel a volume of liquid from the pipette tip.
- the bladder may be moved into the body of the pipette tip when the volume of liquid is expelled from the pipette tip.
- the bladder may expand and contract to accommodate a volume of liquid.
- the bladder may have a resting volume and an expansion volume, with the bladder expanding from the resting volume to the expansion volume when the pressure is applied to the pipette tip to transfer a volume of liquid into the pipette tip.
- the bladder may accommodate a volume of liquid when in the expanded configuration.
- the bladder is disposed within the body in a collapsed or unformed configuration.
- the membranous sac may be folded into the pipette tip body when the pipette tip is at rest.
- the bladder may expand to form the membranous sac when pressure is applied to the pipette tip.
- the bladder may extend between the first and second ends of the body.
- the bladder may include a planar membrane that is positioned between the first and second ends but does not extend between the first and second ends while at rest.
- the planar membrane may remain substantially perpendicular to a longitudinal axis of the pipette tip.
- the membrane may extend towards the first end of the pipette tip, such as in response to gravity.
- the planar membrane may be moved back and forth in response to an applied pressure to accommodate a volume of liquid.
- the planar membrane in response to an applied pressure, may expand and form a membranous sac.
- the bladder is attached to the second end of the body, with the first end of the body arranged to transfer the volume of liquid into and out of the pipette tip.
- the bladder also may be attached to the first end of the body or to a location in between the first and second ends of the body. In some embodiments, the bladder may be permanently attached or may be removably attached to the pipette body.
- the bladder is arranged to separate the liquid being transferred (e.g., media being transferred from a cell culture vessel) and the pipette or other suitable manipulator arranged to apply a pressure to the pipette tip.
- the extent to which the liquid contacts the bladder depends on the volume of liquid being drawn into the pipette and the pressure being applied to the pipette tip. For example, if only a small volume of liquid is drawn into the pipette, the liquid may only contact the body of the pipette, with the bladder contacting air above the liquid.
- the bladder divides the pipette tip into first and second compartments, the first compartments being in fluid communication with the first end to transfer liquid into and out of the pipette tip and the second compartment being in fluid communication with the second end for receiving an applied pressure, such as a negative pressure.
- a first side of the bladder may be exposed to the first chamber and a second side of the bladder may be exposed to the second chamber.
- the first side of the bladder may be exposed to the liquid being transferred into and out of the pipette tip body while the second side of the bladder is exposed to the pipette.
- the bladder may reduce or even eliminate cross-contamination between the liquid and the pipette by physically separating the liquid from the pipette.
- contaminants may not pass between the pipette (e.g., the piston of the pipette) and the liquid.
- the bladder may be formed of a material that is impermeable to known or possible contaminants.
- the bladder is formed of a membrane that is hydrophobic or treated to be hydrophobic.
- the bladder also may formed of a membrane having a nonporous material or of a material with a porosity less than the size of known or possible contaminants.
- the bladder is formed of a material that traps the contaminants in the membrane wall.
- the membrane may be thick enough to prevent contaminants from reaching the liquid while the pipette is being used, yet still be flexible enough to allow the bladder to be manipulated by the applied pressure.
- the bladder is arranged to separate the liquid from a source of air and/or a vacuum source.
- the bladder also may separate the liquid from other configurations used to apply and remove air to create the vacuum.
- the liquid transfer system may include a pump, compressed air, valves, membranes or other suitable elements that are separated from the transferred liquid.
- the vacuum source may be created by moving (e.g., removing or supplying) a fluid such as air or liquid.
- the pipette may be connected to a liquid supply (e.g., a pump and valve) via one or more fluid conduits.
- a liquid supply e.g., a pump and valve
- other configurations may be used with the pipette tips to create the vacuum.
- a hand-held pipette may be used, with a plunger being depressed to create a vacuum source.
- Such a hand-held pipette may have an embedded pump for creating the vacuum.
- a volume of liquid may be transferred into or out of the pipette tip, such as from the culture vessel into the pipette tip and/or from the pipette tip to a cell culture vessel.
- being transferred, drawn, and/or expelled into or out of the pipette tip may mean that the volume of liquid is transferred, drawn, and/or expelled into or out of the inner volume of the body of the pipette tip. It also may mean that the volume of liquid is transferred, drawn, or expelled into or out of the bladder (e.g., the stretched membrane) as well as the inner volume.
- the applied pressure is a negative pressure that creates a vacuum that is applied to the bladder.
- a negative pressure may mean that there is a negative pressure differential between the air pressure in a container, the pressure of the air in the pipette and/or pipette tip above the bladder, and the air pressure of the environment (e.g., of the atmosphere outside the tip and/or below the bladder).
- the more air that is removed from the pipette and/or pipette tip above the bladder the greater the vacuum force being applied on the bladder.
- the extent of the vacuum depends on the surface tension and volumetric weight of the culture media. Accordingly, these additional factors can affect the pressure differential that is required to draw liquid (e.g., the culture media) into the pipette tip.
- the bladder in response to the applied negative pressure, e.g., a negative pressure applied via a manipulator, such as a pipette, the bladder is moved outside of the inner volume defined by the body.
- a negative pressure applied via a manipulator such as a pipette
- the bladder is moved outside of the inner volume defined by the body.
- being moved outside the body of the pipette tip and/or pipette may mean that the bladder is retracted out of the inner volume defined by the pipette tip body.
- the bladder may move outwardly beyond a plane extending through the second end of the body.
- the bladder is at least partially retracted outside of the body.
- a volume of liquid is drawn into the pipette tip.
- a volume of liquid may be drawn into the bladder.
- the bladder need not extend outside of the body when pressure is applied to the pipette tip to draw a volume of liquid into the inner volume.
- the bladder may be extended but not move outwardly beyond the body.
- the bladder may be moved inside of the body (e.g., towards the first end of the body) in response to an applied pressure.
- the applied pressure is a positive pressure.
- a positive pressure may mean that there is a positive pressure differential between the air pressure in a container, the pressure of the air in the pipette and/or pipette tip above the bladder, and the air pressure of the environment (e.g., of the atmosphere outside the tip and/or below the bladder).
- the bladder when the pressure applied to the bladder is greater than the pressure of the environment, the bladder is moved (e.g., pushed or retracted) back into the body to dispense at least a portion of a volume (e.g., a volume of liquid media) from the pipette tip.
- the pipette tip is arranged to accommodate a volume of liquid.
- at least a portion of the inner volume of the body may be arranged to accommodate the volume of liquid.
- the portion of the inner volume capable of accommodating a liquid may be defined based on the position of the bladder within the body. For example, if the bladder is positioned at a location midway between the first and second ends, the pipette tip may be arranged to accommodate a volume of liquid that is only about half of the total volume of the inner volume.
- the volume of liquid accommodated by the pipette tip also may include a volume of liquid that the bladder is capable of accommodating.
- the volume of the bladder includes a volume enclosed by the membranous sac, such as the expansion volume if the bladders is configured to expand and contract.
- the volume of the membranous sac includes the volume that the membrane is stretched from the resting position to the expanded position (e.g., when the membrane is stretched to take on the shape of a bladder).
- the total volume of liquid accommodated by the pipette tip may be less than or equal to a sum of the volume of the inner volume of the pipette tip body and a volume accommodated by the bladder.
- a pipette tip may have a body that can accommodate 1 ⁇ L of liquid and a bladder that may accommodate up to about 9 ⁇ L.
- the pipette may be configured to accommodate volumes between about 0 ⁇ L and 10 ⁇ L of liquid.
- the may also be made of an elastic material that allows the bladder to expand and accommodate an even larger volume of liquid.
- the pipettes may be configured to accommodate a larger range of volumes of liquid than traditional pipettes (e.g., a typical 1 ⁇ L pipette tip is limited to volumes between 0 ⁇ L and 1 ⁇ L).
- the volume of liquid accommodated by the pipette tip is proportional to an amplitude of the pressure differential (e.g., between the air in the container and the environment) and the duration of the applied pressure. For example, applying a greater negative pressure for a longer period of time may draw a larger volume of liquid into the pipette tip than applying a lesser negative pressure to the bladder for the same time period.
- the bladder may be permanently attached to the pipette tip body (e.g., at the second end).
- the bladder also may be removably attached to the body. For example, the bladder may be snapped into the pipette tip prior to use.
- the liquid transfer device includes a manipulator, such as a pipette, that, in some embodiments, is positioned adjacent the second end of the tip.
- the tip may be removably attached to the manipulator.
- the pipette includes a pipette shell which is disposed inside the pipette to separate the pipette body from the pipette tip.
- the pipette shell may further minimize cross contamination between the pipette and the liquid being drawn into the pipette tip.
- the pipette shell is disposable.
- the pipette shell may be attached to the pipette tip and/or pipette while the liquid is being drawn into the pipette tip and thereafter disposed.
- the pipette shell may be reusable. As will be appreciated, in such embodiments, the pipette shell may be sterilized between uses.
- the pipette shell may be discharged from the pipette while still being attached to the pipette tip.
- the pipette shell may be used for storing the pipette tip and the liquid drawn into the pipette tip.
- a pressure is applied to the pipette tip via the pipette shell.
- the pipette shell may have an opening through which pressure (e.g., air or fluid pressure) is applied.
- the pipette shell may include a valve for regulating the pressure applied to the pipette tip.
- the liquid transfer system also includes a second pipette tip having a second pipette body defining a volume and having first and second ends, and a bladder sealingly attached to the body of the second pipette tip.
- the bladder is disposable in the inner volume of the second pipette tip.
- the bladder may be disposed at a position between the first and second ends, and extend towards the first end (such as when at rest).
- the manipulator may be arranged to apply a pressure to the first and/or second bladders to transfer a second volume of liquid into or out of the first and/or second pipette tips, respectively.
- the first and second volumes are transferred out of the same culture vessel, although the first and second volumes may be transferred out of different culture vessels (e.g., transferring the first volume of liquid out of a first cell culture vessel and transferring a second volume of liquid out of a second cell culture media).
- the pipette tip is reusable. That is, the pipette may be used to transfer two or more volumes of media containing cells from the same culture vessel prior to disposal. The pipette also may be used to transfer volumes of media from two or more culture vessels. In such embodiments, as will be appreciated, the pipette tip may be sterilized (e.g., via treatment with an antiseptic solution) prior to transferring each sample. The pipette tip also may be disposable such that the tip is only used for a single liquid transfer. In these situations, the pipette tip may be removably attached to the pipette.
- the pipette tip may be used to evaluate the volume of the liquid being transferred into the pipette tip. For example, a sample of the volume of liquid in the pipette tip may be subject to further testing to determine the number of cells in the sample, which could be extrapolated to determine the number of cells in the volume of liquid (or in the culture vessel).
- the pipette tip is used in a cell culture incubator having an incubator cabinet with an internal chamber for incubating cells in one or more cell culture vessels.
- the pipette tip may be fluidly coupled to a manipulator that applies a pressure to the bladder (e.g., the formed membranous sac and/or the at rest planar membrane) in the pipette tip body.
- the manipulator may include one or more pipettes arranged to transfer a volume of media comprising the cells into or out of one or more cell culture vessels within the internal chamber.
- the incubator cabinet also has a door opening from an external environment to the internal chamber.
- An imager may be used to image the cells within the internal chamber.
- a cell culture vessel transfer device may be used to move one or more cell culture vessels between locations within the internal chamber.
- an “incubator cabinet” is a housing that includes one or more chambers configured to hold one or more cell culture vessels.
- an incubator cabinet includes a transfer chamber and an internal chamber, one or both of which are configured to hold one or more cell culture vessels.
- an incubator may include one or more other elements such as one or more gas sources (e.g., a compressed gas cylinder or ozone generator), tubing (e.g., to convey one or more liquids or gases such as water, distilled water, deionized water, cell culture medium, air, carbon dioxide, ozone, and oxygen), airflow mechanisms (e.g., valves, release valves, pinholes, gas regulators, and mass flow regulators), pressure mechanisms (e.g., a pump such as a dry scroll pump, rotary pump, momentum transfer pump, diffusion pump, or diaphragm pump; a suction tube; a vacuum system; and an air blower), environmental monitors and controls (e.g., a gas sensor and/or monitor to sense and/or control concentrations of gases such as carbon dioxide, oxygen, and ozone; heat sources or sinks; temperature monitors and controls; humidity monitors; gas scrubbers; air filters; instrumentation for measuring particulate matter; pressure gauges; and flow meters), doors (
- gas sources
- an “internal chamber” is a chamber disposed in an incubator cabinet.
- An internal chamber may include one or more windows (e.g., optical windows made of glass, plastic, composite, or other substantially transparent material for viewing an area inside the incubator cabinet).
- An internal chamber may include at least one door (e.g., for permitting the transfer of items into or out of the internal chamber).
- the at least one door may be disposed between the internal chamber and a transfer chamber.
- an interlock may prevent the door from opening at an undesirable time (e.g., when a portion of the incubator cabinet is open to the surrounding environment so that contaminants cannot enter the internal chamber).
- An internal chamber may be of any appropriate size and geometry.
- an incubator cabinet may include one or more partitions to define different regions of an internal chamber.
- One or more internal chambers or partitions thereof may have different environmental conditions.
- the environment e.g., air pressure, gas content, temperature, light, and humidity
- an internal chamber may have a gas-tight or hermetic seal, e.g., around one or more windows or doors.
- sealants such as grease and/or mechanical elements such as o-rings, gaskets, septa, KF, LF, QF, quick coupling, or other sealing mechanisms may be used to establish one or more gas-tight seals.
- sealants such as grease and/or mechanical elements such as o-rings, gaskets, septa, KF, LF, QF, quick coupling, or other sealing mechanisms may be used to establish one or more gas-tight seals.
- grooves, depressions, protrusions, and/or molded plastic elements may facilitate in establishing one or more gas-tight seals.
- An internal chamber may be made of any useful material.
- an internal chamber may include one or more plastics, polymers, metals, or glasses.
- a “door” is an element that permits communication between two or more environments or regions when opened and prevents communication between the two or more environments or regions when closed.
- a door may be of any type, such as a sliding door, pocket door, swinging door, hinged door, revolving door, pivot door, or folding door.
- the door may be manually, mechanically, or electrically operated. For example, an operator may open or close a door by manually grasping, pulling, pushing, and/or otherwise physically interacting with the door or an element thereof (e.g., a handle) or by operating a mechanical control (e.g., a button, toggle, spin-wheel, key, switch, cursor, screw, dial, screen, or touch-screen).
- a mechanical control e.g., a button, toggle, spin-wheel, key, switch, cursor, screw, dial, screen, or touch-screen.
- a door may be controlled by electrical or digital controls, such as by a computer.
- a door may be an automatically opening door.
- a door may include a sensor, such as a pressure, infrared, motion, or remote sensor, that detects whether the door is open or closed and/or controls when the door opens or closes.
- a door may open by mechanical, pneumatic, electrical, or other means.
- one or more doors may include one or more locking mechanisms.
- one or more doors may include one or more interlocks (e.g., a mechanical interlock such as a pin, bar, or lock or an electrical interlock such as a switch) to prevent one or more doors from opening at an undesirable time (e.g., when one or more chambers are open to the outside environment).
- interlocks e.g., a mechanical interlock such as a pin, bar, or lock or an electrical interlock such as a switch
- a transfer device for moving one or more items may be used to move items between the transfer chamber and the internal chamber.
- the transfer device comprises a conveyor belt or other similar device for maneuvering items.
- items that can be moved by transfer devices include cell culture vessels, pipettes, containers, syringes and other materials and instruments utilized in the culture of cells.
- more than one transfer device may be included.
- one or more transfer devices are located in the transfer chamber and/or in the internal chamber.
- a transfer device may include one or more robotic elements.
- a transfer device may comprise include one or more robotic arms capable of gripping, lifting, pushing, grabbing, sliding, rotating, translating, releasing, raising, lowering, and/or tilting one or more items (e.g., pipettes).
- the transfer device is a cell culture vessel transfer device.
- a “cell culture vessel transfer device” refers to a device that can transfer one or more cell culture vessels from a first location to a second location.
- the transfer device is anchored within the internal chamber.
- the transfer device may transfer one or more items to or from multiple locations in an incubator cabinet.
- a cell culture vessel transfer device may be used to move a cell culture vessel from a transfer chamber to an internal chamber, and/or from a storage location to an imaging location.
- an incubator cabinet includes more than one transfer device for moving one or more items (e.g., separate means for transferring items between and within chambers).
- a cell culture vessel transfer device may include one or more elements such as valves (e.g., electromagnetic or pneumatic valves), gears, motors (e.g., electrical or stepper motors), stages (e.g., xy or xyz stages), pistons, brakes, cables, ball-screw assemblies, rack-and-pinion arrangements, grippers, arms, pivot points, joints, translational elements, or other mechanical or electrical elements.
- a cell culture vessel transfer device may include one or more robotic elements.
- a cell culture vessel transfer device may include a robotic arm capable of gripping, lifting, pushing, grabbing, sliding, rotating, translating, releasing, raising, lowering, and/or tilting one or more cell culture vessels.
- a cell culture vessel transfer device selectively and releasably grips one or more cell culture vessels.
- a cell culture vessel transfer device may include an arm coupled to a mechanical gripper.
- an arm may include a mechanical gripper at or near one end for releasably gripping a cell culture vessel and be securely coupled to a surface or element of the incubator at or near the other end.
- a robotic arm includes a pivot point where the mechanical gripper couples to the arm and one or more pivot and/or translational joints along the arm to permit flexible rotation and translation of a portion of the arm. In this manner, a robotic arm may access one or more cell culture vessels at different horizontal and vertical positions within an incubator cabinet (e.g., within a storage array in an internal chamber).
- a cell culture vessel transfer device is an automated transfer device.
- the automated transfer device may be a robotic arm controlled by a computer that is programmed to move cell culture vessels from a storage location within the internal chamber of the incubator to an imaging location within the internal chamber of the incubator.
- a cell culture vessel transfer device is manually operated.
- a robotic arm located inside the internal chamber of an incubator may be operated by a user-controlled joystick from a location outside of the internal chamber of the incubator in order to move cell culture vessels from a storage location within the internal chamber of the incubator to an imaging location within the internal chamber of the incubator.
- a “cell culture vessel” is a device including a housing and one or more chambers for culturing cells.
- the housing is a frame.
- the frame may be coupled to a lid.
- the one or more chambers may include cell culturing media including one or more membranes.
- a cell culture vessel may include nutrients for promoting the growth of cells.
- a cell culture vessel may entirely enclose one or more cells or groups thereof.
- the housing of a cell culture vessel may include one or more pores or openings to permit the transfer of gases between a cell culture vessel and its surrounding environment.
- Non-limiting examples of cell culture vessels include flasks, suspension culture flasks, spinner flasks, plates, petri dishes and/or bags.
- a cell culture vessel includes a transparent or optically clear window.
- a lid coupled to the housing of a cell culture vessel may include an optically clear portion for viewing cells e.g., with a microscope or other imager.
- a cell culture vessel includes one or more portions that are substantially non-reflective.
- the cell culture vessel is barcoded. Therefore, in some embodiments, the incubator includes a barcode reader.
- cell culture vessels may be pre-kitted with one or more reagents desired for a particular purpose, e.g., for growing cells, for differentiating cells, for subjecting cells to a particular assay condition, etc.
- pre-kitted cell culture vessels contain reagents useful for performing a particular experiment (e.g., cell growth media, growth factors, selection agents, labeling agents, etc.) on a cell culture, in advance of the experiment.
- Pre-kitted cell culture vessels may facilitate experimental protocols by providing cell culture-ready vessels that do not require the addition of reagents.
- progenitor cells from a patient may be added to a cell culture vessel pre-kitted with reagents for cell differentiation for the purpose of expanding a population of differentiated cells for autologous cell therapy.
- Pre-kitted cell culture vessels can be stored at any appropriate temperature, which is determined by the recommended storage parameters of the reagents within the pre-kitted cell culture vessel.
- pre-kitted cell culture storage vessels are stored prior to use at temperatures between about ⁇ 80° C. and about 37° C.
- pre-kitted cell culture storage vessels are stored prior to use at temperatures between about ⁇ 80° C. and about ⁇ 20° C.
- pre-kitted cell culture storage vessels are stored prior to use at temperatures between about ⁇ 20° C.
- pre-kitted cell culture storage vessels are stored prior to use at temperatures between about 4° C. and about 37° C.
- pre-kitted cell culture vessels are disposable.
- pre-kitted cell culture vessels are reusable and/or refillable.
- a “storage location” refers to a location at which one or more cell culture vessels is stored (e.g., within an incubator cabinet). For example, one or more cell culture vessels may be stored at a storage location and later transferred to a different location (e.g., an imaging location). The storage location may be disposed in the internal chamber of the incubator cabinet.
- a storage location may be configured for storing a plurality of cell culture vessels.
- a storage location may include one or more storage arrays, racks, shelves, pigeon-holes, cubbies, trays, slots, or other positions or mechanisms.
- a storage location may be configured to store cell culture vessels horizontally, while in other embodiments it may configured to store cell culture vessels vertically.
- a storage location may include a plurality of slots to receive cell culture vessels stacked vertically over one another.
- a storage location may be configured to hold 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 100, or any other number of cell culture vessels.
- a storage location may be configured to hold greater than 100 cell culture vessels.
- a storage location may include a mechanism for moving one or more storage arrays, racks, shelves, pigeon-holes, cubbies, trays, slots, or other positions or mechanisms.
- a storage location may include one or more motors and movable stages (e.g., an xy or xyz stage) to move a storage rack from one position in an internal chamber to another position in an internal chamber, e.g., to facilitate access to one or more cell culture vessels stored in different locations.
- the incubator cabinet may include one or more cell culture vessel transfer devices for moving one or more cell culture vessels.
- a storage location may be configured to securely hold or receive one or more cell culture vessels.
- one or more components of the storage location may include one or more locking mechanisms that have one or more adhesive, magnetic, electrical, and/or mechanical components (e.g., snaps, fasteners, locks, clasps, gaskets, o-rings, septa, springs, and other engagement members).
- a storage location and/or cell culture vessel may include one or more grooves or depressions and/or may involve pieces of molded plastic.
- a cell culture vessel may include one or more protruded features (e.g., a rim or knob) that are molded for insertion into one or more corresponding grooves, holes, or depressions at a storage location.
- a cell culture vessel may include one or more grooves, holes, or depressions that are molded to fit one or more corresponding protruded features at a storage location.
- an “imager” refers to an imaging device for measuring light (e.g., transmitted or scattered light), color, morphology, or other detectable parameters such as a number of elements or a combination thereof.
- An imager may also be referred to as an imaging device.
- an imager includes one or more lenses, fibers, cameras (e.g., a charge-coupled device camera or CMOS camera), apertures, mirrors, light sources (e.g., a laser or lamp), or other optical elements.
- An imager may be a microscope. In some embodiments, the imager is a bright-field microscope. In other embodiments, the imager is a holographic imager or microscope. In other embodiments, the imager is a fluorescence imager or microscope.
- a “fluorescence microscope” refers to an imaging device which is able to detect light emitted from fluorescent markers present either within and/or on the surface of cells or other biological entities, said markers emitting light at a specific wavelength in response to the absorption a light of a different wavelength.
- a “bright-field microscope” is an imager that illuminates a sample and produces an image based on the light absorbed by the sample. Any appropriate bright-field microscope may be used in combination with an incubator cabinet provided herein.
- a “holographic imager” is an imager that provides information about an object (e.g., sample) by measuring both intensity and phase information of electromagnetic radiation (e.g., a wave front). For example, a holographic microscope measures both the light transmitted after passing through a sample as well as the interference pattern (e.g., phase information) obtained by combining the beam of light transmitted through the sample with a reference beam.
- a holographic imager may also be a device that records, via one or more radiation detectors, the pattern of electromagnetic radiation from a substantially coherent source, diffracted or scattered directly by the objects to be imaged, without interfering with a separate reference beam and with or without any refractive or reflective optical elements between the substantially coherent source and the radiation detector(s).
- an incubator cabinet includes a single imager. In some embodiments, an incubator cabinet includes two imagers. In some embodiments, the two imagers are the same type of imager (e.g., two holographic imagers or two bright-field microscopes). In some embodiments, the first imager is a bright-field microscope and the second imager is a holographic imager. In some embodiments, an incubator cabinet comprises more than 2 imagers. In some embodiments, cell culture incubators comprise three imagers. In some embodiments, cell culture incubators having 3 imagers comprise a holographic microscope, a bright-field microscope, and a fluorescence microscope.
- an “imaging location” is the location where an imager images one or more cells.
- an imaging location may be disposed above a light source and/or in vertical alignment with one or more optical elements (e.g., lens, apertures, mirrors, objectives, and light collectors).
- optical elements e.g., lens, apertures, mirrors, objectives, and light collectors.
- fiducial mark refers to a feature that facilitates alignment of one or more components.
- fiducial marks may include one or more hole apertures over a fluorescent media or printed or embossed fluorescent material.
- fiducial marks may include grids, lines, or symbols.
- one or more cell culture vessels include one or more fiducial marks to facilitate alignment of one or more cell culture vessels with an imager.
- fiducial marks may be associated with moving parts, including transfer devices and robotics devices.
- a cell culture vessel is substantially aligned with an imager. In some embodiments, a cell culture vessel is substantially aligned with an imager via the use of at least one fiducial mark.
- the term “substantially aligned” implies that one or more elements are substantially overlapping, identical, and/or in line with one another.
- the substantial alignment of one or more cell culture vessels at one or more locations may facilitate the analysis of a sample by permitting overlapping images of the cell culture vessel to be obtained. For example, a cell culture vessel may be imaged at a first imaging location by a first imager and subsequently imaged at a second imaging location by a second imager.
- the images recorded by the first and second imagers may be combined (“stitched together”) for analysis.
- One or more fiducial marks present on one or more cell culture vessels may facilitate substantial alignment.
- one or more fiducial marks present at one or more imaging or other locations may facilitate substantial alignment.
- a “manipulator for manipulating cells” refers to a device for manipulating cells in the internal chamber.
- the manipulator may include one or more needles, capillaries, pipettes, and/or micromanipulators.
- the manipulator may include a cell picker.
- a manipulator for manipulating cells may operate by detecting desirable cells or groups thereof present at a first location based on a predetermined criterion and transferring the desired cells or groups thereof from the first location to a second location.
- a cell picker may detect, pick, and/or transfer desirable or undesirable (e.g., pre-differentiated cell weeding) cells or groups thereof based on a manual or automated analysis.
- information produced by an imager may be analyzed to detect desirable or undesirable cells.
- the cell picker may then transfer the desirable or undesirable cells to the second location.
- an imager may image cells in or on a cell culture vessel at an imaging location, and the image used to identify desirable or undesirable cells or groups thereof.
- the cell picker may then transfer the desirable or undesirable cells, e.g., by contacting each desired cell or cells with a needle, capillary, pipette, or micromanipulator and effecting a movement of the cell or cells, from their first location to a second location in or on the cell culture vessel or elsewhere in the internal chamber.
- the first location of the cells may be in or on a cell culture vessel.
- a cell picker transfers cells from a first location in or on a cell culture vessel to a second location on the same cell culture vessel. In other embodiments, a cell picker transfers cells from a first location in or on a first cell culture vessel to a second location in or on a second cell culture vessel. In certain other embodiments, a cell picker transfers cells from a first location in or on a cell culture vessel to a second location in the internal chamber that is not in or on a cell culture vessel.
- the manipulator includes at least one microelectrode.
- the term “microelectrode” refers to an electrical conductor used to deliver electrical stimulation to a cell.
- microelectrodes can be used to deliver genetic material into a cell by electroporation.
- the manipulator includes at least one microinjector.
- microinjectors are glass micropipettes that have been pulled to form a sharp, hollow structure capable of piercing the membrane of a cell and serving as a conduit for the introduction of genetic material into the cell.
- a manipulator is manually operated.
- a manipulator having a cell picker located inside the internal chamber of an incubator cabinet may be electronically-linked to and controlled by a user-directed joystick located outside the internal chamber of the incubator cabinet.
- the user-directed joystick is connected to a display device.
- the display device shows images captured by an imaging device inside the internal chamber of the incubator cabinet.
- a manipulator is automated.
- a manipulator inside an internal chamber of an incubator cabinet may be electronically connected to a controller outside of the incubator cabinet, which is electronically connected to a computer that directs the manipulator.
- the controller may instruct the manipulator to apply a vacuum to one or more pipette tips fluidly connected to the manipulator.
- One or more elements of the manipulator for manipulating cells may be sterilized, for example using a sterilizing composition or method (e.g., ethanol or ozone gas, UV Light, Hydrogen peroxide), prior to manipulation.
- a sterilizing composition or method e.g., ethanol or ozone gas, UV Light, Hydrogen peroxide
- manipulation location refers to the location at which cells are manipulated by a manipulator for manipulating cells (e.g., a cell picker). In certain embodiments, the manipulation location may be the same as the imaging location.
- the cell culture incubator includes an incubator cabinet with an imaging location and a manipulating location.
- Cells of a cell culture vessel are imaged at the imaging location by an imager and manipulated at the manipulating location by a manipulator.
- the imaging location and the manipulating location are two distinct locations within the incubator cabinet.
- the cell culture incubator may include a transfer device that moves cell culture vessels between the imaging location and the storage location.
- the imaging location and the manipulating location are the same, such that the cells of culture vessels are imaged at the manipulation location.
- an imager may be used in conjunction with a manipulator.
- an imager may image cells in or on a cell culture vessel at an imaging location, and the image used to identify desirable cells or groups thereof.
- the cell picker which may or may not be resident at the imaging location, may then transfer the desirable or undesirable cells, e.g., by contacting each desired cell or cells with a needle, capillary, pipette, or micromanipulator and effecting a movement of the cell or cells, from their first location to a second location in or on the cell culture vessel or elsewhere in the internal chamber.
- a cell picker transfers cells from a first location in or on a cell culture vessel to a second location on the same cell culture vessel.
- a cell picker transfers cells from a first location in or on a first cell culture vessel to a second location in or on a second cell culture vessel. In certain other embodiments, a cell picker transfers cells from a first location in or on a cell culture vessel to a second location in the internal chamber that is not in or on a cell culture vessel.
- a single location within the incubator cabinet may serve as an imaging location and a manipulating location.
- cells are imaged as they are manipulated by the manipulator.
- the imaging location and imaging location may be at separate locations within the incubator cabinet.
- the manipulator includes sensors that allow it to report its position and determine when it has touched the bottom of the cell culture vessel.
- an imager may be used to guide the manipulator in order to achieve repeatability and accuracy.
- compliance e.g., springiness
- the manipulator may be used to relax the need for extreme mechanical accuracy.
- one or more manipulators are used to manipulate one or more pipettes as described in this document. In some embodiments, manipulators are used to place and/or remove pipette tips on the pipettes.
- FIG. 1 illustrates a pipette tip ( 50 ) according to one aspect of the present document.
- the pipette tip ( 50 ) includes a body ( 52 ) defining an inner volume and having first and second ends ( 56 , 54 ).
- the pipette tip ( 50 ) also includes a bladder ( 58 ) disposed within the inner volume of the body ( 52 ).
- the bladder ( 58 ) is defined by a membranous sac, formed by a membrane ( 60 ), that extends towards the first end ( 56 ).
- the second end ( 54 ) of the pipette tip ( 50 ) is arranged to be attached (e.g., removably attached) to a pipette (see FIG. 5 ).
- the first end ( 56 ) is the exit end of the body ( 52 ).
- the first end ( 56 ) may be configured to transfer a volume of liquid into and out of the pipette tip ( 50 ), such as into and out of the inner volume of the body ( 52 ).
- the bladder ( 58 ) may be defined by a planar membrane ( 60 ) that is substantially perpendicular to a longitudinal axis A of the pipette tip ( 50 ). As will be appreciated, in some embodiments, at least a portion of the membrane ( 60 ) may extend towards the first end ( 56 ) of the body in response to gravity. In some embodiments, in response to an applied pressure, the planar membrane ( 60 ) may move back and forth. In some embodiments, in response to the applied pressure, the planar membrane ( 60 ) may expand and contract. For example, the bladder ( 58 ) may expand from the planar membrane ( 60 ) shown in FIG. 2 to the membranous sac shown in FIG. 1 .
- the bladder ( 58 ) may be attached to the second end ( 54 ) of the body ( 52 ) and extend towards the first end ( 56 ) of the body. In such embodiments, the bladder ( 58 ) may be attached to the body ( 52 ) at a periphery of the bladder ( 58 ). In some embodiments, the bladder may be sealingly attached to the body ( 52 ) such that a fluid tight seal is formed between the body ( 52 ) and the bladder ( 58 ). In such embodiments, as will be described, liquid may not travel beyond the bladder, at the location where the bladder is attached to the body, and contaminants may not travel into the inner volume.
- the bladder ( 58 ) is attached to the second end ( 54 ) in the embodiment shown in FIG. 1
- the bladder ( 58 ) may be attached to another suitable location of the body.
- the bladder ( 58 ) may be attached to a location in between the first and second ends ( 56 , 54 ) of the body ( 52 ).
- the bladder ( 58 ) may still extend towards a first end ( 56 ) of the body ( 52 ).
- the bladder ( 58 ) may extend only part of the way toward the first end ( 56 ) of the body, while in other embodiments, the bladder may extend to a position at or near the first end ( 56 ) of the body. As shown in FIG. 4 A , in still another embodiment, the bladder ( 58 ) may be attached at or near the first end ( 56 ) of the body ( 52 ).
- the bladder ( 58 ) divides the body ( 52 ) into two chambers ( 62 , 64 ).
- the first chamber ( 62 ) is in fluid communication with the first end ( 56 ) of the pipette tip, e.g., where the liquid is transferred into and out of the body
- the second chamber ( 64 ) is in fluid communication with the second end of the body ( 54 ).
- the second chamber ( 64 ) also may be in fluid communication with a pipette (see, e.g., FIG. 5 A ) for receiving an applied pressure (e.g., a negative pressure, as described in this document).
- a first side of the bladder may be exposed to the transferred liquid while a second, opposite side of the bladder may be exposed to the pipette.
- the bladder ( 58 ) may separate the pipette from the transferred liquid.
- the bladder may separate the culture media transferred into the pipette tip from the pipette ( 66 ). Such separation may reduce or even eliminate contamination between the pipette and the media in such embodiments
- the bladder ( 58 ) is permanently attached to the body ( 52 ) of the pipette tip ( 50 ).
- the bladder ( 58 ) may be bonded, glued, fastened, or otherwise attached, to the pipette tip.
- the bladder ( 58 ) also may be ultrasonically welded to the pipette tip.
- the bladder ( 58 ) may be removably attachable to the pipette tip ( 50 ).
- the bladder ( 58 ) may be snapped onto the body ( 52 ) of the pipette tip ( 50 ) prior to use (e.g., prior to transferring the volume of liquid into or out of the pipette tip).
- such attachment methods may form a fluid tight seal between the bladder and the body.
- the bladder ( 58 ) is formed of a membrane made of a strong yet flexible material.
- the bladder ( 58 ) may be arranged to expand and contract to accommodate the volume of liquid.
- the bladder ( 58 ) also may be moved between a position inside of the body to a position outside of the body to accommodate the volume of liquid.
- the bladder ( 58 ) may have elastomeric properties.
- the bladder ( 58 ) also may be formed of a membrane ( 60 ) made of organic and/or inorganic materials.
- the bladder ( 58 ) includes a polymeric structure.
- the bladder ( 58 ) includes a latex material.
- the bladder ( 58 ) is arranged to retain the liquid within the bladder ( 58 ).
- the bladder may be formed of a membrane ( 60 ) that is non-porous and/or liquid impermeable.
- the membrane may be made of a hydrophobic material or may be treated to be hydrophobic. As will be appreciated, such characteristics of the membrane may prevent the transferred liquid from passing from the pipette tip into the pipette, which may contaminate the pipette (and future samples).
- the bladder ( 60 ) may include a smooth surface. In some embodiments, the bladder ( 58 ) does not include folds, while in other embodiments, the bladder may include folds.
- the bladder ( 58 ) may include a convex configuration when the bladder is at rest (e.g., there is no applied pressure).
- the bladder may have a curved configuration below a plane X that extends through the periphery of the bladder.
- at least a portion of bladder may move on the other side of the plane X in response to an applied pressure.
- the bladder may take on a concave configuration above the plane X in response to an applied pressure.
- the pipette tip ( 50 ) is configured to transfer a range of volumes of a liquid (e.g., from about 1 ⁇ L to about 10 mL, or more, of liquid).
- the pipette tip ( 50 ) may be configured to transfer culture media between a culture vessel and the pipette tip and back to the culture vessel or to another culture vessel.
- a manipulator such as a pipette ( 66 ) (see FIG. 5 A ), may be configured to apply a pressure to the pipette tip to transfer the desired volume(s) of liquid into and out of the pipette tip.
- a controller may be programmed to instruct the pipette ( 66 ) transfer the desired volume(s) of liquid into the pipette tip.
- the volume of liquid accommodated by the pipette tip is proportional to the pressure applied to the bladder. That is, the volume of liquid drawn into (or dispensed out of) the pipette tip is dependent on the amplitude of the pressure differential (e.g., between air in the container and the environment) and the duration of the applied pressure. For example, applying a greater negative pressure for a longer period of time will draw a larger volume of liquid into the pipette tip than applying a lesser negative pressure to the bladder for the same time period.
- the pipette ( 66 ) may be instructed (e.g., via human intervention or via a controller) to apply a pressure to the bladder for the period of time corresponding to the desired volume of liquid.
- the bladder ( 58 ) and/or pipette tip ( 50 ) may comprise a plastic material.
- the bladder ( 58 ) may include a polyurethane and/or silicone material.
- the pipette tip ( 50 ) comprises a polycarbonate, polypropylene, polyethylene, and polystyrene material, although other suitable materials may be used.
- the pipette tip ( 50 ) may have a frusto conical shape, although other suitable shapes may be used (e.g., a cylindrical shape).
- FIGS. 5 A- 5 E illustrate embodiments of the pipette tip ( 50 ) being used to transfer a volume of liquid, such as a volume of media containing cells ( 68 ), into and out of the pipette tip ( 50 ).
- FIG. 5 A shows the pipette tip ( 50 ) attached to a pipette ( 66 ).
- the bladder ( 58 ) has divided the pipette tip into two chambers ( 62 , 64 ), with the first chamber ( 62 ) being in fluid communication with the first end ( 56 ) of the body ( 52 ) and the second chamber ( 64 ) being in fluid communication with the second end ( 54 ) of the body and with the pipette ( 66 ).
- the bladder may separate the media culture from the pipette.
- the second chamber ( 64 ) is arranged to receive first and second applied pressures to transfer a volume of liquid into and out of the pipette tip ( 50 ), respectively.
- the first end ( 56 ) of the pipette tip 50 is inserted into media ( 68 ) containing cells stored in a culture vessel ( 70 ).
- the bladder ( 58 ) when the pipette tip ( 50 ) is first attached to the pipette ( 66 ) and no pressure has been applied to the bladder ( 58 ), the bladder ( 58 ) is disposed inside of the body ( 52 ) and extends from the second end ( 54 ) towards the first end ( 56 ). As with other embodiments, in this at-rest position, the bladder extends below the plane X extending through the periphery. As shown in FIG.
- the media ( 68 ) in response to the applied pressure, has been drawn in to the body ( 52 ) and into the bladder ( 58 ) of the pipette tip ( 50 ). As will be appreciated, in other embodiments, the media ( 68 ) may be drawn into only one of the bladder ( 58 ) and the body ( 52 ). As described in this document, the level of media drawn into the pipette tip body ( 52 ) and/or bladder ( 58 ) depends on the applied pressure and the duration of applied pressure.
- the first pressure P 1 applied to the bladder ( 58 ) may be a negative pressure. As described in this document, such a negative pressure may create a vacuum that is applied to the bladder ( 58 ), thus causing the bladder ( 58 ) to retract out of the body ( 52 ) to draw the media ( 68 ) into the pipette tip ( 50 ).
- the bladder ( 58 ) may be been completely retracted out of the body ( 52 ) of the pipette tip ( 50 ) and into a body ( 72 ) of the pipette ( 66 ). In other embodiments, the bladder ( 58 ) may be only partially retracted into the pipette body ( 72 ). In still other embodiments, as shown in FIGS. 3 B and 4 B , the bladder need not be retracted out of the pipette tip body when a pressure is applied.
- the movement of the bladder with respect to the body of the pipette tip may be determined based on the position in which the bladder is attached to the body of the pipette tip, the size and stretchability of the bladder, and the applied pressure.
- a substantially planar membrane may be attached at the second end of the pipette tip body but not be moveable out of the pipette tip body (e.g., beyond the plane extending through the second end of the pipette tip body.
- the bladder may be positioned midway between the first and second ends. In such embodiments, even with the bladder moving and/or expanding, the bladder does not move out of the inner volume of the pipette tip.
- the bladder may extend outwardly beyond the first end of the pipette tip body when the bladder is in an at-rest position.
- the bladder in embodiments in which the bladder is retracted out of the pipette tip body, the bladder may be arranged to accommodate a volume of liquid.
- the volume of accommodated liquid in the bladder may be less than or equal to the volume V 1 of the bladder.
- the exact volume of accommodated liquid in the bladder may vary depending on the pressure exerted on the pipette tip and the amount to which the bladder is extracted outwardly beyond the pipette tip body.
- the pipette tip ( 50 ) may be configured to accommodate a volume of liquid.
- the volume of accommodated liquid may be less than or equal to a sum of the volume V 1 of the bladder ( 58 ) and a volume V 2 of the body ( 52 ) of the pipette tip ( 50 ).
- the volume of the body of the pipette tip ( 50 ) is defined as the volume of between the first end ( 56 ) of the body ( 52 ) and the location where the bladder ( 58 ) is attached to the body (see, e.g., the line labeled X, a plane extending through the periphery of the bladder).
- the volume V 2 of the body is defined as the volume between the first and second ends ( 56 , 54 ).
- the volume may be defined as a volume between the first end a the plane extending through the periphery of the bladder, at an intermediate location.
- the volume of the bladder is defined as the volume enclosed by the membrane ( 60 ) attached to the body ( 52 ). That is, the volume of the bladder ( 58 ) may include the volume between the membrane ( 60 ) in the moved/expanded configuration and the location to which the bladder is attached to the body (e.g., the plane extending through the periphery).
- the volume of media ( 68 ) drawn into the pipette tip ( 50 ) need not fill the entire volume defined by the sum of the volumes of the bladder and the pipette tip body.
- the volume of the liquid may be less than the sum of the volume of the body and the volume of the bladder in some embodiments. In some embodiments, however, the entire volume may be accommodated by the media.
- the media ( 68 ) may then be transferred out of the pipette tip ( 50 ) and back to the same culture vessel ( 70 ).
- the media ( 68 ) also may be transferred to a another culture vessel ( 70 ).
- a second pressure P 2 may be applied to the bladder to move the bladder towards the first end ( 56 ) of the body ( 52 ) (see arrow), thus expelling the media from the pipette tip.
- the entire volume of media need not be expelled from the pipette tip.
- the steps shown in FIGS. 5 B- 5 D may be repeated with the same pipette tip ( 50 ) and culture vessel ( 70 ). Once the transfer(s) have been finished, the pipette tip ( 50 ) may be removed from the pipette ( 66 ), as shown in FIG. 5 E . In embodiments in which the pipette tip ( 50 ) is reused with different culture vessels, the pipette tip ( 50 ) may be sterilized prior to repeating the steps shown in FIGS. 5 B- 5 D with the new culture vessel. As will be appreciated, the pipette tip ( 50 ) also may be disposed after each liquid transfer, with a fresh pipette tip ( 50 ) being attached to the pipette ( 66 ).
- the pipette tips may be used to transfer other types of fluids (e.g., air or water).
- the pipette tip ( 50 ) is removed from the pipette ( 66 ) by pulling the pipette tip ( 50 ) away from the pipette ( 66 ), (see the arrow in FIG. 5 E ).
- the pipette ( 66 ) may have an ejection button (not shown) to eject the pipette tip ( 50 ) from the pipette ( 66 ).
- FIGS. 5 A- 5 E illustrate a bladder ( 58 ) being moved (e.g., retracted) into and out of the pipette tip
- the first and second pressures P 1 , P 2 may be used to expand and contract the bladder to draw in and dispense the liquid from the bladder.
- the bladder may be expanded into the body ( 72 ) of the pipette ( 66 ).
- FIGS. 5 A- 5 E include a bladder defined by a membranous sac
- the same steps may be repeated with a pipette tip ( 50 ) having a bladder ( 58 ) defined by a planar membrane.
- the first pressure P 1 may be used to move the membrane back and forth.
- the first pressure P 1 may be used to stretch the planar membrane into the membranous sac, which is thereafter used to accommodate the volume of liquid.
- the second pressure P 2 also may be used to move the stretched bladder back into the body of the pipette tip ( 50 ) to dispense the liquid from the pipette tip ( 50 ) and return the membranous sac to the planar membrane configuration.
- FIGS. 5 A- 5 E show the pipette tip ( 50 ) being attached directly to the pipette ( 66 ), with the bladder ( 58 ) being retractable into the body ( 72 ) of the pipette ( 66 ), in other embodiments, the pipette tip ( 50 ) may be further separated from the pipette ( 66 ).
- the pipette may include a pipette shell ( 74 ) that is disposed within the body ( 72 ) of the pipette ( 66 ) and arranged to receive the bladder ( 58 ) in response to an applied pressure. In such an embodiment, as shown in FIG.
- the pipette shell ( 74 ) may include a body ( 76 ) into which the bladder ( 58 ) is retracted in response to the first pressure P 1 .
- the body ( 76 ) of the pipette shell ( 74 ) may be greater than or equal to the volume V 1 of the bladder ( 58 ).
- the pipette shell ( 74 ) is removably attachable to the pipette ( 66 ) and/or the pipette tip ( 50 ).
- the pipette shell ( 74 ) may be attached to the pipette ( 66 ) and/or pipette tip ( 50 ) prior to attaching the pipette tip ( 50 ) to the pipette ( 66 ) and drawing a volume of liquid into the pipette tip ( 50 ).
- the pipette tip ( 50 ) may be separated from the pipette shell ( 74 ) after the liquid has been drawn into and out of the pipette tip ( 50 ). In other embodiments, the pipette shell ( 74 ) may remain attached to the pipette tip ( 50 ) after the pipette tip ( 50 ) has drawn the liquid into the pipette tip ( 50 ). In such embodiments, the liquid sample may be stored with the pipette tip.
- the pipette shell ( 74 ) may be arranged to maintain the pressure applied to the pipette tip ( 50 ) after the pipette tip ( 50 ) has been separated from pipette ( 66 ) so that the pipette tip ( 50 ) may be stored in an upright position.
- the pipette tip ( 50 ) and pipette shell ( 74 ) may be inverted, with pipette shell ( 74 ) serving as storage for the retracted bladder (with the liquid sample).
- a cover (not shown) may be attached to the pipette tip ( 50 ) for storing the liquid sample.
- the pipette shell ( 74 ) includes a pressure applicator ( 78 ) that is configured to allow the pressure to be applied to the pipette tip (e.g., via the pipette ( 66 )).
- the pressure applicator ( 78 ) includes an opening in the pipette shell ( 74 ) through with the pressure may be applied to the bladder.
- the pressure applicator ( 78 ) may include a valve for regulating the applied pressure (e.g., a negative pressure) to the bladder.
- the pipette shell may be made of a similar material as the pipette tip and bladder.
- the pipette shell may be made of a plastic material.
- the pipette shell may be made of a rigid material, thus allowing the pipette shell to rest stably on a surface after an attached pipette tip and pipette shell are inverted.
- the pipette shell ( 74 ) may be disposable, although the pipette shell ( 74 ) also may be reusable. In embodiments in which the pipette shell is reusable, the pipette shell may be sterilized in between uses.
- FIG. 7 illustrates an embodiment in which the pipette tip ( 50 ) is used in a cell culture incubator.
- the cell culture incubator includes an incubator cabinet having an internal chamber ( 100 ) for incubation of cells in one or more cell culture vessels.
- the incubator cabinet includes an external door ( 101 ) that opens and closes to permit communication between an external environment and the incubator cabinet.
- the external door opens and closes to permit communication between an external environment and the internal chamber.
- the internal chamber is configured to hold one or more cell culture vessels.
- the one or more cell culture vessels are stored in a storage location ( 102 ). In some embodiments, the storage location is a free-standing structure.
- a storage location may be a test tube or culture flask rack that can be removed from the internal chamber of the incubator for loading and unloading of culture vessels.
- the storage location is affixed to a surface of the internal chamber.
- the storage location may be a series of racks or shelves that are connected to the walls or floor of the internal chamber and are thus not able to be removed from the incubator cabinet.
- the cell culture incubator includes a cell culture vessel transfer device ( 103 ) for moving one or more cell culture vessels.
- the cell culture transfer device may be affixed to any appropriate surface of the internal chamber of the incubator.
- the cell culture vessel transfer device may be affixed to the top or ceiling of the internal chamber.
- the cell culture vessel transfer device may be affixed to a side wall of the internal chamber.
- the cell culture vessel transfer device is not affixed to the wall of the internal chamber.
- the cell culture vessel transfer device may rest on a wheeled tripod or other mobile structure that can be moved around the internal chamber.
- the transfer device moves one or more cell culture vessels from a storage location ( 102 ) to an imaging location ( 105 ) or to a manipulation location ( 107 ).
- the transfer device ( 103 ) can also move one or more cell culture vessels from an imaging location ( 105 ) to a manipulation location ( 107 ) or from a manipulation location ( 107 ) to an imaging location ( 105 ).
- the transfer device ( 103 ) moves one or more cell culture vessels from an imaging location ( 105 ) or a manipulation location ( 107 ) to a storage location ( 102 ).
- the incubator cabinet includes a first imaging location ( 105 ) and a manipulation location ( 107 ).
- one or more imaging locations are located on a surface of the internal chamber opposite from an imager.
- imaging locations are platforms, either free-standing or affixed to a surface of the internal chamber.
- the platform is movable.
- a movable platform may be affixed to two or more rods that allow the platform to be moved left, right, forward, backward, up or down in relation to an imager.
- the movable platform is motorized.
- the incubator cabinet includes a first imager ( 104 ) that images the cells of cell culture vessels when the vessels are at the first imaging location ( 105 ).
- the first imager is a bright-field microscope.
- the first imager is a holographic microscope.
- a manipulator manipulates the cells of cell culture vessels when the vessels are at the manipulation location ( 107 ).
- the manipulator has an array of needles, capillaries, pipettes, and/or micromanipulators.
- the manipulator may include a cell picker.
- a manipulator has a cell picker.
- manipulation locations share many characteristics with imaging locations, as described herein.
- the manipulator ( 106 ) may be in fluid communication with two of the disclosed pipette tips ( 50 ) for transferring a volume of media containing cells into and out of the pipette tips ( 50 ).
- the manipulator ( 106 ) may be in fluid communication with only one pipette tip in some embodiments or with three or more pipette tips in other embodiments.
- the manipulator may be in fluid communication with an array of pipette tips.
- the manipulator may apply first and second pressures to manipulate the bladder (e.g., move, retract, expand, contract or stretch).
- FIG. 8 depicts another illustrative embodiment of a cell culture incubator.
- the incubator cabinet has a second imager ( 108 ).
- the second imaging location may be at or near the manipulation location ( 107 ).
- the second imaging location and the manipulation location ( 107 ) are the same location.
- a second imager ( 108 ) images the cells of cell culture vessels while the cells are manipulated by the manipulator ( 106 ).
- the second imager is a bright-field microscope.
- the second imager is a holographic microscope.
- FIG. 9 depicts an illustrative embodiment of a cell culture incubator.
- the cell culture incubator has an imaging location and a manipulation location that are the same location ( 105 ).
- the manipulator ( 106 ) may be in fluid communication with one or more pipette tips ( 50 ) for transferring the volume of media containing cells into and out of the pipette tip(s).
- FIG. 10 depicts illustrative embodiments of further components of a cell culture incubator.
- further components are any component of the incubator that is not otherwise listed or show in one of the previous embodiments or figures.
- a cell culture incubator contains barcoded cell culture vessels ( 109 ).
- a cell culture incubator has a barcode scanner ( 110 ) located inside the internal chamber of the incubator cabinet.
- the barcode reader communicates with a computer ( 111 ) to relay information about the cell culture vessel for which the barcode has been scanned.
- a barcode scanner may be affixed to any surface of the internal chamber.
- a barcode scanner can be affixed to a wall of the internal chamber in close proximity to an imaging location ( 105 ).
- the cell culture incubator contains at least one probe and/or at least one sensor ( 113 ) that measures environmental conditions within the internal chamber.
- probes to measure environmental conditions include but are not limited to temperature probes, pressure probes, carbon dioxide (CO 2 ) sensors, oxygen (O 2 ) sensors and relative humidity sensors.
- the at least one probe and/or at least one sensor located within an instrument housing ( 112 ).
- the at least one probe and/or at least one sensor is connected to a controller ( 114 ).
- the controller ( 114 ) communicates with a computer ( 111 ). Additionally, the controller ( 114 ) may communicate with a fluid dispensing system ( 115 ).
- the controller ( 114 ) may direct the fluid dispensing system ( 116 ) to inject CO 2 gas into the internal chamber in order to increase the CO 2 level of the internal chamber.
- the controller ( 114 ) also may communicate with the manipulator ( 106 ) to transfer a volume of liquid into and out of the pipette tip ( 50 ).
- the controller may instruct the manipulator ( 106 ) to position the pipette tip into a cell culture vessel.
- the controller may instruct the manipulator to apply a first pressure (e.g., a negative pressure) to the second end ( 54 ) of the pipette tip ( 50 ) (e.g., to the membrane ( 60 ) to draw a volume of media containing the cells of the cell culture into the body of the pipette and/or into the bladder ( 58 ).
- a first pressure e.g., a negative pressure
- the controller ( 114 ) may thereafter instruct the manipulator ( 106 ) to apply a second pressure to the second end of the pipette tip ( 50 ) to expel the volume of media from the pipette tip ( 50 ).
- a second pressure e.g., air pressure
- the bladder ( 58 ) may be moved back into the pipette tip ( 50 ) to dispense a volume of liquid from the pipette tip ( 50 ).
- the bladder is arranged to separate the liquid in the pipette tip ( 50 ) from a source of air and/or a vacuum source.
- the bladder may separate the liquid from a pump ( 80 ) in the body ( 72 ) of the pipette ( 66 ).
- the pump ( 80 ) is used to apply the pressure to the bladder ( 58 ).
- the bladder ( 58 ) may separate the liquid from a liquid conduit ( 82 ) that applies the pressure to the bladder ( 58 ).
- the liquid conduit ( 82 ) may be connected to a valve ( 84 ), a pump ( 86 ) and a supply ( 88 ) of pressurized air or fluid, which regulate and apply the pressure that is applied to the bladder ( 58 ).
- a valve ( 84 ) may be connected to a pump ( 86 ) and a supply ( 88 ) of pressurized air or fluid, which regulate and apply the pressure that is applied to the bladder ( 58 ).
- a pump 86
- a supply ( 88 ) of pressurized air or fluid which regulate and apply the pressure that is applied to the bladder ( 58 ).
- either the system may be used in the cell culture incubator.
- the membrane may form other structures suitable for separating the liquid from the pipette and for allowing the pipette tip to be reused.
- the pipette tips ( 50 ) may be nestable.
- a first pipette tip ( 50 a ) may be nested in a second pipette tip ( 50 b ), which, in turn, may be nested in a third pipette tip ( 50 c ).
- the nested pipette tips may be compactly stored in a housing ( 90 ) of a cartridge ( 92 ), such as that shown in FIG. 13 .
- the cartridge ( 92 ) may be used to load the pipette tip ( 50 ) onto the pipette. As shown in FIG.
- the pipette ( 66 ) may be moved towards the cartridge until the pipette is aligned with the pipette tip ( 50 ).
- the pipette may then be pressed downwardly towards the stack of pipette tips (see arrow labeled D) until the first or top pipette tip ( 50 a ) is attached to the pipette ( 66 ) (e.g., via a snap fit attachment).
- a loading process may be performed manually or may be automated.
- the cartridge shows three nested pipette tip ( 50 ), the cartridge may have more or fewer pipette tips in other embodiments. As will be further appreciated, while the pipette tips may be nested within the cartridge, the pipette tips may have other arrangements.
- incubators and methods for culturing, manipulating, and/or monitoring cells under controlled conditions (e.g., under aseptic and/or sterile conditions).
- incubators and methods include automated components.
- incubators and methods are useful for long term cell culture (e.g., to grow and maintain cells for recombinant protein expression or to grow and/or differentiate cells for therapeutic applications such as implantation) .
- cell cultures are grown within a culture vessel in an incubator described herein.
- Cell culture vessels may be configured for culturing cells of different types, including eukaryotic or prokaryotic cells.
- cells are mammalian cells (e.g., human cells, canine cells, bovine cells, ovine cells, feline cells, or rodent cells such as rabbit, mouse, or rat cells).
- cells are insect cells, avian cells, microbial cells (e.g., yeast cells such as Saccharomyces cerevisiae, Kluyveromyces lactis, or Pischia pastoris cells, or bacterial cells such as Escherichia coli, Bacillus subtilis, or Corynebacterium cells), insect cells (e.g., Drosophila cells, or Sf9 or Sf21 cells), plant cells (e.g., algal cells) or cells of any other type.
- microbial cells e.g., yeast cells such as Saccharomyces cerevisiae, Kluyveromyces lactis, or Pischia pastoris cells, or bacterial cells such as Escherichia coli, Bacillus subtilis, or Corynebacterium cells
- insect cells e.g., Drosophila cells, or Sf9 or Sf21 cells
- plant cells e.g., algal cells
- cells are cultured for producing natural products (e.g., taxols, pigments, fatty acids, biofuels, etc.).
- cells are cultured to express recombinant products (e.g., recombinant protein products such as antibodies, hormones, growth factors, or other therapeutic peptides or proteins).
- recombinant products e.g., recombinant protein products such as antibodies, hormones, growth factors, or other therapeutic peptides or proteins.
- cells are expanded and/or differentiated for therapeutic use such as implantation into a subject (e.g., a human subject) in order to provide or supplement a cellular, tissue, or organ function that is missing or defective in the subject.
- cells are from immortalized cell lines.
- cell lines include human cells, for example, HeLa cells, prostate cancer cells (e.g., DU145, PC3 and/or Lncap cells), breast cancer cells (e.g., MCF-7, MDA-MB-438, and/or T47D cells), acute myeloid leukemia cells (e.g., THP-1 cells), glioblastoma cells (e.g., U87 cells), neuroblastoma cells (e.g., SHSY5Y cells), bone cancer cells (e.g., Saos-2 cells) and chronic myelogenous leukemia cells (e.g., KBM-7 cells).
- human cells for example, HeLa cells, prostate cancer cells (e.g., DU145, PC3 and/or Lncap cells), breast cancer cells (e.g., MCF-7, MDA-MB-438, and/or T47D cells), acute myeloid leukemia cells (e.g., THP-1 cells), glioblastom
- cell lines include primate cell lines, rodent cell lines (e.g., rat or mouse cell lines), canine cell lines, feline cell lines, Zebrafish cell lines, Xenopus cell lines, plant cell lines, or any other cell.
- cells are human 293 cells (e.g., 293-T or HEK 293 cells), murine 3T3 cells, Chinese hamster ovary (CHO) cells, CML T1 cells, or Jurkat cells.
- cells are primary cells, feeder cells, or stem cells.
- cells are isolated from a subject (e.g., a human subject).
- cells are primary cells isolated from a tissue or a biopsy sample.
- cells are hematopoietic cells.
- stem cells e.g., embryonic stem cells, mesenchymal stem cells, cancer stem cells, etc.
- cells are isolated from a tissue or organ (e.g., a human tissue or organ), including but not limited to, solid tissues and organs.
- cells can be isolated from placenta, umbilical cord, bone marrow, liver, blood, including cord blood, or any other suitable tissue.
- patient-specific cells are isolated from a patient for culture (e.g., for cell expansion and optionally differentiation) and subsequent re-implantation into the same patient or into a different patient.
- cells grown in the incubators described herein may be used for allogenic or autogeneic therapy.
- cells grown in the incubators disclosed herein may be genetically modified, expanded and reintroduced into a patient for the purpose of providing an immunotherapy (e.g., chimeric antigen receptor therapy (CAR-T), or delivery of CRISPR/Cas modified cells).
- an immunotherapy e.g., chimeric antigen receptor therapy (CAR-T)
- CRISPR/Cas modified cells e.g., chimeric antigen receptor therapy (CAR-T)
- a primary cell culture includes epithelial cells (e.g., corneal epithelial cells, mammary epithelial cells, etc.), fibroblasts, myoblasts (e.g., human skeletal myoblasts), keratinocytes, endothelial cells (e.g., microvascular endothelial cells), neural cells, smooth muscle cells, hematopoietic cells, placental cells, or a combination of two or more thereof.
- epithelial cells e.g., corneal epithelial cells, mammary epithelial cells, etc.
- fibroblasts e.g., myoblasts (e.g., human skeletal myoblasts)
- keratinocytes e.g., endothelial cells
- neural cells e.g., smooth muscle cells, hematopoietic cells, placental cells, or a combination of two or more thereof.
- cells are recombinant cells (e.g., hybridoma cells or cells that express one or more recombinant products). In some embodiments, cells are infected with one or more viruses.
- cells are isolated from tissues or biological samples for ex vivo culture in the incubators provided herein.
- cells e.g., white blood cells
- cells are isolated from blood.
- cells are released from tissues or biological samples using physical and/or enzymatic disruption.
- one or more enzymes such as collagenase, trypsin, or pronase are used to digest the extracellular matrix.
- tissue or biological samples are placed in culture medium (e.g., with or without physical or enzymatic disruption), and cells that are released and that grow in the culture medium can be isolated for further culture.
- cell culture refers to a procedure for maintaining and/or growing cells under controlled conditions (e.g., ex vivo).
- cells are cultured under conditions to promote cell growth and replication, conditions to promote expression of a recombinant product, conditions to promote differentiation (e.g., into one or more tissue specific cell types), or a combination of two or more thereof.
- cell culture vessels are configured for culturing cells in suspension. In some embodiments, cell culture vessels are configured for culturing adherent cells. In some embodiments, cell culture vessels are configured for 2D or 3D cell culture. In some embodiments, cell culture vessels include one or more surfaces or micro-carriers to support cell growth. In some embodiments, these are coated with extracellular matrix components (e.g., collagen, fibrin and/or laminin components) to increase adhesion properties and provide other signals needed for growth and differentiation. In some embodiments, cell culture vessels include one or more synthetic hydrogels such as polyacrylamide or polyethylene glycol (PEG) gels to support cell growth. In some embodiments, cell culture vessels include a solid support with embedded nutrients (e.g., a gel or agar, for example for certain bacterial or yeast cultures). In some embodiments, cell culture vessels include a liquid culture medium.
- PEG polyethylene glycol
- cells are cultured in one of any suitable culture media.
- Different culture media having different ranges of pH, glucose concentration, growth factors, and other supplements can be used for different cell types or for different applications.
- custom cell culture media or commercially available cell culture media such as Dulbecco's Modified Eagle Medium, Minimum Essential Medium, RPMI medium, HA or HAT medium, or other media available from Life Technologies or other commercial sources can be used.
- cell culture media include serum (e.g., fetal bovine serum, bovine calf serum, equine serum, porcine serum, or other serum).
- cell culture media are serum-free.
- cell culture media include human platelet lysate (hPL).
- cell culture media include one or more antibiotics (e.g., actinomycin D, ampicillin, carbenicillin, cefotaxime, fosmidomycin, gentamycin, kanamycin, neomycin, penicillin, penicillin streptomycin, polymyxin B, streptomycin, tetracycline, or any other suitable antibiotic or any combination of two or more thereof).
- cell culture media include one or more salts (e.g., balanced salts, calcium chloride, sodium chloride, potassium chloride, magnesium chloride, etc.).
- cell culture media include sodium bicarbonate.
- cell culture media include one or more buffers (e.g., HEPES or other suitable buffer).
- one or more supplements are included.
- supplements include reducing agents (e.g., 2-mercaptoethanol), amino acids, cholesterol supplements, vitamins, transferrin, surfactants (e.g., non-ionic surfactants), CHO supplements, primary cell supplements, yeast solutions, or any combination of two or more thereof.
- one or more growth or differentiation factors are added to cell culture media.
- Growth or differentiation factors e.g., WNT-family proteins, BMP-family proteins, IGF-family proteins, etc.
- growth or differentiation factors and other aspects of a liquid media can be added using automated liquid handlers integrated within the incubators.
- devices and methods described herein provide and maintain appropriate temperature and gas mixtures for cell growth. It should be appreciated that cell growth conditions differ for different cell types and that devices described herein can be programmed to maintain different conditions. In some embodiments, conditions of approximately 37° C., and 5% CO 2 are used for mammalian cells.
- devices and methods described herein are used to generate appropriate pressures for aspirating and/or dispensing liquid from the pipette tips.
- a manipulator ( 106 ) may include sensors that monitor the pressure being applied to the bladder (e.g., the pressure differential between the air pressure in the pipette tip and the air pressure of the environment).
- devices and methods described herein are used to modify or change the culture media or conditions and/or to passage the cells when appropriate.
- the devices and methods are automated (e.g., controlled by a controller ( 114 ) and/or computer ( 111 ), as shown in FIG. 7 ).
- culture media can be removed directly by aspiration and replaced with fresh media.
- media changes can involve centrifuging a cell culture, removing the old culture media and replacing it with fresh media.
- the centrifuge is located in the internal chamber of an incubator.
- culture vessels allow for continuous media replacement.
- the incubators described herein may include one or more components that can be used to process, replace, supply, and/or maintain different aspects of a culture media to support cells. Incubators may include a reservoir containing waste media and/or a reservoir containing fresh media.
- Such reservoirs may be present (e.g., for temporary storage) within a refrigerator inside the incubator or a refrigerated section of the incubator.
- one or more reservoirs are provided outside the incubators and piping is provided into and out from the incubator space to supply or draw from a liquid handler units (e.g., liquid handle units having an aspirator) or temporary reservoir within the incubator to facilitate cells feeding, media changes, and other related needs.
- a liquid handler units e.g., liquid handle units having an aspirator
- temporary reservoir within the incubator to facilitate cells feeding, media changes, and other related needs.
- devices may be provided within the incubator to separate cells from waste media (e.g., centrifuge(s) to facilitate cell pelleting) to facilitate automated media changes as part of an incubator provided herein.
- the document provides a system comprising a cell culture incubator connected to a computer, capable of automatically monitoring and adjusting cell culture conditions for optimal growth of the cell culture.
- cells are passaged within an incubator described herein.
- a cell culture is split and a subset of the cell culture is transferred to a fresh culture vessel for further growth.
- cells are detached (e.g., mechanically, for example using gentle scraping, and/or enzymatically, for example using trypsin-EDTA or one or more other enzymes) from a surface prior to being transferred to a fresh culture vessel.
- a small volume of a cell culture is transferred to a fresh culture vessel.
- cell cultures are manipulated in other ways during culture in incubators and vessels described herein.
- cell cultures may be transfected with nucleic acids (e.g., DNA or RNA) or exposed to viral infection (e.g., using recombinant virus particles to deliver DNA or RNA).
- nucleic acids e.g., DNA or RNA
- viral infection e.g., using recombinant virus particles to deliver DNA or RNA
- Aseptic techniques can be used to prevent or minimize contamination of cell cultures during growth and manipulation.
- equipment e.g., pipettes, fluid handling devices, manipulating devices, other automated or robotic devices, etc.
- Non-limiting techniques include heat exposure (e.g., autoclaving), surface disinfection (e.g., using alcohol, bleach, or other disinfectant), irradiation, and/or exposure to a disinfectant gas (e.g., ozone, hydrogen peroxide, etc.) as described herein.
- a disinfectant gas e.g., ozone, hydrogen peroxide, etc.
- media is sterilized using an appropriate technique.
- Non-limiting techniques include heat exposure (e.g., autoclaving), antimicrobial/antiviral treatment, filtration, and/or irradiation.
- manipulations of cell cultures are performed under aseptic conditions, for example in an environment (e.g., within an incubator chamber) that has been disinfected and in which the air has been filtered to remove potential contaminants.
- cell cultures are grown and maintained under GMP-compliant conditions, including using GMP-compliant media or GMP-compliant liquid handling equipment and performing methods in conjunction with standard operation procedures (SOPs).
- SOPs standard operation procedures
- cell cultures can be monitored and/or evaluated to detect contamination.
- contamination by cells from a different type of organism can be detected.
- contamination of a mammalian cell culture by mycoplasma, bacteria, yeast, or viruses can be detected using any suitable technique.
- cell culture contamination can be detected by assaying for changes or for rates of change of one or more culture properties such as pH, turbidity, etc., that are characteristic of contamination (e.g., by bacteria or yeast) and not characteristic of the cells being grown in culture (e.g., mammalian cells).
- one or more molecular detection assays e.g., PCR, ELISA, RNA labeling, or other enzymatic techniques
- cell-based assays can be used to detect contamination (e.g., mycoplasma, bacterial, yeast, viral, or other contamination).
- cell cultures can be monitored and/or evaluated to detect contamination with cells of similar types (e.g., a human cell line contaminated by different human cells or by different mammalian cells).
- cell cultures and their potential contamination can be evaluated using DNA sequencing or DNA fingerprinting (e.g., short tandem repeat—STR—fingerprinting), isoenzyme analysis, human lymphocyte antigen (HLA) typing, chromosomal analysis, karyotyping, cell morphology, or other techniques.
- DNA sequencing or DNA fingerprinting e.g., short tandem repeat—STR—fingerprinting
- isoenzyme analysis e.g., human lymphocyte antigen (HLA) typing
- chromosomal analysis e.g., chromosomal analysis
- karyotyping e.g., cell morphology, or other techniques.
- cells produced using devices and methods provided herein can be frozen to preserve them for later use and/or for transport.
- cells are mixed with a cryopreservation composition after growth and/or differentiation and prior to freezing.
- a cryopreservation composition can be added to a cell culture vessel or cells can be transferred from a cell culture vessel to a cryopreservation vessel along with a cryopreservation composition.
- cryoprotectants that can be included in a cryopreservation composition include DMSO, glycerol, PEG, sucrose, trehalose, and dextrose.
- a freezer may be present in or in proximity with an incubator to facilitate freezing of cells isolated from cell cultures.
- the cell culture incubators include an incubator cabinet defining an internal chamber for incubation of cells in one or more cell culture vessels, in which the internal chamber is configured to hold the one or more cell culture vessels.
- the incubators include at least one external door (e.g., 1, 2, 3, 4, or more external doors) opening from an external environment directly to the internal chamber, for example to provide alternative access to the internal chamber during periods of time when the incubator is not operational, e.g., during maintenance of the incubator.
- the incubators include a storage location within the internal chamber for storing one or more cell culture vessels.
- a cell culture vessel transfer device is provided in the incubator for moving one or more cell culture vessels from a first imaging location to a storage location and/or from a storage location to an first imaging location.
- incubators or incubator cabinets provided herein are rectangularly cuboidal in shape. In some embodiments incubators or incubator cabinets provided herein have a rectangular footprint in a range of 1 ft 2 to 16 ft 2 . In some embodiments incubators or incubator cabinets provided herein have a rectangular footprint of up to about 1 ft 2 , 2 ft 2 , 3 ft 2 , 4 ft 2 , 5 ft 2 , 6 ft 2 , 7 ft 2 , 8 ft 2 , 9 ft 2 , 10 ft 2 , 11 ft 2 , 12 ft 2 , 13 ft 2 , 14 ft 2 , 15 ft 2 , or 16 ft 2 .
- incubators or incubator cabinets provided herein have a total chamber volume in a range of 1 ft 3 to 100 ft 3 . In some embodiments incubators or incubator cabinets provided herein have a chamber volume of up to about 1 ft 3 , 5 ft 3 , 10 ft 3 , 25 ft 3 , 50 ft 3 or 100 ft 3 . In some embodiments incubators or incubator cabinets provided herein have a rectangular footprint in a range of 0.09 m 2 to 1.78 m 2 .
- incubators or incubator cabinets provided herein have a rectangular footprint of up to about 0.1 m 2 , 0.2 m 2 , 0.3 m 2 , 0.4 m 2 , 0.5 m 2 , 0.6 m 2 , 0.7 m 2 , 0.8 m 2 , 0.9 m 2 , 1.0 m 2 , 1.1 m 2 , 1.2 m 2 , 1.3 m 2 , 1.4 m 2 , 1.5 m 2 , 1.6 m 2 , or 1.7 m 2 .
- incubators or incubator cabinets provided herein have a total chamber volume in a range of 0.03 m 3 to 3 m 3 .
- incubators or incubator cabinets provided herein have a chamber volume of up to about 0.03 m 3 , 0.1 m 3 , 0.3 m 3 , 1 m 3 , or 3 m 3 .
- an incubator cabinet is single-walled. In some embodiments, an incubator is double-walled. In some embodiments, insulation material is provided between the double walls of an incubator cabinet to control heat loss from the cabinet and facilitate temperature control in the cabinet.
- the outer wall of an incubator cabinet includes a sheet metal, e.g., a 14-20 gauge cold rolled steel.
- an inner wall (e.g., a chamber surface) of an incubator cabinet includes electro-polished stainless steel. In some embodiments, an inner wall (e.g., a chamber surface) of an incubator cabinet includes corrosion resistant materials, such as, titanium, cobalt-chrome, tantalum, platinum, zirconium, niobium, stainless steel, and alloys thereof.
- a chamber surface of an incubator cabinet includes a polymeric material such as polytetrafluoroethylene (PTFE), or a polymeric material know under the trade name of Parylene.
- a chamber surface may have anti-microbial properties, such as copper or silver or anti-microbial compounds incorporated into a polymeric surface coating.
- the environment inside an incubator is controlled by a control system that may be configured to control the temperature, humidity, carbon dioxide, oxygen, and other gaseous components (e.g., sterilization gases, such as, ozone, and hydrogen peroxide) inside the incubator(e.g., in one or more internal chambers).
- a control system controls the environmental conditions (e.g., temperature, humidity, carbon dioxide, oxygen and other gaseous components) within each internal chamber separately.
- the humidity of an internal chamber may be maintained at a lower level than an internal chamber having a storage location.
- the incubator is further provided with a monitoring system with predefined sensors.
- an incubator advantageously includes a plurality of sensors responsive to different parameters relevant to cell growth, which may include temperature, air purity, contaminant levels, pH, humidity, N 2 , CO 2 , O 2 , and light.
- parameters in the incubator can be measured using sensors for the duration of a culture or process.
- parameters measured by the sensors are transmitted by the monitoring system via a line to a computer-controlled monitoring and control system for further processing as discussed herein.
- an environmental monitoring system can be used in conjunction with an incubator described herein.
- one or more sensors that provide for the measurement of temperature, air composition (e.g., CO 2 concentration, O 2 concentration, etc.), and/or humidity of the system can be associated with an incubator (e.g., fitted within an incubator cabinet).
- one or more such sensors can be incorporated as part of an incubator (e.g., attached to, integral to, or otherwise connected to an internal wall or door of the incubator).
- one or more sensors can be positioned at any suitable location(s) outside or inside an incubator cabinet (e.g., within a transfer chamber and/or an internal chamber, for example attached to an internal wall, and/or upper or lower internal surface).
- a gas sensor that can provide a reading in real time of the concentration of gas in contact with the sensor (e.g., gas in a cabinet, or ambient air) in percent, parts per million, or any other standard unit.
- Gas sensors for use in the methods and incubators provided herein include CO 2 sensors, O 2 sensors, N 2 sensors, ozone gas detectors, hydrogen peroxide monitors, multi gas monitors, and CO sensors. Such sensors are available from a number of commercial sources.
- the environment of the incubator may be modulated or controlled based upon the information provided by the sensors described herein. For example, the level of CO 2 in an incubator may be increased upon indication from a CO 2 sensor that a lower than desirable concentration of CO 2 is present in the incubator.
- one or more heating or cooling elements can be incorporated within the incubator (e.g., on an inner surface of the cabinet or door, and/or integrated within one or more of the walls and/or the base of the cabinet) for purposes of controlling the temperature within the incubator.
- a heating element can be used for thawing liquids, for example, cell culture media or other reagents.
- one or more air or oxygen sources, carbon filters, and/or one or more humidification or dehumidification systems are connected to the incubator and configured to control the level of oxygen, carbon dioxide, and/or humidity within the incubator (e.g., in response to signals from the one or more sensors in or attached to the incubator).
- one or more controllers are attached to the sensors and other systems to control the internal environment of the incubator.
- an incubator can include one or more light sources (e.g., an incandescent bulb, LED, UV or other light source). These can be placed within the incubator to illuminate regions within the cabinet.
- the culture system operation is monitored using a camera or other light sensitive device that can be placed within or outside the incubator.
- the light source is a sterilizing light source.
- a UV lamp may be located within the transfer chamber and/or the interior chamber of the incubator.
- the incubator includes a transparent object (e.g., window) that allows visible light or other light wavelengths from within the incubator to be detected by a camera or other light sensitive device placed outside the incubator.
- the inner surface of the transparent object can be wiped (e.g., from the inside of the cabinet) to prevent or remove condensation droplets that may accumulate (e.g., due to the humid air inside the incubator) on the inner surface and interfere with the monitoring of the system.
- the surface can be wiped by a wiper that is automatically controlled by a controller.
- a culture cabinet includes windows, doors, or openings that when closed are sealed to preserve sterility after the incubator cabinet has been sterilized.
- each seal of the incubator cabinet is air tight up to a threshold level of pressure (e.g., up to 1 atm).
- a gasket is provide to ensure a desired level of sealing capacity.
- a “gasket” is understood as a mechanical seal that fills the space between two objects, generally to prevent leakage between the two objects while under compression.
- Gaskets are commonly produced by cutting from sheet materials, such as gasket paper, rubber, silicone, metal, cork, felt, neoprene, nitrile rubber, fiberglass, or a plastic polymer (such as polychlorotrifluoro-ethylene). It is often desirable that a gasket be made from a material that provides some degree of yielding such that it is able to deform and tightly fills the space it is designed for, including any slight irregularities. In some embodiments, gaskets can be used with an application of sealant directly to the gasket surface to function properly. In some embodiments, a gasket material can include a closed-cell neoprene foam which is non-reactant with carbon dioxide or ozone.
- Incubators disclosed herein typically include one or more transfer devices for moving one or more items, e.g., from a first location to a second location, within the incubators.
- the one or more items are one or more cell culture vessels.
- the one or more items are useful for maintenance of one or more cell culture vessels and include, but are not limited to, pipettes, capillaries, liquids (e.g., cell culture medium), nutrients, and other materials.
- a transfer device includes a robotic arm.
- the robotic arm includes a platform within an incubator cabinet that may move along a rail or conveyor running in various directions along an inner surface (e.g., inner wall, base, etc.) of incubator cabinet.
- an incubator cabinet may be configured with more than one (e.g., 2, 3, 4, or 5, or more) robotic arms to increase the throughput of the instrument and to provide redundancy in the event that one of the robotic arms fail.
- a transfer device further includes a gripper assembly coupled to a robotic arm.
- the gripper assembly includes one or more grippers mounted on the end of the robotic arm, each gripper having two or more (e.g., 3, 4, 5, or more) gripper fingers.
- each of the gripper fingers on the robotic arm has a groove, friction plate, rubber pad, or other gripping surface. The gripping surface can allow the fingers to grip and transport various types of containers (e.g., culture vessels) within the cabinets.
- the robotic arm may have an absolute encoder either coupled to the gripper assembly, or the platform, or a separate absolute encoder for each of the gripper assembly and/or the platform to determine whether the robotic arm is in a position where it may be safely homed (e.g., returned to a resting or storage configuration and/or location or origin of an operational coordinate system) without hitting an obstruction.
- an absolute encoder either coupled to the gripper assembly, or the platform, or a separate absolute encoder for each of the gripper assembly and/or the platform to determine whether the robotic arm is in a position where it may be safely homed (e.g., returned to a resting or storage configuration and/or location or origin of an operational coordinate system) without hitting an obstruction.
- the robotic arm may instead reach these locations by inserting a container into or removing a container from a shuttle or conveyor belt, located, for example, on the incubator cabinet floor or other surface that moves along an axis (e.g., x-axis, y-axis) and provides access to at least some of those locations to which the robotic arm cannot reach.
- a shuttle or conveyor belt located, for example, on the incubator cabinet floor or other surface that moves along an axis (e.g., x-axis, y-axis) and provides access to at least some of those locations to which the robotic arm cannot reach.
- an incubator cabinet is designed to be used in conjunction with an external assay or laboratory automation system.
- the incubator cabinet may have a door having an opening large enough to allow the gripper arm to pivot outside of the incubator cabinet with a sufficient reach for the fingers to transport culture vessels or other containers or components from a transport line of the laboratory automation system into the incubator cabinet or transport external assay components into and/or out of the incubator cabinet.
- a robotic arm is designed to carry, among other things, culture vessels, in which case movements of the robotic arm are controlled to prevent jerking or accelerations of such vessels or other movements which may cause the spilling of samples from the vessels.
- a robotic arm is designed to carry, among other things, culture vessels, in which case movements of the robotic arm are controlled to prevent movement of such vessels in ways which cause newly plated cells to congregate/concentrate in specific areas of the culture vessel.
- the robotic arm or other components of the incubator can be designed to track precisely where the vessels or other containers are is located.
- a homing mechanism can be used for each of various motors of the arms (e.g., x-motor, theta-motor and z-motor)to position properly the robotic arm to a known location after it is powered up or if a robotic arm collides with another object before resuming operation.
- an uninterruptible power supply (“UPS”) is attached to or within the incubator cabinet, or contained with it, to allow for an orderly shut-down of incubator operations, including saving of various automation and sample information and the completion of any transport or transfer process that is underway (e.g., the transport of a container or vessel that is being carried by the robotic arm to its destination).
- the operator may be alerted to unauthorized opening of the incubator by an audible signal, a visual signal, an electronic signal (e.g., an email or a text message), or in some other manner.
- a sensor or other feature is provided to detect when one or more doors of an incubator are opened (e.g., when an incubator cabinet door, such as an external or internal door, is opened).
- Such features are useful because they allow operators to keep track of or be warned of any unscheduled or unauthorized openings of the incubator (e.g., the incubator cabinet) that could jeopardize sterility, spoil a production, compromise an assay or experiment, etc.
- a radiofrequency beacon or other signal source is located within the incubator (e.g., within the incubator cabinet) that can be used to determine the location of one or more devices within the incubator cabinet (e.g., devices having sensors that can detect the signal and use it to determine their location).
- the devices could have signal sources and the sensor(s) could be located within one or more of the chambers of an incubator cabinet (e.g., located on an internal surface of an internal chamber).
- light signals or lasers can be used to determine the location of one or more devices or components within the incubator cabinet.
- Such information can be communicated, e.g., wired or wirelessly, to an external computer or monitoring station.
- the information can be used to control operation of a transfer device, e.g., a robotic arm, within the incubator cabinet to ensure that the transfer device can grab, manipulate, or maneuver devices or items appropriately within the incubator cabinet.
- a user before containers or vessels are brought into an incubator cabinet, a user can select an automation system protocol based on the particular containers, vessels, ingredients, or cells that are being inserted into the incubator cabinet. Relevant information related to the incubator and/or one or more incubator components, and the cells being grown can be entered into a data system. For example, one or more identifiers such as barcodes (e.g., 1D or 2D barcodes) can be placed on the container or vessel, and other significant information, such as, the type of container, the contents of the container, what assays or manipulations are to be performed on the sample in the container can be specified.
- barcodes e.g., 1D or 2D barcodes
- information related to the incubator system and/or cells can be contained in one or more barcodes, on a separate data system, or a combination thereof.
- the user may also enter information that identifies the dimensionality (e.g., height, diameter) of the vessel or other container or the system itself can be configured to determine the height or other dimensions of the vessel or other container.
- the robotic arm may be requested to transport a particular container, such as when an analytical module is ready to perform an assay or other manipulation on cells grown in the vessels or has completed performing an assay or manipulation.
- the incubators provided herein include several components, including sensors, environmental control systems, robotics, etc. which may operate together at the direction of a computer, processor, microcontroller or other controller.
- the components may include, for example, a transfer device (e.g., robotic arm), a liquid handling devices, a delivery system for delivering culture vessels, a manipulator attached to the disclosed pipette tip, or other components to or from the incubator cabinet, an environmental control system for controlling the temperature and other environmental aspects of the incubator cabinet, a door operation system, an imaging or detection system, and a cell culture assay system.
- operations such as controlling operations of a cell culture incubator and/or components provided therein or interfacing therewith may be implemented using hardware, software or a combination thereof.
- the software code can be executed on any suitable processor or collection of processors, whether provided in a single component or distributed among multiple components.
- processors may be implemented as integrated circuits, with one or more processors in an integrated circuit component.
- a processor may be implemented using circuitry in any suitable format.
- a computer may be embodied in any of a number of forms, such as a rack-mounted computer, a desktop computer, a laptop computer, or a tablet computer. Additionally, a computer may be embedded in a device not generally regarded as a computer but with suitable processing capabilities, including a Personal Digital Assistant (PDA), a smart phone or any other suitable portable, mobile or fixed electronic device, including the incubator itself.
- PDA Personal Digital Assistant
- a computer may have one or more input and output devices. These devices can be used, among other things, to present a user interface. Examples of output devices that can be used to provide a user interface include printers or display screens for visual presentation of output and speakers or other sound generating devices for audible presentation of output. Examples of input devices that can be used for a user interface include keyboards, and pointing devices, such as mice, touch pads, and digitizing tablets. In other examples, a computer may receive input information through speech recognition or in other audible format, through visible gestures, through haptic input (e.g., including vibrations, tactile and/or other forces), or any combination thereof.
- haptic input e.g., including vibrations, tactile and/or other forces
- One or more computers may be interconnected by one or more networks in any suitable form, including as a local area network or a wide area network, such as an enterprise network or the Internet.
- networks may be based on any suitable technology and may operate according to any suitable protocol and may include wireless networks, wired networks, or fiber optic networks.
- the various methods or processes outlined herein may be coded as software that is executable on one or more processors that employ any one of a variety of operating systems or platforms.
- Such software may be written using any of a number of suitable programming languages and/or programming or scripting tools, and may be compiled as executable machine language code or intermediate code that is executed on a framework or virtual machine.
- One or more algorithms for controlling methods or processes provided herein may be embodied as a readable storage medium (or multiple readable media) (e.g., a computer memory, one or more floppy discs, compact discs (CD), optical discs, digital video disks (DVD), magnetic tapes, flash memories, circuit configurations in Field Programmable Gate Arrays or other semiconductor devices, or other tangible storage medium) encoded with one or more programs that, when executed on one or more computers or other processors, perform methods that implement the various methods or processes described herein.
- a readable storage medium e.g., a computer memory, one or more floppy discs, compact discs (CD), optical discs, digital video disks (DVD), magnetic tapes, flash memories, circuit configurations in Field Programmable Gate Arrays or other semiconductor devices, or other tangible storage medium
- a computer readable storage medium may retain information for a sufficient time to provide computer-executable instructions in a non-transitory form.
- Such a computer readable storage medium or media can be transportable, such that the program or programs stored thereon can be loaded onto one or more different computers or other processors to implement various aspects of the methods or processes described herein.
- the term “computer-readable storage medium” encompasses only a computer-readable medium that can be considered to be a manufacture (e.g., article of manufacture) or a machine.
- methods or processes described herein may be embodied as a computer readable medium other than a computer-readable storage medium, such as a propagating signal.
- program or “software” are used herein in a generic sense to refer to any type of code or set of executable instructions that can be employed to program a computer or other processor to implement various aspects of the methods or processes described herein. Additionally, it should be appreciated that according to one aspect of this embodiment, one or more programs that when executed perform a method or process described herein need not reside on a single computer or processor, but may be distributed in a modular fashion amongst a number of different computers or processors to implement various procedures or operations.
- Executable instructions may be in many forms, such as program modules, executed by one or more computers or other devices.
- program modules include routines, programs, objects, components, data structures, etc. that perform particular tasks or implement particular abstract data types.
- functionality of the program modules may be combined or distributed as desired in various embodiments.
- data structures may be stored in computer-readable media in any suitable form.
- data storage include structured, unstructured, localized, distributed, short-term and/or long term storage.
- protocols that can be used for communicating data include proprietary and/or industry standard protocols (e.g., HTTP, HTML, XML, JSON, SQL, web services, text, spreadsheets, etc., or any combination thereof).
- data structures may be shown to have fields that are related through location in the data structure. Such relationships may likewise be achieved by assigning storage for the fields with locations in a computer-readable medium that conveys relationship between the fields.
- any suitable mechanism may be used to establish a relationship between information in fields of a data structure, including through the use of pointers, tags, or other mechanisms that establish relationship between data elements.
- information related to the operation of the incubator can be obtained from one or more sensors associated with the incubator (e.g., located within the incubator cabinet, or located within the incubator but outside the incubator cabinet), and can be stored in computer-readable media to provide information about conditions during a cell culture incubation.
- the readable media comprises a database.
- said database contains data from a single incubator.
- said database contains data from a plurality of incubators.
- data is stored in a manner that makes it tamper-proof.
- all data generated by the instrument e.g., an incubator
- a subset of data is stored.
- the component controls various processes performed inside the incubator.
- a computer may direct control equipment (e.g., a manipulator, an imager, a fluid handling system, etc.).
- the computer controls imaging of cell cultures, picking of cells, weeding of cells (e.g., removal of cell clumps), monitoring of cell culture conditions, adjustment of cell culture conditions, tracking of cell culture vessel movement within the incubator, and/or scheduling of any of the foregoing processes.
- incubator cabinets provided herein are configured with a microscope or other imager or other device for purposes of monitoring cell growth, viability or other aspect of cells.
- the microscope or imager is used in conjunction with an assay performed within the incubator cabinet, such as an image based phenotypic screen or assay.
- incubators provided herein are configured to permit one or more assays to be performed within an incubator cabinet or within a chamber operably connected to an incubator cabinet, e.g., a separate assay chamber that is part of the incubator.
- incubators provided herein are configured to permit performance of a cell counting assay, a replication labeling assay, a cell membrane integrity assay, a cellular ATP-based viability assay, a mitochondrial reductase activity assay, a caspase activity assay, an Annexin V staining assay, a DNA content assay, a DNA degradation assay, a nuclear fragmentation assay, or a combination thereof.
- exemplary assays include BrdU, EdU, or H3-thymidine incorporation assays; DNA content assays using a nucleic acid dye, such as Hoechst Dye, DAPI, actinomycin D, 7-aminoactinomycin D, or propidium iodide; cellular metabolism assays such as AlamarBlue, MTT, XTT, and CellTitre Glo; nuclear fragmentation assays; cytoplasmic histone associated DNA fragmentation assays; PARP cleavage assays; and, TUNEL staining assays.
- DNA content assays using a nucleic acid dye such as Hoechst Dye, DAPI, actinomycin D, 7-aminoactinomycin D, or propidium iodide
- cellular metabolism assays such as AlamarBlue, MTT, XTT, and CellTitre Glo
- nuclear fragmentation assays nuclear fragmentation assays
- incubators provided herein are configured to permit high-throughput screening (HTS) within an incubator cabinet.
- HTS refers to testing of up to, for example, 100,000 compounds per day.
- screening assays may be carried out in a multi-well format, for example, a 96-well, 384-well format, or 1,536-well format, and can be performed using automated protocols. In such high throughput assays, it is possible to screen several thousand different compounds or compositions in a single day.
- each well of a microtiter plate can be used to run a separate assay against a selected test compound, or, if concentration or incubation time effects are to be observed, a plurality of wells can contain test samples of a single compound. It is possible to assay many plates per day; assay screens for up to about 6,000, 20,000, 50,000, or more than 100,000 different compounds are possible using the assays.
- HTS implementations of the assays described herein involve the use of automation.
- an integrated robot system that includes of one or more robotic arms transports assay microplates between multiple assay stations for compound, cell, and/or reagent addition, mixing, incubation, and finally readout or detection.
- an HTS assay may include preparing, incubating, and analyzing many plates simultaneously, further speeding the data-collection process.
- assays can include test cells, control cells, and one or more test compounds, e.g., 10, 100, 1000, 10,000, or more test compounds.
- the cells and test agents can be arranged in one or more vessels in a manner suitable for assessing effect of the test compound(s) on the cells.
- These assays can be performed within one or more incubator cabinets of one or more incubators described herein.
- the vessels contain a suitable tissue culture medium, and the test compounds are present in the tissue culture medium and may be delivered to the culture medium within an incubator cabinet of an incubator provided herein in an automated fashion.
- a medium appropriate for culturing a particular cell type can be selected for use.
- a medium is free or essentially free of serum or tissue extracts, while in other embodiments such a component is present.
- cells are cultured on a plastic or glass surface.
- a reference to “A and/or B,” when used in conjunction with open-ended language such as “comprising” can refer, in one embodiment, to A without B (optionally including elements other than B); in another embodiment, to B without A (optionally including elements other than A); in yet another embodiment, to both A and B (optionally including other elements); etc.
- the phrase “at least one,” in reference to a list of one or more elements, should be understood to mean at least one element selected from any one or more of the elements in the list of elements, but not necessarily including at least one of each and every element specifically listed within the list of elements and not excluding any combinations of elements in the list of elements.
- This definition also allows that elements may optionally be present other than the elements specifically identified within the list of elements to which the phrase “at least one” refers, whether related or unrelated to those elements specifically identified.
- “at least one of A and B” can refer, in one embodiment, to at least one, optionally including more than one, A, with no B present (and optionally including elements other than B); in another embodiment, to at least one, optionally including more than one, B, with no A present (and optionally including elements other than A); in yet another embodiment, to at least one, optionally including more than one, A, and at least one, optionally including more than one, B (and optionally including other elements); etc.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Sustainable Development (AREA)
- Analytical Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Thermal Sciences (AREA)
- Molecular Biology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Devices For Use In Laboratory Experiments (AREA)
- Sampling And Sample Adjustment (AREA)
Abstract
Aspects of the invention relate to liquid transfer systems including a pipette tip having a body defining an inner volume and having first and second ends, the first end arranged to transfer a volume of liquid into and out of the pipette tip and the second end arranged for attachment to a pipette, and a bladder sealingly attached to the body. In some embodiments, the bladder is disposable in the inner volume. The bladder may be defined by a membranous sac and/or a planar membrane. The bladder may be moveable in response to an applied pressure to transfer liquid. The bladder also may be stretchable to accommodate a volume of fluid. In some embodiments, the pipette tip is used in a cell culture incubator, with a manipulator including a pipette that is in fluid communication with the pipette tip.
Description
- This application claims the benefit under 35 U.S.C. § 119(e) to U.S. Provisional Application Ser. No. 62/508,883, entitled “LIQUID TRANSFER SYSTEM” filed on May 19, 2017, which is herein incorporated by reference in its entirety.
- Aspects relate to a liquid transfer system and methods for using the system to transfer a volume of liquid into and out of a pipette tip. Some aspects relate to using such a liquid transfer system in cell culture incubators and to methods for using such incubators.
- Pipettes are used to transfer a volume of liquid, such as transferring media containing cells between cell culture vessels. Cell culture is a useful technique in both research and clinical contexts. For example, culture of mammalian cells is often performed in order to establish clonal cell lines, tissue preparations, in vitro fertilization preparations, or to expand populations of stem cells.
- Presently available pipette tips may introduce contaminants into a sample in the pipette tip. For example, because the pipette tip is open at an end adjacent a pipette, which is used to transfer many different samples into and out of numerous pipette tips, cross-contamination may occur. In embodiments using such pipette tips in a cell cultures, this may lower culture efficiency and repeatability. Additionally, because traditional pipette tips are designed for a single use only, a large volume of waste (e.g., a large pile of used tips) may result during an experiment such as a cell culture being performed in an incubator. Single-use pipette tips also may need a large area for storage. As such, according to some aspects, the instant document provides a liquid transfer system having a pipette tip arranged to minimize or even eliminate cross contamination and to also reduce waste and/or storage space.
- According to one aspect, the instant document provides a pipette tip with a body defining an inner volume and having first and second ends, the first end arranged to pass a liquid into and out of the pipette tip and the second end arranged for attachment to a pipette, and a bladder sealingly attached to the body. In some embodiments, the bladder is disposable in the inner volume of the body. In some embodiments, a first side of the bladder is exposed to a volume of accommodated liquid. In such embodiments, a second, opposite side may be exposed to a pipette. In some embodiments, the bladder may be attached to the second end of the body. The bladder also may be attached to the first end or at a location between the first and second ends.
- In some embodiments, the bladder is arranged to accommodate a volume of liquid or a volume of air above the liquid in the pipette tip (e.g., the air used to displace a volume of liquid). According to some embodiments, the bladder is manipulated (e.g., moved, retracted, expanded, contracted, and/or stretched) to transfer a volume of liquid into or out of the pipette tip. For example, a pressure may be applied to the bladder to manipulate the bladder. In some embodiments, the bladder is arranged to move back and forth in response to an applied pressure. For example, the bladder may be at least partially retracted outside of the pipette tip body to draw a volume of liquid into the pipette tip in response to a negative pressure. In response to a positive pressure, the bladder may be retracted into the pipette tip (e.g., into the inner volume of the pipette tip body) to expel at least a portion of the volume of liquid from the pipette tip. In other embodiments, the bladder is configured to expand and contract in response to the applied pressure. The bladder also may be arranged stretch in response to the applied pressure.
- In some embodiments, the negative pressure creates a vacuum that is applied to the bladder. For example, a negative pressure differential may be created between the air pressure in a container (e.g., the air pressure in the tip) and the air pressure of the environment. In such embodiments, the pressure differential or pressure gradient may be applied across the bladder.
- According to one aspect, the bladder includes a membranous sac that is arranged to accommodate the volume of liquid. In some embodiments, the bladder is disposable in the body of the pipette tip, with the formed, membranous sac folded into the tip. For example, the bladder may be disposed in the pipette tip such that the membranous sac extends from a location at the second end, or between the first and second ends, toward the first end.
- In other embodiments, the bladder includes a planar membrane. In some embodiments, the planar membrane may include an unformed state of a membranous sac. For example, an elastomeric membrane may be disposed in the tip, with the membrane having a planar configuration in a resting state. Once a pressure (e.g., a negative pressure) is applied to the membrane, the membrane may be stretched and/or expanded such that the membrane forms the membranous sac, which may accommodate the volume of liquid. In other embodiments, the planar membrane may simple move back and forth in response to the applied pressure, without expanding and contracting. As will be appreciated, depending upon the material used create the planar membrane, a least a part of the membrane (e.g., a central portion of the membrane) may fall below the plane extending through the membrane (e.g., slightly towards the first end of the pipette tip) in response to gravity, forming a concave arrangement.
- In some embodiments, the pipette tip is arranged to accommodate a volume liquid that is less than or equal to a sum of a volume of the bladder and a volume of an inner volume of the body of the pipette tip. As will be appreciated, the volume of accommodated liquid may be limited by the volume of the bladder.
- In some embodiments, the volume of the bladder includes a volume defined by the membranous sac. In some embodiments, the bladder is formed of a material that allows the bladder to expand beyond the volume of the membranous sac. In such embodiments, the volume of the bladder also may include the volume of the expanded bladder (e.g., the bladder after an applied pressure greater than that needed to simply draw a liquid into the bladder).
- In some embodiments, the bladder is permanently attached to the pipette tip body (e.g., to the second end of the body). In other embodiments, the bladder may be removably attached to the pipette tip body.
- In some embodiments, the second end of the pipette tip is adjacent a pipette. In some embodiments, the bladder (e.g., the formed membranous sac or planar membrane) is positioned at the second end. In some embodiments, the membranous sac extends from the second end of the body towards the first end of the body.
- In some embodiments, the pipette tip is reusable. The pipette tip also may be disposable such that the tip is only used for a single liquid transfer. In these situations, the pipette tip may be removably attached to the pipette.
- According to yet another aspect, this document provides a liquid transfer system that includes a pipette tip having a body defining an inner volume and having first and second ends, the first end arranged to pass a liquid into and out of the pipette tip and the second end arranged for attachment to a pipette, and a bladder sealingly attached to the body. In some embodiments, the bladder is disposable in the inner volume. The system also may include a pipette attached to the pipette tip, the pipette arranged to generate pressure gradients across the bladder to transfer a volume of liquid into and out of the pipette tip.
- In some embodiments, the volume of liquid drawn into (or expelled from) the pipette tip is dependent on the first applied pressure. For example, the volume of liquid drawn into (or dispensed out of) the pipette tip may be based upon the amplitude of the pressure differential (e.g., between air in the container and the environment) and the duration of the applied pressure. As will be appreciated, the volume of liquid accommodated by the pipette tip is limited by the total volume of the pipette tip body and the volume of the bladder.
- In some embodiments, the bladder may be retracted (e.g., partially retracted), expanded or stretched into the body of the pipette in response to the applied pressure. In such an embodiment, the volume of the pipette body may be greater than or equal to the volume of membrane (e.g., the volume of the bladder and/or diaphragm).
- In some embodiments, the pipette body includes a pump which applies the pressure (e.g., via a fluid such as a liquid or air) to the pipette tip. In other embodiments, the pipette is connected to a fluid conduit which applies the pressure (e.g., the negative pressure) to the pipette tip via a valve and pump. As will be appreciated, the fluid conduit may be connected to a fluid supply (e.g., an air or liquid supply).
- In some embodiments, the pipette includes a pipette shell disposed inside the pipette body to separate the pipette body from the pipette tip. As will be appreciated, in such embodiments, the pipette shell may further minimize cross contamination between the pipette and the liquid being drawn into the pipette tip. In some embodiments, the pipette shell is disposable. In other embodiments, the pipette shell may be reusable.
- According to still another aspect, this document provides a pipette tip including a body defining an inner volume and having first and second ends, the first end arranged to pass a liquid into and out of the pipette tip and the second end arranged for attachment to a pipette, and a bladder sealingly attached to the body. In some embodiments, the bladder is disposable in the inner volume of the body. The bladder and at least a portion of the inner volume are arranged to accommodate a volume of fluid.
- In some embodiments, the volume of liquid is less than or equal to a sum of the volume of the bladder and a volume of the body. In some embodiments, the bladder divides the body into first and second compartments. The first compartment may be in fluid communication with the first end and the second compartment may be in fluid communication with the second end. The second compartment may be arranged to receive at last one of a first applied pressure to draw a volume of liquid into the body and a second applied pressure to expel the volume of liquid from the pipette tip.
- In some embodiments, the bladder includes a membrane (e.g., an elastomeric membrane) that has been stretched in response to an applied pressure to form a sac for accommodating a volume of liquid.
- According to another aspect, this document provides a liquid transfer system including a pipette tip having a body defining an inner volume and having first and second ends, the first end arranged to pass a liquid into and out of the pipette tip and the second end arranged for attachment to a pipette, and a bladder sealingly attached to the body. In some embodiments, the bladder is disposable in the inner volume of the body. The system also includes a manipulator arranged to generate pressure gradients across the bladder to transfer a first volume of liquid into or out of the pipette tip.
- In some embodiments, in response to the applied pressure, the bladder is at least partially retracted into an interior volume of the manipulator. In such embodiments, the pressure is a negative pressure and the bladder retracts to draw a volume of the liquid into the body of the pipette. In some embodiments, the manipulator is arranged to apply a pressure of air to the bladder to transfer a portion of the volume of liquid out of the pipette tip. In such embodiments, the bladder is moved into the body.
- The pipette tip may be removably attachable to the manipulator. The manipulator may include a multi-tipped pipette. The pipette shell may be attached to the manipulator prior to attaching the pipette tip.
- In some embodiments, the system includes a second pipette tip defining an inner volume and having a second body with third and fourth ends, the third end arranged to transfer fluid in and out of the body and the fourth end arranged for attachment to a manipulator, and a second bladder sealingly attached to the inner volume of the second body. In some embodiments, the bladder is disposable in the second body. In such an embodiment, the manipulator also may be arranged to apply a pressure to the second bladder to transfer a second volume of liquid into or out of the third end of the pipette tip.
- In some embodiments, the first and second pipette tips are configured to transfer first and second volumes, respectively, from the same cell culture vessel. In other embodiments, the first and second pipette tips transfer first and second volumes from first and second cell culture vessels, respectively.
- In some embodiments, a system includes more than two pipettes (e.g., 3, 4, 5, 6, 7, 8, 9, 10, or more) having pipette tips as described in this document.
- According to another aspect, this document provides a cell incubator having an internal chamber for incubation of cells in one or more cell culture vessels, a door opening from an external environment to said internal chamber, an imager arranged to imaging the cells within the internal chamber, a manipulator for manipulating the cells in the one or more cell culture vessels within the internal chamber, wherein the manipulator comprises at least one pipette configured to transfer a first volume of media comprising the cells into or out of the one or more cell culture vessels within the internal chamber, a pipette tip in fluid communication with the pipette, the pipette tip having a body defining an inner volume and having first and second ends, the first end arranged to transfer a volume of liquid into and out of the pipette tip and the second end arranged for attachment to a manipulator, and a bladder sealingly attached to the pipette tip, and a cell culture vessel transfer device for moving the one or more cell culture vessels between locations within the internal chamber. The manipulator applies a pressure to the bladder to transfer a first volume of media comprising the cells into or out of the pipette tip. In some embodiments, the first volume of media is proportional to the applied pressure. In some embodiments, the bladder is disposable within the inner volume of the pipette tip.
- In some embodiments, the pipette applies a pressure to the bladder of the pipette tip to draw the first volume of media into the pipette tip. In some embodiments, the applied pressure is a negative pressure that applies a vacuum to the bladder.
- In some embodiments, the incubator includes a second pipette for transferring a second volume of media containing cells into or out of one or more cell culture vessels within the internal chamber. A second pipette tip may be used with the second pipette. The second tip may have a body defining an inner volume and having third and fourth ends, the third end arranged to transfer liquid into and out of the pipette tip and the fourth end arranged for attachment to a manipulator, such as a pipette. In some embodiments, the second bladder is disposable in the inner volume of the second body. In some embodiments, the bladder includes a membranous sac extending from the fourth end, or a location between the third and fourth ends, toward the third end. In some embodiments, the fourth end is attached to the manipulator. In some embodiments, an incubator includes more than two pipettes (e.g., 3, 4, 5, 6, 7 8, 9, 10 or more), each of which can be used with a pipette tip as described in this document.
- In such embodiments, the first and second pipette tips may be configured to transfer first and second volumes, respectively, out of the same cell culture vessel. In other embodiments, the first and second tips are configured to transfer first and second volumes out of first and second cell culture vessels, respectively.
- According to another aspect, this document provides a pipette tip that may be nestable with other pipette tips. In some embodiments, the nested pipette tips may be compactly stored in a cartridge. In some embodiments, the pipette tips may be loaded directly onto the pipette via the cartridge.
- According to still another aspect, this document provides a cartridge for dispensing pipette tips. In some embodiments, the cartridge includes a housing and two or more pipette tips. Each pipette tip includes a body defining an inner volume and having first and second ends, the first end arranged to pass a liquid into and out of the pipette tip and the second end arranged for attachment to a pipette, and a bladder sealingly attached to the body. The two or more pipette tips are nestable. In some embodiments, the bladder is disposable within the inner volume.
- According to another aspect, this document provides a method of transferring a volume of liquid into or out of a pipette tip having a body defining an inner volume and having first and second ends, the first end arranged to pass a liquid into and out of the pipette tip and a second end arranged for attachment to a pipette, and a bladder sealingly attached to the body. The method includes applying a first pressure gradient across the bladder of the pipette tip to cause a volume of liquid to be drawn into the pipette tip via the first end of the body.
- It should be appreciated that the foregoing concepts, and additional concepts discussed below, may be arranged in any suitable combination, as the present disclosure is not limited in this respect.
- The foregoing and other aspects, embodiments, and features of the present teachings can be more fully understood from the following description in conjunction with the accompanying drawings.
- The accompanying drawings are not intended to be drawn to scale. In the drawings, each identical or nearly identical component that is illustrated in various figures may be represented by a like numeral. For purposes of clarity, not every component may be labeled in every drawing. Various embodiments of the invention will now be described, by way of example, with reference to the accompanying drawings, in which:
-
FIGS. 1 and 2 are schematic cross-sectional side views of pipette tips according to some embodiments; -
FIG. 3A is a schematic cross-sectional side view of a pipette tip according to one embodiment; -
FIG. 3B is a schematic illustration of the pipette tip ofFIG. 3A , with a bladder in an extended configuration; -
FIG. 4A is a schematic cross-sectional side view of a pipette tip according to another embodiment; -
FIG. 4B is a schematic cross-sectional side view of the pipette tip ofFIG. 4A , with a bladder in an extended configuration; -
FIG. 5A -FIG. 5E are schematic illustrations of a volume of liquid being transferred into and out of a pipette tip attached to a pipette; -
FIGS. 6A and 6B are schematic illustrations of a volume of liquid being transferred into a pipette tip attached to a pipette with a pipette shell; -
FIG. 7 is a schematic of an illustrative embodiment of a cell culture incubator having an imager, a manipulator, and a pipette tip; -
FIGS. 8-9 are schematics of illustrative embodiments of cell culture incubators, withFIG. 8 showing a schematic of a cell culture incubator having a second imager andFIG. 6 showing a schematic of a cell culture incubator, wherein the imaging location and the manipulating location are the same location; -
FIG. 10 is a schematic depicting further components of cell culture incubators; -
FIGS. 11A and 11B are schematic representations of a pipette arranged to apply a pressure to a pipette tip; -
FIG. 12 is a schematic representation of nested pipette tips; and -
FIG. 13 is a schematic representation of a cartridge of pipette tips. - Presently available pipettes are used to measure and transfer a volume liquid. For example, a pipette may draw a sample of a media containing cells from a first culture vessel and thereafter dispense the sample into a second culture vessel. Pipettes may be hand-held, with a user grasping and manipulating the pipette to transfer the measured volume of liquid.
- For example, with piston-driven pipettes, a user may depress a plunger to create a vacuum and draw a sample of liquid into a pipette tip. In other examples, the pipette may be automated. In such examples, the automated pipette may be used with a controller (e.g., a computer in an incubator) that controls the strength and duration of the applied pressure.
- Unfortunately, presently available pipette tips used with such pipettes (e.g., with the pipettes in the incubator) may introduce contaminants into a liquid. For example, when an unused pipette tip is attached to a previously used pipette to transfer a volume of liquid, because the pipette tip is open at an end adjacent to the pipette, cross contamination may occur between the pipette and the liquid in the pipette tip. In embodiments using presently available pipette tips in a cell culture, this may lower culture efficiency and repeatability. Additionally, because the pipette tips are designed for a single use only, a large volume of waste (e.g., a large pile of used tips) may be amassed, such as during cell culture maintenance.
- Applicant has recognized that by providing a pipette tip that may separate a volume of liquid being transferred into the pipette tip from the pipette, various advantages may be Applicant has further recognized that advantages may be realized by providing a pipette tip that may be reusable.
- Accordingly, in some aspects, this document relates to a pipette tip having a body defining an inner volume and having first and second ends, the first end arranged to pass liquid into and out of the pipette tip and the second end arranged for attachment to a pipette, and a bladder sealingly attached to the body. In some embodiments, the bladder is disposable within the inner volume. As will be appreciated, in other embodiments, the bladder is not disposable within the inner volume. In some embodiments, the bladder may be placed between the transferred liquid and the pipette. In some embodiments the bladder may extends from a position between the first and second ends of the body toward the first end of the body. For example, the bladder may be attached at the second end and may extend toward the first end of the body, such as when the bladder is in a compressed configuration.
- In some embodiments, at least a portion of the inner volume is arranged to accommodate a volume of liquid. In some embodiments, the bladder may be arranged to accommodate a volume of liquid. In some embodiments, the bladder may be expandable to accommodate the volume of liquid.
- For purposes herein, being sealingly attached to the body means that the bladder is attached to the body such that a seal is formed at the location where the bladder is attached to the body. For example, the bladder may be heat sealed, glued, bonded, or otherwise suitably attached to the body to create the seal. In some embodiments, the bladder may be attached to the body at a periphery of the bladder. In some embodiments, by being sealingly attached to the body, a volume of transferred liquid may not pass outside of the inner volume at the location where the bladder is attached to the body. In such embodiments, contaminants also may not pass into the inner volume at this attachment location.
- For purposes herein, the term “bladder” refers to flexible membrane that is arranged to move (e.g., in response to an applied pressure) to transfer a volume of fluid into and out of the body of the pipette tip body. In some embodiments, the bladder is arranged to accommodate a volume of liquid that is transferred into the inner volume of the pipette tip body. In some embodiments, the bladder may include a membranous sac. The bladder also may include a substantially planar membrane. As will be appreciated, the bladder may have other suitable arrangements in other embodiments.
- In some embodiments, the bladder is arranged to move back and forth when pressure is applied to the pipette tip to transfer the volume of liquid. For example, the bladder may be moved in a direction away from the first end of the pipette tip when pressure is applied to the pipette tip to draw a volume of liquid into the inner volume. In some embodiments, the bladder may be moved toward the first end of the body to expel a volume of liquid from the pipette tip. For example, in embodiments in which the bladder moves outside of the body to accommodate the volume of liquid, the bladder may be moved into the body of the pipette tip when the volume of liquid is expelled from the pipette tip.
- In some embodiments, the bladder may expand and contract to accommodate a volume of liquid. In such embodiments, the bladder may have a resting volume and an expansion volume, with the bladder expanding from the resting volume to the expansion volume when the pressure is applied to the pipette tip to transfer a volume of liquid into the pipette tip. In some embodiments, the bladder may accommodate a volume of liquid when in the expanded configuration.
- In some embodiments, the bladder is disposed within the body in a collapsed or unformed configuration. For example, the membranous sac may be folded into the pipette tip body when the pipette tip is at rest. In such an example, the bladder may expand to form the membranous sac when pressure is applied to the pipette tip. As will be appreciated, in such an example, the bladder may extend between the first and second ends of the body. In other embodiments, the bladder may include a planar membrane that is positioned between the first and second ends but does not extend between the first and second ends while at rest. In some embodiments, the planar membrane may remain substantially perpendicular to a longitudinal axis of the pipette tip. As will be appreciated, in some embodiments, at least a portion of the membrane may extend towards the first end of the pipette tip, such as in response to gravity. In such embodiments, the planar membrane may be moved back and forth in response to an applied pressure to accommodate a volume of liquid. In other embodiments, in response to an applied pressure, the planar membrane may expand and form a membranous sac.
- In some embodiments, the bladder is attached to the second end of the body, with the first end of the body arranged to transfer the volume of liquid into and out of the pipette tip. The bladder also may be attached to the first end of the body or to a location in between the first and second ends of the body. In some embodiments, the bladder may be permanently attached or may be removably attached to the pipette body.
- In some embodiments, the bladder is arranged to separate the liquid being transferred (e.g., media being transferred from a cell culture vessel) and the pipette or other suitable manipulator arranged to apply a pressure to the pipette tip. In other words, only the bladder and/or the body of the pipette tip may contact the liquid being transferred. As will be appreciated, the extent to which the liquid contacts the bladder depends on the volume of liquid being drawn into the pipette and the pressure being applied to the pipette tip. For example, if only a small volume of liquid is drawn into the pipette, the liquid may only contact the body of the pipette, with the bladder contacting air above the liquid.
- In some embodiments, the bladder divides the pipette tip into first and second compartments, the first compartments being in fluid communication with the first end to transfer liquid into and out of the pipette tip and the second compartment being in fluid communication with the second end for receiving an applied pressure, such as a negative pressure. In some embodiments, a first side of the bladder may be exposed to the first chamber and a second side of the bladder may be exposed to the second chamber. In this regard, the first side of the bladder may be exposed to the liquid being transferred into and out of the pipette tip body while the second side of the bladder is exposed to the pipette. In such embodiments, the bladder may reduce or even eliminate cross-contamination between the liquid and the pipette by physically separating the liquid from the pipette. In some embodiments, because the transferred liquid does not contact the pipette and only contacts the bladder and/or the pipette tip body, contaminants may not pass between the pipette (e.g., the piston of the pipette) and the liquid.
- As will be appreciated, depending on the material used to form the bladder, it may still be possible for contaminants to pass through the bladder and contaminate the liquid even when the liquid is physically separated from the pipette. As such, according to some aspects, the bladder may be formed of a material that is impermeable to known or possible contaminants. For example, in some embodiments, the bladder is formed of a membrane that is hydrophobic or treated to be hydrophobic. The bladder also may formed of a membrane having a nonporous material or of a material with a porosity less than the size of known or possible contaminants. In some embodiments, the bladder is formed of a material that traps the contaminants in the membrane wall. For example, the membrane may be thick enough to prevent contaminants from reaching the liquid while the pipette is being used, yet still be flexible enough to allow the bladder to be manipulated by the applied pressure.
- In some embodiments, the bladder is arranged to separate the liquid from a source of air and/or a vacuum source. As will be appreciated, the bladder also may separate the liquid from other configurations used to apply and remove air to create the vacuum. For example, the liquid transfer system may include a pump, compressed air, valves, membranes or other suitable elements that are separated from the transferred liquid.
- In some embodiments, the vacuum source may be created by moving (e.g., removing or supplying) a fluid such as air or liquid. In such embodiments, the pipette may be connected to a liquid supply (e.g., a pump and valve) via one or more fluid conduits. As will be appreciated, other configurations may be used with the pipette tips to create the vacuum. For example, a hand-held pipette may be used, with a plunger being depressed to create a vacuum source. Such a hand-held pipette may have an embedded pump for creating the vacuum.
- As described in this document, in response to an applied pressure, a volume of liquid may be transferred into or out of the pipette tip, such as from the culture vessel into the pipette tip and/or from the pipette tip to a cell culture vessel. For purposes herein, being transferred, drawn, and/or expelled into or out of the pipette tip may mean that the volume of liquid is transferred, drawn, and/or expelled into or out of the inner volume of the body of the pipette tip. It also may mean that the volume of liquid is transferred, drawn, or expelled into or out of the bladder (e.g., the stretched membrane) as well as the inner volume.
- In some embodiments, the applied pressure is a negative pressure that creates a vacuum that is applied to the bladder. For purpose herein, a negative pressure may mean that there is a negative pressure differential between the air pressure in a container, the pressure of the air in the pipette and/or pipette tip above the bladder, and the air pressure of the environment (e.g., of the atmosphere outside the tip and/or below the bladder). As will be appreciated, the more air that is removed from the pipette and/or pipette tip above the bladder, the greater the vacuum force being applied on the bladder. In some embodiments, the extent of the vacuum (and, thus, the extent of the negative pressure) depends on the surface tension and volumetric weight of the culture media. Accordingly, these additional factors can affect the pressure differential that is required to draw liquid (e.g., the culture media) into the pipette tip.
- In some embodiments, in response to the applied negative pressure, e.g., a negative pressure applied via a manipulator, such as a pipette, the bladder is moved outside of the inner volume defined by the body. For purposes herein, being moved outside the body of the pipette tip and/or pipette may mean that the bladder is retracted out of the inner volume defined by the pipette tip body. For example, the bladder may move outwardly beyond a plane extending through the second end of the body. In some embodiments, the bladder is at least partially retracted outside of the body. In such embodiments, when the bladder is retracted in response to the applied negative pressure, a volume of liquid is drawn into the pipette tip. In some embodiments, in response to the applied pressure, a volume of liquid may be drawn into the bladder.
- As will be appreciated, the bladder need not extend outside of the body when pressure is applied to the pipette tip to draw a volume of liquid into the inner volume. For example, in embodiments in which the bladder is disposed midway between the first and second ends of the body, the bladder may be extended but not move outwardly beyond the body. As will be further appreciated, although embodiments have been described in which a negative pressure is used to draw the bladder outwardly of the body, in other embodiments, the bladder may be moved inside of the body (e.g., towards the first end of the body) in response to an applied pressure.
- In some embodiments, the applied pressure is a positive pressure. As will be appreciated, a positive pressure may mean that there is a positive pressure differential between the air pressure in a container, the pressure of the air in the pipette and/or pipette tip above the bladder, and the air pressure of the environment (e.g., of the atmosphere outside the tip and/or below the bladder). In some embodiments, when the pressure applied to the bladder is greater than the pressure of the environment, the bladder is moved (e.g., pushed or retracted) back into the body to dispense at least a portion of a volume (e.g., a volume of liquid media) from the pipette tip.
- In some embodiments, the pipette tip is arranged to accommodate a volume of liquid. In some embodiments, at least a portion of the inner volume of the body may be arranged to accommodate the volume of liquid. As will be appreciated, the portion of the inner volume capable of accommodating a liquid may be defined based on the position of the bladder within the body. For example, if the bladder is positioned at a location midway between the first and second ends, the pipette tip may be arranged to accommodate a volume of liquid that is only about half of the total volume of the inner volume. In some embodiments, the volume of liquid accommodated by the pipette tip, also may include a volume of liquid that the bladder is capable of accommodating. In some embodiments, the volume of the bladder includes a volume enclosed by the membranous sac, such as the expansion volume if the bladders is configured to expand and contract. For example, in some embodiments, the volume of the membranous sac includes the volume that the membrane is stretched from the resting position to the expanded position (e.g., when the membrane is stretched to take on the shape of a bladder). In this regard, the total volume of liquid accommodated by the pipette tip may be less than or equal to a sum of the volume of the inner volume of the pipette tip body and a volume accommodated by the bladder.
- In some embodiments, a pipette tip may have a body that can accommodate 1 μL of liquid and a bladder that may accommodate up to about 9 μL. In such a situation, the pipette may be configured to accommodate volumes between about 0 μL and 10 μL of liquid. In some embodiments, the may also be made of an elastic material that allows the bladder to expand and accommodate an even larger volume of liquid. As will be appreciated, in these embodiments, the pipettes may be configured to accommodate a larger range of volumes of liquid than traditional pipettes (e.g., a typical 1 μL pipette tip is limited to volumes between 0 μL and 1 μL).
- In some embodiments, the volume of liquid accommodated by the pipette tip is proportional to an amplitude of the pressure differential (e.g., between the air in the container and the environment) and the duration of the applied pressure. For example, applying a greater negative pressure for a longer period of time may draw a larger volume of liquid into the pipette tip than applying a lesser negative pressure to the bladder for the same time period.
- In some embodiments, the bladder may be permanently attached to the pipette tip body (e.g., at the second end). The bladder also may be removably attached to the body. For example, the bladder may be snapped into the pipette tip prior to use.
- In some embodiments, the liquid transfer device includes a manipulator, such as a pipette, that, in some embodiments, is positioned adjacent the second end of the tip. The tip may be removably attached to the manipulator.
- In some embodiments, the pipette includes a pipette shell which is disposed inside the pipette to separate the pipette body from the pipette tip. As will be appreciated, in such embodiments, the pipette shell may further minimize cross contamination between the pipette and the liquid being drawn into the pipette tip. In some embodiments, the pipette shell is disposable. In such embodiments, the pipette shell may be attached to the pipette tip and/or pipette while the liquid is being drawn into the pipette tip and thereafter disposed. In other embodiments, the pipette shell may be reusable. As will be appreciated, in such embodiments, the pipette shell may be sterilized between uses.
- In some embodiments, the pipette shell may be discharged from the pipette while still being attached to the pipette tip. In such embodiments, the pipette shell may be used for storing the pipette tip and the liquid drawn into the pipette tip. In some embodiments, a pressure is applied to the pipette tip via the pipette shell. For example, in some embodiments, the pipette shell may have an opening through which pressure (e.g., air or fluid pressure) is applied. In other embodiments, the pipette shell may include a valve for regulating the pressure applied to the pipette tip.
- In some embodiments, the liquid transfer system also includes a second pipette tip having a second pipette body defining a volume and having first and second ends, and a bladder sealingly attached to the body of the second pipette tip. In some embodiments, the bladder is disposable in the inner volume of the second pipette tip. In some embodiments, the bladder may be disposed at a position between the first and second ends, and extend towards the first end (such as when at rest). In such embodiments, the manipulator may be arranged to apply a pressure to the first and/or second bladders to transfer a second volume of liquid into or out of the first and/or second pipette tips, respectively. In some embodiments, the first and second volumes are transferred out of the same culture vessel, although the first and second volumes may be transferred out of different culture vessels (e.g., transferring the first volume of liquid out of a first cell culture vessel and transferring a second volume of liquid out of a second cell culture media).
- In some embodiments, the pipette tip is reusable. That is, the pipette may be used to transfer two or more volumes of media containing cells from the same culture vessel prior to disposal. The pipette also may be used to transfer volumes of media from two or more culture vessels. In such embodiments, as will be appreciated, the pipette tip may be sterilized (e.g., via treatment with an antiseptic solution) prior to transferring each sample. The pipette tip also may be disposable such that the tip is only used for a single liquid transfer. In these situations, the pipette tip may be removably attached to the pipette.
- In some embodiments, the pipette tip may be used to evaluate the volume of the liquid being transferred into the pipette tip. For example, a sample of the volume of liquid in the pipette tip may be subject to further testing to determine the number of cells in the sample, which could be extrapolated to determine the number of cells in the volume of liquid (or in the culture vessel).
- In some embodiments, the pipette tip is used in a cell culture incubator having an incubator cabinet with an internal chamber for incubating cells in one or more cell culture vessels. In such embodiments, the pipette tip may be fluidly coupled to a manipulator that applies a pressure to the bladder (e.g., the formed membranous sac and/or the at rest planar membrane) in the pipette tip body. The manipulator may include one or more pipettes arranged to transfer a volume of media comprising the cells into or out of one or more cell culture vessels within the internal chamber. In some embodiments, the incubator cabinet also has a door opening from an external environment to the internal chamber. An imager may be used to image the cells within the internal chamber. A cell culture vessel transfer device may be used to move one or more cell culture vessels between locations within the internal chamber.
- As used herein, an “incubator cabinet” is a housing that includes one or more chambers configured to hold one or more cell culture vessels. In some embodiments, an incubator cabinet includes a transfer chamber and an internal chamber, one or both of which are configured to hold one or more cell culture vessels. In some embodiments, an incubator may include one or more other elements such as one or more gas sources (e.g., a compressed gas cylinder or ozone generator), tubing (e.g., to convey one or more liquids or gases such as water, distilled water, deionized water, cell culture medium, air, carbon dioxide, ozone, and oxygen), airflow mechanisms (e.g., valves, release valves, pinholes, gas regulators, and mass flow regulators), pressure mechanisms (e.g., a pump such as a dry scroll pump, rotary pump, momentum transfer pump, diffusion pump, or diaphragm pump; a suction tube; a vacuum system; and an air blower), environmental monitors and controls (e.g., a gas sensor and/or monitor to sense and/or control concentrations of gases such as carbon dioxide, oxygen, and ozone; heat sources or sinks; temperature monitors and controls; humidity monitors; gas scrubbers; air filters; instrumentation for measuring particulate matter; pressure gauges; and flow meters), doors (e.g., openings or panels) windows (e.g., optical windows made of glass, plastic, composite, or other substantially transparent material for viewing an area inside the incubator cabinet), ports (e.g., to permit the introduction or removal of one or more gases or liquids), light sources (e.g., lamps, bulbs, lasers, and diodes), optical elements (e.g., microscope objectives, mirrors, lenses, filters, apertures, wave plates, windows, polarizers, fibers, beam splitters, and beam combiners), imaging elements (e.g., barcode readers, cameras, etc.), electrical elements (e.g., circuits, cables, power cords, and power supplies such as batteries, generators, and direct or alternating current supplies), computers, mechanical elements (e.g., motors, wheels, gears, robotic elements, and actuators such as pneumatic actuators, electromagnetic actuators, motors with cams, piezoelectric actuators, and motors with lead screws), and control elements (e.g., spin-wheels, buttons, keys, toggles, switches, cursors, screws, dials, screens, and touch-screens). In some embodiments, one or more of these other elements are part of the incubator, but are external to the incubator cabinet. In some embodiments, one or more of these other elements are included within the incubator cabinet.
- As used herein, an “internal chamber” is a chamber disposed in an incubator cabinet. An internal chamber may include one or more windows (e.g., optical windows made of glass, plastic, composite, or other substantially transparent material for viewing an area inside the incubator cabinet). An internal chamber may include at least one door (e.g., for permitting the transfer of items into or out of the internal chamber). In some embodiments, the at least one door may be disposed between the internal chamber and a transfer chamber. In certain embodiments, an interlock may prevent the door from opening at an undesirable time (e.g., when a portion of the incubator cabinet is open to the surrounding environment so that contaminants cannot enter the internal chamber). An internal chamber may be of any appropriate size and geometry. In some embodiments, an incubator cabinet may include one or more partitions to define different regions of an internal chamber. One or more internal chambers or partitions thereof may have different environmental conditions. The environment (e.g., air pressure, gas content, temperature, light, and humidity) inside an internal chamber may be measured and/or controlled by one or more meters, monitors, sensors, controls, pumps, valves, apertures, and/or light sources. In some embodiments, an internal chamber may have a gas-tight or hermetic seal, e.g., around one or more windows or doors. In particular embodiments, sealants such as grease and/or mechanical elements such as o-rings, gaskets, septa, KF, LF, QF, quick coupling, or other sealing mechanisms may be used to establish one or more gas-tight seals. In some embodiments, grooves, depressions, protrusions, and/or molded plastic elements may facilitate in establishing one or more gas-tight seals.
- An internal chamber may be made of any useful material. In some embodiments, an internal chamber may include one or more plastics, polymers, metals, or glasses.
- As used herein, a “door” is an element that permits communication between two or more environments or regions when opened and prevents communication between the two or more environments or regions when closed. A door may be of any type, such as a sliding door, pocket door, swinging door, hinged door, revolving door, pivot door, or folding door. The door may be manually, mechanically, or electrically operated. For example, an operator may open or close a door by manually grasping, pulling, pushing, and/or otherwise physically interacting with the door or an element thereof (e.g., a handle) or by operating a mechanical control (e.g., a button, toggle, spin-wheel, key, switch, cursor, screw, dial, screen, or touch-screen). In certain embodiments, a door may be controlled by electrical or digital controls, such as by a computer. A door may be an automatically opening door. For example, a door may include a sensor, such as a pressure, infrared, motion, or remote sensor, that detects whether the door is open or closed and/or controls when the door opens or closes. A door may open by mechanical, pneumatic, electrical, or other means. In some embodiments, one or more doors may include one or more locking mechanisms. In particular environments, one or more doors may include one or more interlocks (e.g., a mechanical interlock such as a pin, bar, or lock or an electrical interlock such as a switch) to prevent one or more doors from opening at an undesirable time (e.g., when one or more chambers are open to the outside environment).
- A transfer device for moving one or more items may be used to move items between the transfer chamber and the internal chamber. In some embodiments, the transfer device comprises a conveyor belt or other similar device for maneuvering items. Non-limiting examples of items that can be moved by transfer devices include cell culture vessels, pipettes, containers, syringes and other materials and instruments utilized in the culture of cells. In some embodiments, more than one transfer device may be included. In some embodiments, one or more transfer devices are located in the transfer chamber and/or in the internal chamber. In some embodiments, a transfer device may include one or more robotic elements. For example, a transfer device may comprise include one or more robotic arms capable of gripping, lifting, pushing, grabbing, sliding, rotating, translating, releasing, raising, lowering, and/or tilting one or more items (e.g., pipettes).
- In some embodiments, the transfer device is a cell culture vessel transfer device. As used herein, a “cell culture vessel transfer device” refers to a device that can transfer one or more cell culture vessels from a first location to a second location. In some embodiments, the transfer device is anchored within the internal chamber. In certain embodiments, the transfer device may transfer one or more items to or from multiple locations in an incubator cabinet. For example, a cell culture vessel transfer device may be used to move a cell culture vessel from a transfer chamber to an internal chamber, and/or from a storage location to an imaging location. In some embodiments, an incubator cabinet includes more than one transfer device for moving one or more items (e.g., separate means for transferring items between and within chambers). A cell culture vessel transfer device may include one or more elements such as valves (e.g., electromagnetic or pneumatic valves), gears, motors (e.g., electrical or stepper motors), stages (e.g., xy or xyz stages), pistons, brakes, cables, ball-screw assemblies, rack-and-pinion arrangements, grippers, arms, pivot points, joints, translational elements, or other mechanical or electrical elements. In some embodiments, a cell culture vessel transfer device may include one or more robotic elements. For example, a cell culture vessel transfer device may include a robotic arm capable of gripping, lifting, pushing, grabbing, sliding, rotating, translating, releasing, raising, lowering, and/or tilting one or more cell culture vessels. In some cases, the cell culture vessel transfer device selectively and releasably grips one or more cell culture vessels. In certain embodiments, a cell culture vessel transfer device may include an arm coupled to a mechanical gripper. For example, an arm may include a mechanical gripper at or near one end for releasably gripping a cell culture vessel and be securely coupled to a surface or element of the incubator at or near the other end. In some embodiments, a robotic arm includes a pivot point where the mechanical gripper couples to the arm and one or more pivot and/or translational joints along the arm to permit flexible rotation and translation of a portion of the arm. In this manner, a robotic arm may access one or more cell culture vessels at different horizontal and vertical positions within an incubator cabinet (e.g., within a storage array in an internal chamber).
- In some embodiments, a cell culture vessel transfer device is an automated transfer device. For example, the automated transfer device may be a robotic arm controlled by a computer that is programmed to move cell culture vessels from a storage location within the internal chamber of the incubator to an imaging location within the internal chamber of the incubator. In some embodiments, a cell culture vessel transfer device is manually operated. For example, a robotic arm located inside the internal chamber of an incubator may be operated by a user-controlled joystick from a location outside of the internal chamber of the incubator in order to move cell culture vessels from a storage location within the internal chamber of the incubator to an imaging location within the internal chamber of the incubator.
- As used herein, a “cell culture vessel” is a device including a housing and one or more chambers for culturing cells. In some embodiments, the housing is a frame. The frame may be coupled to a lid. The one or more chambers may include cell culturing media including one or more membranes. In some embodiments, a cell culture vessel may include nutrients for promoting the growth of cells. In certain embodiments, a cell culture vessel may entirely enclose one or more cells or groups thereof. The housing of a cell culture vessel may include one or more pores or openings to permit the transfer of gases between a cell culture vessel and its surrounding environment. Non-limiting examples of cell culture vessels include flasks, suspension culture flasks, spinner flasks, plates, petri dishes and/or bags. In certain embodiments, a cell culture vessel includes a transparent or optically clear window. For example, a lid coupled to the housing of a cell culture vessel may include an optically clear portion for viewing cells e.g., with a microscope or other imager. In some embodiments, a cell culture vessel includes one or more portions that are substantially non-reflective. In some embodiments, the cell culture vessel is barcoded. Therefore, in some embodiments, the incubator includes a barcode reader.
- In some embodiments, cell culture vessels may be pre-kitted with one or more reagents desired for a particular purpose, e.g., for growing cells, for differentiating cells, for subjecting cells to a particular assay condition, etc. In some embodiments, pre-kitted cell culture vessels contain reagents useful for performing a particular experiment (e.g., cell growth media, growth factors, selection agents, labeling agents, etc.) on a cell culture, in advance of the experiment. Pre-kitted cell culture vessels may facilitate experimental protocols by providing cell culture-ready vessels that do not require the addition of reagents. For example, progenitor cells from a patient may be added to a cell culture vessel pre-kitted with reagents for cell differentiation for the purpose of expanding a population of differentiated cells for autologous cell therapy. Pre-kitted cell culture vessels can be stored at any appropriate temperature, which is determined by the recommended storage parameters of the reagents within the pre-kitted cell culture vessel. In some embodiments, pre-kitted cell culture storage vessels are stored prior to use at temperatures between about −80° C. and about 37° C. In some embodiments, pre-kitted cell culture storage vessels are stored prior to use at temperatures between about −80° C. and about −20° C. In some embodiments, pre-kitted cell culture storage vessels are stored prior to use at temperatures between about −20° C. and about 4° C. In some embodiments, pre-kitted cell culture storage vessels are stored prior to use at temperatures between about 4° C. and about 37° C. In some embodiments, pre-kitted cell culture vessels are disposable. In some embodiments, pre-kitted cell culture vessels are reusable and/or refillable.
- As used herein, a “storage location” refers to a location at which one or more cell culture vessels is stored (e.g., within an incubator cabinet). For example, one or more cell culture vessels may be stored at a storage location and later transferred to a different location (e.g., an imaging location). The storage location may be disposed in the internal chamber of the incubator cabinet. A storage location may be configured for storing a plurality of cell culture vessels. For example, a storage location may include one or more storage arrays, racks, shelves, pigeon-holes, cubbies, trays, slots, or other positions or mechanisms. In some embodiments, a storage location may be configured to store cell culture vessels horizontally, while in other embodiments it may configured to store cell culture vessels vertically. For example, a storage location may include a plurality of slots to receive cell culture vessels stacked vertically over one another. A storage location may be configured to hold 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 100, or any other number of cell culture vessels. In some embodiments, a storage location may be configured to hold greater than 100 cell culture vessels. In some embodiments, a storage location may include a mechanism for moving one or more storage arrays, racks, shelves, pigeon-holes, cubbies, trays, slots, or other positions or mechanisms. For example, a storage location may include one or more motors and movable stages (e.g., an xy or xyz stage) to move a storage rack from one position in an internal chamber to another position in an internal chamber, e.g., to facilitate access to one or more cell culture vessels stored in different locations. In some embodiments, the incubator cabinet may include one or more cell culture vessel transfer devices for moving one or more cell culture vessels.
- A storage location may be configured to securely hold or receive one or more cell culture vessels. For example, one or more components of the storage location may include one or more locking mechanisms that have one or more adhesive, magnetic, electrical, and/or mechanical components (e.g., snaps, fasteners, locks, clasps, gaskets, o-rings, septa, springs, and other engagement members). In some embodiments, a storage location and/or cell culture vessel may include one or more grooves or depressions and/or may involve pieces of molded plastic. For example, a cell culture vessel may include one or more protruded features (e.g., a rim or knob) that are molded for insertion into one or more corresponding grooves, holes, or depressions at a storage location. In some cases, a cell culture vessel may include one or more grooves, holes, or depressions that are molded to fit one or more corresponding protruded features at a storage location.
- As used herein, an “imager” refers to an imaging device for measuring light (e.g., transmitted or scattered light), color, morphology, or other detectable parameters such as a number of elements or a combination thereof. An imager may also be referred to as an imaging device. In certain embodiments, an imager includes one or more lenses, fibers, cameras (e.g., a charge-coupled device camera or CMOS camera), apertures, mirrors, light sources (e.g., a laser or lamp), or other optical elements. An imager may be a microscope. In some embodiments, the imager is a bright-field microscope. In other embodiments, the imager is a holographic imager or microscope. In other embodiments, the imager is a fluorescence imager or microscope.
- As used herein, a “fluorescence microscope” refers to an imaging device which is able to detect light emitted from fluorescent markers present either within and/or on the surface of cells or other biological entities, said markers emitting light at a specific wavelength in response to the absorption a light of a different wavelength.
- As used herein, a “bright-field microscope” is an imager that illuminates a sample and produces an image based on the light absorbed by the sample. Any appropriate bright-field microscope may be used in combination with an incubator cabinet provided herein.
- As used herein, a “holographic imager” is an imager that provides information about an object (e.g., sample) by measuring both intensity and phase information of electromagnetic radiation (e.g., a wave front). For example, a holographic microscope measures both the light transmitted after passing through a sample as well as the interference pattern (e.g., phase information) obtained by combining the beam of light transmitted through the sample with a reference beam.
- A holographic imager may also be a device that records, via one or more radiation detectors, the pattern of electromagnetic radiation from a substantially coherent source, diffracted or scattered directly by the objects to be imaged, without interfering with a separate reference beam and with or without any refractive or reflective optical elements between the substantially coherent source and the radiation detector(s).
- In some embodiments, an incubator cabinet includes a single imager. In some embodiments, an incubator cabinet includes two imagers. In some embodiments, the two imagers are the same type of imager (e.g., two holographic imagers or two bright-field microscopes). In some embodiments, the first imager is a bright-field microscope and the second imager is a holographic imager. In some embodiments, an incubator cabinet comprises more than 2 imagers. In some embodiments, cell culture incubators comprise three imagers. In some embodiments, cell culture incubators having 3 imagers comprise a holographic microscope, a bright-field microscope, and a fluorescence microscope.
- As used herein, an “imaging location” is the location where an imager images one or more cells. For example, an imaging location may be disposed above a light source and/or in vertical alignment with one or more optical elements (e.g., lens, apertures, mirrors, objectives, and light collectors).
- As used herein, a “fiducial mark” refers to a feature that facilitates alignment of one or more components. In some embodiments, fiducial marks may include one or more hole apertures over a fluorescent media or printed or embossed fluorescent material. In other embodiments, fiducial marks may include grids, lines, or symbols. In some embodiments, one or more cell culture vessels include one or more fiducial marks to facilitate alignment of one or more cell culture vessels with an imager. In some embodiments, fiducial marks may be associated with moving parts, including transfer devices and robotics devices.
- In some embodiments, a cell culture vessel is substantially aligned with an imager. In some embodiments, a cell culture vessel is substantially aligned with an imager via the use of at least one fiducial mark. As used herein, the term “substantially aligned” implies that one or more elements are substantially overlapping, identical, and/or in line with one another. The substantial alignment of one or more cell culture vessels at one or more locations (e.g., imaging locations) may facilitate the analysis of a sample by permitting overlapping images of the cell culture vessel to be obtained. For example, a cell culture vessel may be imaged at a first imaging location by a first imager and subsequently imaged at a second imaging location by a second imager. If the imaging fields of the respective imagers are substantially aligned, the images recorded by the first and second imagers may be combined (“stitched together”) for analysis. One or more fiducial marks present on one or more cell culture vessels may facilitate substantial alignment. In some cases, one or more fiducial marks present at one or more imaging or other locations (e.g., manipulation or maintenance locations) may facilitate substantial alignment.
- As used herein, a “manipulator for manipulating cells” refers to a device for manipulating cells in the internal chamber. The manipulator may include one or more needles, capillaries, pipettes, and/or micromanipulators. For example, the manipulator may include a cell picker. A manipulator for manipulating cells may operate by detecting desirable cells or groups thereof present at a first location based on a predetermined criterion and transferring the desired cells or groups thereof from the first location to a second location. A cell picker may detect, pick, and/or transfer desirable or undesirable (e.g., pre-differentiated cell weeding) cells or groups thereof based on a manual or automated analysis. In some embodiments, information produced by an imager may be analyzed to detect desirable or undesirable cells. The cell picker may then transfer the desirable or undesirable cells to the second location. For example, an imager may image cells in or on a cell culture vessel at an imaging location, and the image used to identify desirable or undesirable cells or groups thereof. The cell picker may then transfer the desirable or undesirable cells, e.g., by contacting each desired cell or cells with a needle, capillary, pipette, or micromanipulator and effecting a movement of the cell or cells, from their first location to a second location in or on the cell culture vessel or elsewhere in the internal chamber. In some embodiments, the first location of the cells may be in or on a cell culture vessel. In particular embodiments, a cell picker transfers cells from a first location in or on a cell culture vessel to a second location on the same cell culture vessel. In other embodiments, a cell picker transfers cells from a first location in or on a first cell culture vessel to a second location in or on a second cell culture vessel. In certain other embodiments, a cell picker transfers cells from a first location in or on a cell culture vessel to a second location in the internal chamber that is not in or on a cell culture vessel.
- In some embodiments, the manipulator includes at least one microelectrode. As used herein, the term “microelectrode” refers to an electrical conductor used to deliver electrical stimulation to a cell. For example, microelectrodes can be used to deliver genetic material into a cell by electroporation. In some embodiments, the manipulator includes at least one microinjector. Generally, microinjectors are glass micropipettes that have been pulled to form a sharp, hollow structure capable of piercing the membrane of a cell and serving as a conduit for the introduction of genetic material into the cell.
- In some embodiments, a manipulator is manually operated. For example, a manipulator having a cell picker located inside the internal chamber of an incubator cabinet may be electronically-linked to and controlled by a user-directed joystick located outside the internal chamber of the incubator cabinet. In some embodiments, the user-directed joystick is connected to a display device. In some embodiments, the display device shows images captured by an imaging device inside the internal chamber of the incubator cabinet.
- In some embodiments, a manipulator is automated. For example, a manipulator inside an internal chamber of an incubator cabinet may be electronically connected to a controller outside of the incubator cabinet, which is electronically connected to a computer that directs the manipulator. For example, the controller may instruct the manipulator to apply a vacuum to one or more pipette tips fluidly connected to the manipulator.
- One or more elements of the manipulator for manipulating cells may be sterilized, for example using a sterilizing composition or method (e.g., ethanol or ozone gas, UV Light, Hydrogen peroxide), prior to manipulation.
- As used herein, “manipulation location” refers to the location at which cells are manipulated by a manipulator for manipulating cells (e.g., a cell picker). In certain embodiments, the manipulation location may be the same as the imaging location.
- According to one aspect, the cell culture incubator includes an incubator cabinet with an imaging location and a manipulating location. Cells of a cell culture vessel are imaged at the imaging location by an imager and manipulated at the manipulating location by a manipulator. In some embodiments, the imaging location and the manipulating location are two distinct locations within the incubator cabinet. The cell culture incubator may include a transfer device that moves cell culture vessels between the imaging location and the storage location. In other embodiments, the imaging location and the manipulating location are the same, such that the cells of culture vessels are imaged at the manipulation location.
- In some embodiments, an imager may be used in conjunction with a manipulator. For example, an imager may image cells in or on a cell culture vessel at an imaging location, and the image used to identify desirable cells or groups thereof. The cell picker, which may or may not be resident at the imaging location, may then transfer the desirable or undesirable cells, e.g., by contacting each desired cell or cells with a needle, capillary, pipette, or micromanipulator and effecting a movement of the cell or cells, from their first location to a second location in or on the cell culture vessel or elsewhere in the internal chamber. In some embodiments, a cell picker transfers cells from a first location in or on a cell culture vessel to a second location on the same cell culture vessel. In other embodiments, a cell picker transfers cells from a first location in or on a first cell culture vessel to a second location in or on a second cell culture vessel. In certain other embodiments, a cell picker transfers cells from a first location in or on a cell culture vessel to a second location in the internal chamber that is not in or on a cell culture vessel.
- In some embodiments, a single location within the incubator cabinet may serve as an imaging location and a manipulating location. In one embodiment, cells are imaged as they are manipulated by the manipulator. In some embodiments, the imaging location and imaging location may be at separate locations within the incubator cabinet.
- In some embodiments, the manipulator includes sensors that allow it to report its position and determine when it has touched the bottom of the cell culture vessel. In some embodiments, an imager may be used to guide the manipulator in order to achieve repeatability and accuracy. In some embodiments, compliance (e.g., springiness) in the manipulator may be used to relax the need for extreme mechanical accuracy.
- In some embodiments, one or more manipulators are used to manipulate one or more pipettes as described in this document. In some embodiments, manipulators are used to place and/or remove pipette tips on the pipettes.
- Turning now to the figures,
FIG. 1 illustrates a pipette tip (50) according to one aspect of the present document. As shown in this figure, the pipette tip (50) includes a body (52) defining an inner volume and having first and second ends (56, 54). The pipette tip (50) also includes a bladder (58) disposed within the inner volume of the body (52). In this embodiment, the bladder (58) is defined by a membranous sac, formed by a membrane (60), that extends towards the first end (56). In some embodiments, the second end (54) of the pipette tip (50) is arranged to be attached (e.g., removably attached) to a pipette (seeFIG. 5 ). In some embodiments, the first end (56) is the exit end of the body (52). In such embodiment, the first end (56) may be configured to transfer a volume of liquid into and out of the pipette tip (50), such as into and out of the inner volume of the body (52). - In some embodiments, as shown in
FIG. 2 , the bladder (58) may be defined by a planar membrane (60) that is substantially perpendicular to a longitudinal axis A of the pipette tip (50). As will be appreciated, in some embodiments, at least a portion of the membrane (60) may extend towards the first end (56) of the body in response to gravity. In some embodiments, in response to an applied pressure, the planar membrane (60) may move back and forth. In some embodiments, in response to the applied pressure, the planar membrane (60) may expand and contract. For example, the bladder (58) may expand from the planar membrane (60) shown inFIG. 2 to the membranous sac shown inFIG. 1 . - Turning back to
FIG. 1 , in some embodiments, the bladder (58) may be attached to the second end (54) of the body (52) and extend towards the first end (56) of the body. In such embodiments, the bladder (58) may be attached to the body (52) at a periphery of the bladder (58). In some embodiments, the bladder may be sealingly attached to the body (52) such that a fluid tight seal is formed between the body (52) and the bladder (58). In such embodiments, as will be described, liquid may not travel beyond the bladder, at the location where the bladder is attached to the body, and contaminants may not travel into the inner volume. - As will be appreciated, although the bladder (58) is attached to the second end (54) in the embodiment shown in
FIG. 1 , in other embodiments, the bladder (58) may be attached to another suitable location of the body. For example, as shown inFIGS. 2 and 3A , the bladder (58) may be attached to a location in between the first and second ends (56, 54) of the body (52). As shown inFIG. 3A , the bladder (58) may still extend towards a first end (56) of the body (52). In some embodiments, the bladder (58) may extend only part of the way toward the first end (56) of the body, while in other embodiments, the bladder may extend to a position at or near the first end (56) of the body. As shown inFIG. 4A , in still another embodiment, the bladder (58) may be attached at or near the first end (56) of the body (52). - In some embodiments, as shown in
FIG. 1 -FIG. 4A , the bladder (58) divides the body (52) into two chambers (62, 64). In such embodiments, the first chamber (62) is in fluid communication with the first end (56) of the pipette tip, e.g., where the liquid is transferred into and out of the body, and the second chamber (64) is in fluid communication with the second end of the body (54). The second chamber (64) also may be in fluid communication with a pipette (see, e.g.,FIG. 5A ) for receiving an applied pressure (e.g., a negative pressure, as described in this document). In such embodiments, a first side of the bladder may be exposed to the transferred liquid while a second, opposite side of the bladder may be exposed to the pipette. In this regard, the bladder (58) may separate the pipette from the transferred liquid. As shown inFIG. 5C , for example, the bladder may separate the culture media transferred into the pipette tip from the pipette (66). Such separation may reduce or even eliminate contamination between the pipette and the media in such embodiments - In some embodiments, the bladder (58) is permanently attached to the body (52) of the pipette tip (50). In such embodiments, the bladder (58) may be bonded, glued, fastened, or otherwise attached, to the pipette tip. The bladder (58) also may be ultrasonically welded to the pipette tip. In other embodiments, the bladder (58) may be removably attachable to the pipette tip (50). For example, the bladder (58) may be snapped onto the body (52) of the pipette tip (50) prior to use (e.g., prior to transferring the volume of liquid into or out of the pipette tip). As will be appreciated in view of the above, such attachment methods may form a fluid tight seal between the bladder and the body.
- In some embodiments, the bladder (58) is formed of a membrane made of a strong yet flexible material. For example, in some embodiments, the bladder (58) may be arranged to expand and contract to accommodate the volume of liquid. The bladder (58) also may be moved between a position inside of the body to a position outside of the body to accommodate the volume of liquid. In some embodiments, the bladder (58) may have elastomeric properties. The bladder (58) also may be formed of a membrane (60) made of organic and/or inorganic materials. In some embodiments, the bladder (58) includes a polymeric structure. In some embodiments, the bladder (58) includes a latex material. In some embodiments, the bladder (58) is arranged to retain the liquid within the bladder (58). In such embodiments, the bladder may be formed of a membrane (60) that is non-porous and/or liquid impermeable. For example, the membrane may be made of a hydrophobic material or may be treated to be hydrophobic. As will be appreciated, such characteristics of the membrane may prevent the transferred liquid from passing from the pipette tip into the pipette, which may contaminate the pipette (and future samples).
- In some embodiments, the bladder (60) may include a smooth surface. In some embodiments, the bladder (58) does not include folds, while in other embodiments, the bladder may include folds.
- In some embodiments, as shown in
FIG. 1 , the bladder (58) may include a convex configuration when the bladder is at rest (e.g., there is no applied pressure). In such embodiments, the bladder may have a curved configuration below a plane X that extends through the periphery of the bladder. In some embodiments, at least a portion of bladder may move on the other side of the plane X in response to an applied pressure. In some embodiments, the bladder may take on a concave configuration above the plane X in response to an applied pressure. - In some embodiments, the pipette tip (50) is configured to transfer a range of volumes of a liquid (e.g., from about 1 μL to about 10 mL, or more, of liquid). For example, the pipette tip (50) may be configured to transfer culture media between a culture vessel and the pipette tip and back to the culture vessel or to another culture vessel. As will be appreciated, a manipulator, such as a pipette (66) (see
FIG. 5A ), may be configured to apply a pressure to the pipette tip to transfer the desired volume(s) of liquid into and out of the pipette tip. In some embodiments, a controller may be programmed to instruct the pipette (66) transfer the desired volume(s) of liquid into the pipette tip. - As will be appreciated, in these examples, the volume of liquid accommodated by the pipette tip is proportional to the pressure applied to the bladder. That is, the volume of liquid drawn into (or dispensed out of) the pipette tip is dependent on the amplitude of the pressure differential (e.g., between air in the container and the environment) and the duration of the applied pressure. For example, applying a greater negative pressure for a longer period of time will draw a larger volume of liquid into the pipette tip than applying a lesser negative pressure to the bladder for the same time period. As such, in these embodiments, the pipette (66) may be instructed (e.g., via human intervention or via a controller) to apply a pressure to the bladder for the period of time corresponding to the desired volume of liquid.
- In some embodiments, the bladder (58) and/or pipette tip (50) may comprise a plastic material. For example, the bladder (58) may include a polyurethane and/or silicone material. In one embodiment, the pipette tip (50) comprises a polycarbonate, polypropylene, polyethylene, and polystyrene material, although other suitable materials may be used. In some embodiments, as shown in
FIG. 1 , the pipette tip (50) may have a frusto conical shape, although other suitable shapes may be used (e.g., a cylindrical shape). -
FIGS. 5A-5E illustrate embodiments of the pipette tip (50) being used to transfer a volume of liquid, such as a volume of media containing cells (68), into and out of the pipette tip (50).FIG. 5A shows the pipette tip (50) attached to a pipette (66). As shown in this figure, the bladder (58) has divided the pipette tip into two chambers (62, 64), with the first chamber (62) being in fluid communication with the first end (56) of the body (52) and the second chamber (64) being in fluid communication with the second end (54) of the body and with the pipette (66). In this regard, the bladder may separate the media culture from the pipette. - As shown in
FIGS. 5C-5D , in some embodiments, the second chamber (64) is arranged to receive first and second applied pressures to transfer a volume of liquid into and out of the pipette tip (50), respectively. To begin transferring a volume of liquid into the pipette tip (50), as shown inFIG. 5B , the first end (56) of thepipette tip 50 is inserted into media (68) containing cells stored in a culture vessel (70). As shown inFIGS. 5A and 5B , when the pipette tip (50) is first attached to the pipette (66) and no pressure has been applied to the bladder (58), the bladder (58) is disposed inside of the body (52) and extends from the second end (54) towards the first end (56). As with other embodiments, in this at-rest position, the bladder extends below the plane X extending through the periphery. As shown inFIG. 5C , when a first pressure P1 is applied to the bladder, the bladder (58) is retracted in a direction away from the first end (56) of the pipette tip (50) (see arrow), thus drawing the media 68) into the pipette tip (50). In this arrangement, at least a portion of the bladder is moved on the other side of the plane X - As shown in
FIG. 5C , in response to the applied pressure, the media (68) has been drawn in to the body (52) and into the bladder (58) of the pipette tip (50). As will be appreciated, in other embodiments, the media (68) may be drawn into only one of the bladder (58) and the body (52). As described in this document, the level of media drawn into the pipette tip body (52) and/or bladder (58) depends on the applied pressure and the duration of applied pressure. - In some embodiments, the first pressure P1 applied to the bladder (58) may be a negative pressure. As described in this document, such a negative pressure may create a vacuum that is applied to the bladder (58), thus causing the bladder (58) to retract out of the body (52) to draw the media (68) into the pipette tip (50).
- As shown in
FIG. 5C , in some embodiments, the bladder (58) may be been completely retracted out of the body (52) of the pipette tip (50) and into a body (72) of the pipette (66). In other embodiments, the bladder (58) may be only partially retracted into the pipette body (72). In still other embodiments, as shown inFIGS. 3B and 4B , the bladder need not be retracted out of the pipette tip body when a pressure is applied. As will be appreciated, the movement of the bladder with respect to the body of the pipette tip may be determined based on the position in which the bladder is attached to the body of the pipette tip, the size and stretchability of the bladder, and the applied pressure. For example, a substantially planar membrane may be attached at the second end of the pipette tip body but not be moveable out of the pipette tip body (e.g., beyond the plane extending through the second end of the pipette tip body. In other embodiments, as shown inFIGS. 3A and 3B , the bladder may be positioned midway between the first and second ends. In such embodiments, even with the bladder moving and/or expanding, the bladder does not move out of the inner volume of the pipette tip. As will be appreciated, in embodiments in which the bladder is attached at the first end of the pipette tip body, the bladder may extend outwardly beyond the first end of the pipette tip body when the bladder is in an at-rest position. - Turning back to
FIG. 5C , in embodiments in which the bladder is retracted out of the pipette tip body, the bladder may be arranged to accommodate a volume of liquid. In such embodiments, the volume of accommodated liquid in the bladder may be less than or equal to the volume V1 of the bladder. The exact volume of accommodated liquid in the bladder may vary depending on the pressure exerted on the pipette tip and the amount to which the bladder is extracted outwardly beyond the pipette tip body. - As described in this document, the pipette tip (50) may be configured to accommodate a volume of liquid. In some embodiments, as shown in
FIG. 5C , the volume of accommodated liquid may be less than or equal to a sum of the volume V1 of the bladder (58) and a volume V2 of the body (52) of the pipette tip (50). For purposes herein, the volume of the body of the pipette tip (50) is defined as the volume of between the first end (56) of the body (52) and the location where the bladder (58) is attached to the body (see, e.g., the line labeled X, a plane extending through the periphery of the bladder). As will be appreciated, in the embodiment shown inFIG. 5C , where the bladder (58) is attached at the second end (54) of the body, the volume V2 of the body is defined as the volume between the first and second ends (56, 54). In embodiments in which the bladder is attached to a location in between the first and second ends (56, 54), however, the volume may be defined as a volume between the first end a the plane extending through the periphery of the bladder, at an intermediate location. For purposes herein, the volume of the bladder is defined as the volume enclosed by the membrane (60) attached to the body (52). That is, the volume of the bladder (58) may include the volume between the membrane (60) in the moved/expanded configuration and the location to which the bladder is attached to the body (e.g., the plane extending through the periphery). - As will be appreciated, the volume of media (68) drawn into the pipette tip (50) need not fill the entire volume defined by the sum of the volumes of the bladder and the pipette tip body. Thus, the volume of the liquid may be less than the sum of the volume of the body and the volume of the bladder in some embodiments. In some embodiments, however, the entire volume may be accommodated by the media.
- Once the media (68) has been transferred into the pipette tip (50), the media (68) may then be transferred out of the pipette tip (50) and back to the same culture vessel (70). The media (68) also may be transferred to a another culture vessel (70). In either situation, as shown in
FIG. 5D , a second pressure P2 may be applied to the bladder to move the bladder towards the first end (56) of the body (52) (see arrow), thus expelling the media from the pipette tip. As will be appreciated, the entire volume of media need not be expelled from the pipette tip. - In embodiments in which additional liquid transfers are to be performed via the pipette (66), the steps shown in
FIGS. 5B-5D may be repeated with the same pipette tip (50) and culture vessel (70). Once the transfer(s) have been finished, the pipette tip (50) may be removed from the pipette (66), as shown inFIG. 5E . In embodiments in which the pipette tip (50) is reused with different culture vessels, the pipette tip (50) may be sterilized prior to repeating the steps shown inFIGS. 5B-5D with the new culture vessel. As will be appreciated, the pipette tip (50) also may be disposed after each liquid transfer, with a fresh pipette tip (50) being attached to the pipette (66). - As will be appreciated, although embodiments are shown and described for transferring a fluids, such as a culture media, the pipette tips may be used to transfer other types of fluids (e.g., air or water).
- In some embodiments, the pipette tip (50) is removed from the pipette (66) by pulling the pipette tip (50) away from the pipette (66), (see the arrow in
FIG. 5E ). In other embodiments, the pipette (66) may have an ejection button (not shown) to eject the pipette tip (50) from the pipette (66). - As will be appreciated, although the embodiments shown in
FIGS. 5A-5E illustrate a bladder (58) being moved (e.g., retracted) into and out of the pipette tip, in other embodiments, the first and second pressures P1, P2 may be used to expand and contract the bladder to draw in and dispense the liquid from the bladder. In such embodiments, the bladder may be expanded into the body (72) of the pipette (66). - As will be further appreciated, although the embodiments shown in
FIGS. 5A-5E include a bladder defined by a membranous sac, the same steps may be repeated with a pipette tip (50) having a bladder (58) defined by a planar membrane. In such an embodiment, the first pressure P1 may be used to move the membrane back and forth. In other embodiments, the first pressure P1 may be used to stretch the planar membrane into the membranous sac, which is thereafter used to accommodate the volume of liquid. In such embodiments, the second pressure P2 also may be used to move the stretched bladder back into the body of the pipette tip (50) to dispense the liquid from the pipette tip (50) and return the membranous sac to the planar membrane configuration. - Although
FIGS. 5A-5E show the pipette tip (50) being attached directly to the pipette (66), with the bladder (58) being retractable into the body (72) of the pipette (66), in other embodiments, the pipette tip (50) may be further separated from the pipette (66). For example, as shown inFIG. 6A , the pipette may include a pipette shell (74) that is disposed within the body (72) of the pipette (66) and arranged to receive the bladder (58) in response to an applied pressure. In such an embodiment, as shown inFIG. 6B , the pipette shell (74) may include a body (76) into which the bladder (58) is retracted in response to the first pressure P1. As with the pipette body (72), the body (76) of the pipette shell (74) may be greater than or equal to the volume V1 of the bladder (58). In some embodiments, the pipette shell (74) is removably attachable to the pipette (66) and/or the pipette tip (50). For example, the pipette shell (74) may be attached to the pipette (66) and/or pipette tip (50) prior to attaching the pipette tip (50) to the pipette (66) and drawing a volume of liquid into the pipette tip (50). - In some embodiments, the pipette tip (50) may be separated from the pipette shell (74) after the liquid has been drawn into and out of the pipette tip (50). In other embodiments, the pipette shell (74) may remain attached to the pipette tip (50) after the pipette tip (50) has drawn the liquid into the pipette tip (50). In such embodiments, the liquid sample may be stored with the pipette tip. For example, the pipette shell (74) may be arranged to maintain the pressure applied to the pipette tip (50) after the pipette tip (50) has been separated from pipette (66) so that the pipette tip (50) may be stored in an upright position. In embodiments in which the applied pressure is lost once the pipette tip has been separated from the pipette, the pipette tip (50) and pipette shell (74) may be inverted, with pipette shell (74) serving as storage for the retracted bladder (with the liquid sample). In some embodiments, a cover (not shown) may be attached to the pipette tip (50) for storing the liquid sample.
- In some embodiments, the pipette shell (74) includes a pressure applicator (78) that is configured to allow the pressure to be applied to the pipette tip (e.g., via the pipette (66)). In some embodiments, the pressure applicator (78) includes an opening in the pipette shell (74) through with the pressure may be applied to the bladder. In other embodiments, the pressure applicator (78) may include a valve for regulating the applied pressure (e.g., a negative pressure) to the bladder.
- In some embodiments, the pipette shell may be made of a similar material as the pipette tip and bladder. For example, the pipette shell may be made of a plastic material. As will be appreciated, the pipette shell may be made of a rigid material, thus allowing the pipette shell to rest stably on a surface after an attached pipette tip and pipette shell are inverted.
- In such embodiments, the pipette shell (74) may be disposable, although the pipette shell (74) also may be reusable. In embodiments in which the pipette shell is reusable, the pipette shell may be sterilized in between uses.
-
FIG. 7 illustrates an embodiment in which the pipette tip (50) is used in a cell culture incubator. The cell culture incubator includes an incubator cabinet having an internal chamber (100) for incubation of cells in one or more cell culture vessels. The incubator cabinet includes an external door (101) that opens and closes to permit communication between an external environment and the incubator cabinet. In some embodiments, the external door opens and closes to permit communication between an external environment and the internal chamber. The internal chamber is configured to hold one or more cell culture vessels. The one or more cell culture vessels are stored in a storage location (102). In some embodiments, the storage location is a free-standing structure. For example, a storage location may be a test tube or culture flask rack that can be removed from the internal chamber of the incubator for loading and unloading of culture vessels. In some embodiments, the storage location is affixed to a surface of the internal chamber. For example, the storage location may be a series of racks or shelves that are connected to the walls or floor of the internal chamber and are thus not able to be removed from the incubator cabinet. - In some embodiments, the cell culture incubator includes a cell culture vessel transfer device (103) for moving one or more cell culture vessels. The cell culture transfer device may be affixed to any appropriate surface of the internal chamber of the incubator. For example, the cell culture vessel transfer device may be affixed to the top or ceiling of the internal chamber. Alternatively, the cell culture vessel transfer device may be affixed to a side wall of the internal chamber. In some embodiments, the cell culture vessel transfer device is not affixed to the wall of the internal chamber. For example, the cell culture vessel transfer device may rest on a wheeled tripod or other mobile structure that can be moved around the internal chamber.
- In some embodiments, the transfer device moves one or more cell culture vessels from a storage location (102) to an imaging location (105) or to a manipulation location (107). The transfer device (103) can also move one or more cell culture vessels from an imaging location (105) to a manipulation location (107) or from a manipulation location (107) to an imaging location (105). When imaging or manipulation are complete, the transfer device (103) moves one or more cell culture vessels from an imaging location (105) or a manipulation location (107) to a storage location (102).
- In some embodiments, the incubator cabinet includes a first imaging location (105) and a manipulation location (107). In some embodiments, one or more imaging locations are located on a surface of the internal chamber opposite from an imager. In some embodiments, imaging locations are platforms, either free-standing or affixed to a surface of the internal chamber. In some embodiments, the platform is movable. For example, a movable platform may be affixed to two or more rods that allow the platform to be moved left, right, forward, backward, up or down in relation to an imager. In some embodiments, the movable platform is motorized.
- In some embodiments, the incubator cabinet includes a first imager (104) that images the cells of cell culture vessels when the vessels are at the first imaging location (105). In some embodiments, the first imager is a bright-field microscope. In some embodiments, the first imager is a holographic microscope.
- In some embodiments, a manipulator (106) manipulates the cells of cell culture vessels when the vessels are at the manipulation location (107). In some embodiments, the manipulator has an array of needles, capillaries, pipettes, and/or micromanipulators. For example, the manipulator may include a cell picker. In some embodiments, a manipulator has a cell picker. Generally, manipulation locations share many characteristics with imaging locations, as described herein.
- As shown in
FIG. 7 , the manipulator (106) may be in fluid communication with two of the disclosed pipette tips (50) for transferring a volume of media containing cells into and out of the pipette tips (50). As will be appreciated, the manipulator (106) may be in fluid communication with only one pipette tip in some embodiments or with three or more pipette tips in other embodiments. In some embodiments, the manipulator may be in fluid communication with an array of pipette tips. In such embodiments, the manipulator may apply first and second pressures to manipulate the bladder (e.g., move, retract, expand, contract or stretch). -
FIG. 8 depicts another illustrative embodiment of a cell culture incubator. In some embodiments, the incubator cabinet has a second imager (108). The second imaging location may be at or near the manipulation location (107). In some embodiments, the second imaging location and the manipulation location (107) are the same location. In some embodiments, a second imager (108) images the cells of cell culture vessels while the cells are manipulated by the manipulator (106). In some embodiments, the second imager is a bright-field microscope. In some embodiments, the second imager is a holographic microscope. -
FIG. 9 depicts an illustrative embodiment of a cell culture incubator. In some embodiments, the cell culture incubator has an imaging location and a manipulation location that are the same location (105). As with prior embodiments, the manipulator (106) may be in fluid communication with one or more pipette tips (50) for transferring the volume of media containing cells into and out of the pipette tip(s). -
FIG. 10 depicts illustrative embodiments of further components of a cell culture incubator. As will be appreciated, further components are any component of the incubator that is not otherwise listed or show in one of the previous embodiments or figures. In some embodiments, a cell culture incubator contains barcoded cell culture vessels (109). Thus, in some embodiments, a cell culture incubator has a barcode scanner (110) located inside the internal chamber of the incubator cabinet. In some embodiments, the barcode reader communicates with a computer (111) to relay information about the cell culture vessel for which the barcode has been scanned. In some cases, a barcode scanner may be affixed to any surface of the internal chamber. For example, a barcode scanner can be affixed to a wall of the internal chamber in close proximity to an imaging location (105). - In some embodiments, the cell culture incubator contains at least one probe and/or at least one sensor (113) that measures environmental conditions within the internal chamber. Examples of probes to measure environmental conditions include but are not limited to temperature probes, pressure probes, carbon dioxide (CO2) sensors, oxygen (O2) sensors and relative humidity sensors. In some embodiments, the at least one probe and/or at least one sensor located within an instrument housing (112). The at least one probe and/or at least one sensor is connected to a controller (114). In some embodiments, the controller (114) communicates with a computer (111). Additionally, the controller (114) may communicate with a fluid dispensing system (115). For example, if a CO2 sensor indicates a low CO2 level in the internal chamber, the controller (114) may direct the fluid dispensing system (116) to inject CO2 gas into the internal chamber in order to increase the CO2 level of the internal chamber.
- As will be appreciated, the controller (114) also may communicate with the manipulator (106) to transfer a volume of liquid into and out of the pipette tip (50). For example, the controller may instruct the manipulator (106) to position the pipette tip into a cell culture vessel. Next, the controller may instruct the manipulator to apply a first pressure (e.g., a negative pressure) to the second end (54) of the pipette tip (50) (e.g., to the membrane (60) to draw a volume of media containing the cells of the cell culture into the body of the pipette and/or into the bladder (58). The controller (114) may thereafter instruct the manipulator (106) to apply a second pressure to the second end of the pipette tip (50) to expel the volume of media from the pipette tip (50). As will be appreciated, and as shown in
FIGS. 5E and 5E , in response to the second pressure (e.g., air pressure), the bladder (58) may be moved back into the pipette tip (50) to dispense a volume of liquid from the pipette tip (50). - In some embodiments, the bladder is arranged to separate the liquid in the pipette tip (50) from a source of air and/or a vacuum source. As shown in
FIG. 11A , the bladder may separate the liquid from a pump (80) in the body (72) of the pipette (66). As will be appreciated, the pump (80) is used to apply the pressure to the bladder (58). In other embodiments, as shown inFIG. 11B , the bladder (58) may separate the liquid from a liquid conduit (82) that applies the pressure to the bladder (58). In such embodiments, the liquid conduit (82) may be connected to a valve (84), a pump (86) and a supply (88) of pressurized air or fluid, which regulate and apply the pressure that is applied to the bladder (58). As will be appreciated, either the system may be used in the cell culture incubator. - As will be further appreciated, although embodiments are shown and described as having a bladder in the body, in other embodiments, the membrane may form other structures suitable for separating the liquid from the pipette and for allowing the pipette tip to be reused.
- According to another aspect of the present document, as shown in
FIGS. 12 and 13 , the pipette tips (50) may be nestable. In that regard, a first pipette tip (50 a) may be nested in a second pipette tip (50 b), which, in turn, may be nested in a third pipette tip (50 c). In some embodiments, the nested pipette tips may be compactly stored in a housing (90) of a cartridge (92), such as that shown inFIG. 13 . In some embodiments, the cartridge (92) may be used to load the pipette tip (50) onto the pipette. As shown inFIG. 13 , the pipette (66) may be moved towards the cartridge until the pipette is aligned with the pipette tip (50). The pipette may then be pressed downwardly towards the stack of pipette tips (see arrow labeled D) until the first or top pipette tip (50 a) is attached to the pipette (66) (e.g., via a snap fit attachment). Such a loading process may be performed manually or may be automated. - As will be appreciated, although the cartridge shows three nested pipette tip (50), the cartridge may have more or fewer pipette tips in other embodiments. As will be further appreciated, while the pipette tips may be nested within the cartridge, the pipette tips may have other arrangements.
- This document relates to incubators and methods for culturing, manipulating, and/or monitoring cells under controlled conditions (e.g., under aseptic and/or sterile conditions). In some aspects, incubators and methods include automated components. In some aspects, incubators and methods are useful for long term cell culture (e.g., to grow and maintain cells for recombinant protein expression or to grow and/or differentiate cells for therapeutic applications such as implantation) . In some embodiments, cell cultures are grown within a culture vessel in an incubator described herein.
- Cell culture vessels may be configured for culturing cells of different types, including eukaryotic or prokaryotic cells. In some embodiments, cells are mammalian cells (e.g., human cells, canine cells, bovine cells, ovine cells, feline cells, or rodent cells such as rabbit, mouse, or rat cells). In some embodiments, cells are insect cells, avian cells, microbial cells (e.g., yeast cells such as Saccharomyces cerevisiae, Kluyveromyces lactis, or Pischia pastoris cells, or bacterial cells such as Escherichia coli, Bacillus subtilis, or Corynebacterium cells), insect cells (e.g., Drosophila cells, or Sf9 or Sf21 cells), plant cells (e.g., algal cells) or cells of any other type.
- In some embodiments, cells are cultured for producing natural products (e.g., taxols, pigments, fatty acids, biofuels, etc.). In some embodiments, cells are cultured to express recombinant products (e.g., recombinant protein products such as antibodies, hormones, growth factors, or other therapeutic peptides or proteins). In some embodiments, cells are expanded and/or differentiated for therapeutic use such as implantation into a subject (e.g., a human subject) in order to provide or supplement a cellular, tissue, or organ function that is missing or defective in the subject.
- In some embodiments, cells are from immortalized cell lines. Non-limiting examples of cell lines include human cells, for example, HeLa cells, prostate cancer cells (e.g., DU145, PC3 and/or Lncap cells), breast cancer cells (e.g., MCF-7, MDA-MB-438, and/or T47D cells), acute myeloid leukemia cells (e.g., THP-1 cells), glioblastoma cells (e.g., U87 cells), neuroblastoma cells (e.g., SHSY5Y cells), bone cancer cells (e.g., Saos-2 cells) and chronic myelogenous leukemia cells (e.g., KBM-7 cells). In some embodiments, cell lines include primate cell lines, rodent cell lines (e.g., rat or mouse cell lines), canine cell lines, feline cell lines, Zebrafish cell lines, Xenopus cell lines, plant cell lines, or any other cell. In some embodiments, cells are human 293 cells (e.g., 293-T or HEK 293 cells), murine 3T3 cells, Chinese hamster ovary (CHO) cells, CML T1 cells, or Jurkat cells.
- In some embodiments, cells are primary cells, feeder cells, or stem cells. In some embodiments, cells are isolated from a subject (e.g., a human subject). In some embodiments, cells are primary cells isolated from a tissue or a biopsy sample. In some embodiments, cells are hematopoietic cells. In some embodiments, cells are stem cells, e.g., embryonic stem cells, mesenchymal stem cells, cancer stem cells, etc. In some embodiments, cells are isolated from a tissue or organ (e.g., a human tissue or organ), including but not limited to, solid tissues and organs. In some embodiments, cells can be isolated from placenta, umbilical cord, bone marrow, liver, blood, including cord blood, or any other suitable tissue. In some embodiments, patient-specific cells are isolated from a patient for culture (e.g., for cell expansion and optionally differentiation) and subsequent re-implantation into the same patient or into a different patient. Accordingly, in some embodiments, cells grown in the incubators described herein may be used for allogenic or autogeneic therapy. In some embodiments, cells grown in the incubators disclosed herein may be genetically modified, expanded and reintroduced into a patient for the purpose of providing an immunotherapy (e.g., chimeric antigen receptor therapy (CAR-T), or delivery of CRISPR/Cas modified cells).
- In some embodiments, a primary cell culture includes epithelial cells (e.g., corneal epithelial cells, mammary epithelial cells, etc.), fibroblasts, myoblasts (e.g., human skeletal myoblasts), keratinocytes, endothelial cells (e.g., microvascular endothelial cells), neural cells, smooth muscle cells, hematopoietic cells, placental cells, or a combination of two or more thereof.
- In some embodiments, cells are recombinant cells (e.g., hybridoma cells or cells that express one or more recombinant products). In some embodiments, cells are infected with one or more viruses.
- In some embodiments, cells are isolated from tissues or biological samples for ex vivo culture in the incubators provided herein. In some embodiments, cells (e.g., white blood cells) are isolated from blood. In some embodiments, cells are released from tissues or biological samples using physical and/or enzymatic disruption. In some embodiments, one or more enzymes such as collagenase, trypsin, or pronase are used to digest the extracellular matrix. In some embodiments, tissue or biological samples are placed in culture medium (e.g., with or without physical or enzymatic disruption), and cells that are released and that grow in the culture medium can be isolated for further culture.
- As used herein, cell culture refers to a procedure for maintaining and/or growing cells under controlled conditions (e.g., ex vivo). In some embodiments, cells are cultured under conditions to promote cell growth and replication, conditions to promote expression of a recombinant product, conditions to promote differentiation (e.g., into one or more tissue specific cell types), or a combination of two or more thereof.
- In some embodiments, cell culture vessels are configured for culturing cells in suspension. In some embodiments, cell culture vessels are configured for culturing adherent cells. In some embodiments, cell culture vessels are configured for 2D or 3D cell culture. In some embodiments, cell culture vessels include one or more surfaces or micro-carriers to support cell growth. In some embodiments, these are coated with extracellular matrix components (e.g., collagen, fibrin and/or laminin components) to increase adhesion properties and provide other signals needed for growth and differentiation. In some embodiments, cell culture vessels include one or more synthetic hydrogels such as polyacrylamide or polyethylene glycol (PEG) gels to support cell growth. In some embodiments, cell culture vessels include a solid support with embedded nutrients (e.g., a gel or agar, for example for certain bacterial or yeast cultures). In some embodiments, cell culture vessels include a liquid culture medium.
- In some embodiments, cells are cultured in one of any suitable culture media. Different culture media having different ranges of pH, glucose concentration, growth factors, and other supplements can be used for different cell types or for different applications. In some embodiments, custom cell culture media or commercially available cell culture media such as Dulbecco's Modified Eagle Medium, Minimum Essential Medium, RPMI medium, HA or HAT medium, or other media available from Life Technologies or other commercial sources can be used. In some embodiments, cell culture media include serum (e.g., fetal bovine serum, bovine calf serum, equine serum, porcine serum, or other serum). In some embodiments, cell culture media are serum-free. In some embodiments, cell culture media include human platelet lysate (hPL). In some embodiments, cell culture media include one or more antibiotics (e.g., actinomycin D, ampicillin, carbenicillin, cefotaxime, fosmidomycin, gentamycin, kanamycin, neomycin, penicillin, penicillin streptomycin, polymyxin B, streptomycin, tetracycline, or any other suitable antibiotic or any combination of two or more thereof). In some embodiments, cell culture media include one or more salts (e.g., balanced salts, calcium chloride, sodium chloride, potassium chloride, magnesium chloride, etc.). In some embodiments, cell culture media include sodium bicarbonate. In some embodiments, cell culture media include one or more buffers (e.g., HEPES or other suitable buffer). In some embodiments, one or more supplements are included. Non-limiting examples of supplements include reducing agents (e.g., 2-mercaptoethanol), amino acids, cholesterol supplements, vitamins, transferrin, surfactants (e.g., non-ionic surfactants), CHO supplements, primary cell supplements, yeast solutions, or any combination of two or more thereof. In some embodiments, one or more growth or differentiation factors are added to cell culture media. Growth or differentiation factors (e.g., WNT-family proteins, BMP-family proteins, IGF-family proteins, etc.) can be added individually or in combination, e.g., as a differentiation cocktail comprising different factors that bring about differentiation toward a particular lineage. Growth or differentiation factors and other aspects of a liquid media can be added using automated liquid handlers integrated within the incubators.
- In some aspects, devices and methods described herein provide and maintain appropriate temperature and gas mixtures for cell growth. It should be appreciated that cell growth conditions differ for different cell types and that devices described herein can be programmed to maintain different conditions. In some embodiments, conditions of approximately 37° C., and 5% CO2 are used for mammalian cells.
- In some embodiments, devices and methods described herein are used to generate appropriate pressures for aspirating and/or dispensing liquid from the pipette tips. For example a manipulator (106) may include sensors that monitor the pressure being applied to the bladder (e.g., the pressure differential between the air pressure in the pipette tip and the air pressure of the environment). In some embodiments, devices and methods described herein are used to modify or change the culture media or conditions and/or to passage the cells when appropriate. In some embodiments, the devices and methods are automated (e.g., controlled by a controller (114) and/or computer (111), as shown in
FIG. 7 ). - In some embodiments (e.g., for adherent cell cultures), culture media can be removed directly by aspiration and replaced with fresh media. In some embodiments (e.g., for non-adherent/suspension cultures), media changes can involve centrifuging a cell culture, removing the old culture media and replacing it with fresh media. In some embodiments, the centrifuge is located in the internal chamber of an incubator. In some embodiments, culture vessels allow for continuous media replacement. In some embodiments, the incubators described herein may include one or more components that can be used to process, replace, supply, and/or maintain different aspects of a culture media to support cells. Incubators may include a reservoir containing waste media and/or a reservoir containing fresh media. Such reservoirs may be present (e.g., for temporary storage) within a refrigerator inside the incubator or a refrigerated section of the incubator. In some embodiments, one or more reservoirs are provided outside the incubators and piping is provided into and out from the incubator space to supply or draw from a liquid handler units (e.g., liquid handle units having an aspirator) or temporary reservoir within the incubator to facilitate cells feeding, media changes, and other related needs. For suspension cells, devices may be provided within the incubator to separate cells from waste media (e.g., centrifuge(s) to facilitate cell pelleting) to facilitate automated media changes as part of an incubator provided herein. In some embodiments, the document provides a system comprising a cell culture incubator connected to a computer, capable of automatically monitoring and adjusting cell culture conditions for optimal growth of the cell culture.
- In some embodiments, cells are passaged within an incubator described herein. In some embodiments, a cell culture is split and a subset of the cell culture is transferred to a fresh culture vessel for further growth. In some embodiments (e.g., for adherent cell cultures), cells are detached (e.g., mechanically, for example using gentle scraping, and/or enzymatically, for example using trypsin-EDTA or one or more other enzymes) from a surface prior to being transferred to a fresh culture vessel. In some embodiments (e.g., for suspension cell cultures), a small volume of a cell culture is transferred to a fresh culture vessel.
- In some embodiments, cell cultures are manipulated in other ways during culture in incubators and vessels described herein. For example, cell cultures may be transfected with nucleic acids (e.g., DNA or RNA) or exposed to viral infection (e.g., using recombinant virus particles to deliver DNA or RNA).
- Aseptic techniques can be used to prevent or minimize contamination of cell cultures during growth and manipulation. In some embodiments equipment (e.g., pipettes, fluid handling devices, manipulating devices, other automated or robotic devices, etc.) that is used for cell culture is sterilized using an appropriate technique. Non-limiting techniques include heat exposure (e.g., autoclaving), surface disinfection (e.g., using alcohol, bleach, or other disinfectant), irradiation, and/or exposure to a disinfectant gas (e.g., ozone, hydrogen peroxide, etc.) as described herein. In some embodiments, media is sterilized using an appropriate technique. Non-limiting techniques include heat exposure (e.g., autoclaving), antimicrobial/antiviral treatment, filtration, and/or irradiation.
- In some embodiments, manipulations of cell cultures are performed under aseptic conditions, for example in an environment (e.g., within an incubator chamber) that has been disinfected and in which the air has been filtered to remove potential contaminants.
- In some embodiments, cell cultures are grown and maintained under GMP-compliant conditions, including using GMP-compliant media or GMP-compliant liquid handling equipment and performing methods in conjunction with standard operation procedures (SOPs).
- In some embodiments, cell cultures can be monitored and/or evaluated to detect contamination. In some embodiments, contamination by cells from a different type of organism can be detected. In some embodiments, contamination of a mammalian cell culture by mycoplasma, bacteria, yeast, or viruses can be detected using any suitable technique. In some embodiments, cell culture contamination can be detected by assaying for changes or for rates of change of one or more culture properties such as pH, turbidity, etc., that are characteristic of contamination (e.g., by bacteria or yeast) and not characteristic of the cells being grown in culture (e.g., mammalian cells). In some embodiments, one or more molecular detection assays (e.g., PCR, ELISA, RNA labeling, or other enzymatic techniques) or cell-based assays can be used to detect contamination (e.g., mycoplasma, bacterial, yeast, viral, or other contamination).
- In some embodiments, cell cultures can be monitored and/or evaluated to detect contamination with cells of similar types (e.g., a human cell line contaminated by different human cells or by different mammalian cells). In some embodiments, cell cultures and their potential contamination can be evaluated using DNA sequencing or DNA fingerprinting (e.g., short tandem repeat—STR—fingerprinting), isoenzyme analysis, human lymphocyte antigen (HLA) typing, chromosomal analysis, karyotyping, cell morphology, or other techniques.
- In some embodiments, cells produced using devices and methods provided herein can be frozen to preserve them for later use and/or for transport. In some embodiments, cells are mixed with a cryopreservation composition after growth and/or differentiation and prior to freezing. A cryopreservation composition can be added to a cell culture vessel or cells can be transferred from a cell culture vessel to a cryopreservation vessel along with a cryopreservation composition. Non-limiting examples of cryoprotectants that can be included in a cryopreservation composition include DMSO, glycerol, PEG, sucrose, trehalose, and dextrose. In some embodiments, a freezer may be present in or in proximity with an incubator to facilitate freezing of cells isolated from cell cultures.
- This document relates to incubators and methods for culturing, manipulating, and/or monitoring cells under controlled conditions (e.g., under aseptic and/or sterile conditions). In some embodiments, the cell culture incubators provided herein include an incubator cabinet defining an internal chamber for incubation of cells in one or more cell culture vessels, in which the internal chamber is configured to hold the one or more cell culture vessels. In some cases, in addition to an internal door from the transfer chamber to the internal chamber, the incubators include at least one external door (e.g., 1, 2, 3, 4, or more external doors) opening from an external environment directly to the internal chamber, for example to provide alternative access to the internal chamber during periods of time when the incubator is not operational, e.g., during maintenance of the incubator. In some embodiments, the incubators include a storage location within the internal chamber for storing one or more cell culture vessels. In some embodiments, a cell culture vessel transfer device is provided in the incubator for moving one or more cell culture vessels from a first imaging location to a storage location and/or from a storage location to an first imaging location.
- In some embodiments, incubators or incubator cabinets provided herein are rectangularly cuboidal in shape. In some embodiments incubators or incubator cabinets provided herein have a rectangular footprint in a range of 1 ft2 to 16 ft2. In some embodiments incubators or incubator cabinets provided herein have a rectangular footprint of up to about 1 ft2, 2 ft2, 3 ft2, 4 ft2, 5 ft2, 6 ft2, 7 ft2, 8 ft2, 9 ft2, 10 ft2, 11 ft2, 12 ft2, 13 ft2, 14 ft2, 15 ft2, or 16 ft2. In some embodiments incubators or incubator cabinets provided herein have a total chamber volume in a range of 1 ft3 to 100 ft3. In some embodiments incubators or incubator cabinets provided herein have a chamber volume of up to about 1 ft3, 5 ft3, 10 ft3, 25 ft3, 50 ft3 or 100 ft3. In some embodiments incubators or incubator cabinets provided herein have a rectangular footprint in a range of 0.09 m2 to 1.78 m2. In some embodiments incubators or incubator cabinets provided herein have a rectangular footprint of up to about 0.1 m2, 0.2 m2, 0.3 m2, 0.4 m2, 0.5 m2, 0.6 m2, 0.7 m2, 0.8 m2, 0.9 m2, 1.0 m2, 1.1 m2, 1.2 m2, 1.3 m2, 1.4 m2, 1.5 m2, 1.6 m2, or 1.7 m2. In some embodiments, incubators or incubator cabinets provided herein have a total chamber volume in a range of 0.03 m3 to 3 m3. In some embodiments incubators or incubator cabinets provided herein have a chamber volume of up to about 0.03 m3, 0.1 m3, 0.3 m3, 1 m3, or 3 m3.
- In some embodiments, an incubator cabinet is single-walled. In some embodiments, an incubator is double-walled. In some embodiments, insulation material is provided between the double walls of an incubator cabinet to control heat loss from the cabinet and facilitate temperature control in the cabinet. In some embodiments, the outer wall of an incubator cabinet includes a sheet metal, e.g., a 14-20 gauge cold rolled steel. In some embodiments, an inner wall (e.g., a chamber surface) of an incubator cabinet includes electro-polished stainless steel. In some embodiments, an inner wall (e.g., a chamber surface) of an incubator cabinet includes corrosion resistant materials, such as, titanium, cobalt-chrome, tantalum, platinum, zirconium, niobium, stainless steel, and alloys thereof. However, in some embodiments, a chamber surface of an incubator cabinet includes a polymeric material such as polytetrafluoroethylene (PTFE), or a polymeric material know under the trade name of Parylene. In some embodiments, a chamber surface may have anti-microbial properties, such as copper or silver or anti-microbial compounds incorporated into a polymeric surface coating.
- In some embodiments, the environment inside an incubator is controlled by a control system that may be configured to control the temperature, humidity, carbon dioxide, oxygen, and other gaseous components (e.g., sterilization gases, such as, ozone, and hydrogen peroxide) inside the incubator(e.g., in one or more internal chambers). In some embodiments, a control system controls the environmental conditions (e.g., temperature, humidity, carbon dioxide, oxygen and other gaseous components) within each internal chamber separately. For example, in order to protect sensitive mechanical, electronic and optical components, the humidity of an internal chamber may be maintained at a lower level than an internal chamber having a storage location. In some embodiments, the incubator is further provided with a monitoring system with predefined sensors. Examples of monitoring devices include, but are not limited, to oxygen monitors, carbon dioxide monitors, ozone gas detectors, hydrogen peroxide monitors and multi gas monitors. For example, in some embodiments, an incubator advantageously includes a plurality of sensors responsive to different parameters relevant to cell growth, which may include temperature, air purity, contaminant levels, pH, humidity, N2, CO2, O2, and light. By means of this monitoring system, parameters in the incubator can be measured using sensors for the duration of a culture or process. In some embodiments, parameters measured by the sensors are transmitted by the monitoring system via a line to a computer-controlled monitoring and control system for further processing as discussed herein.
- In some embodiments, an environmental monitoring system can be used in conjunction with an incubator described herein. In some embodiments, one or more sensors that provide for the measurement of temperature, air composition (e.g., CO2 concentration, O2 concentration, etc.), and/or humidity of the system can be associated with an incubator (e.g., fitted within an incubator cabinet). In some embodiments, one or more such sensors can be incorporated as part of an incubator (e.g., attached to, integral to, or otherwise connected to an internal wall or door of the incubator). In some cases, one or more sensors can be positioned at any suitable location(s) outside or inside an incubator cabinet (e.g., within a transfer chamber and/or an internal chamber, for example attached to an internal wall, and/or upper or lower internal surface).
- In some embodiments, a gas sensor is provided that can provide a reading in real time of the concentration of gas in contact with the sensor (e.g., gas in a cabinet, or ambient air) in percent, parts per million, or any other standard unit. Gas sensors for use in the methods and incubators provided herein include CO2 sensors, O2 sensors, N2 sensors, ozone gas detectors, hydrogen peroxide monitors, multi gas monitors, and CO sensors. Such sensors are available from a number of commercial sources. In some cases, the environment of the incubator may be modulated or controlled based upon the information provided by the sensors described herein. For example, the level of CO2 in an incubator may be increased upon indication from a CO2 sensor that a lower than desirable concentration of CO2 is present in the incubator.
- In some embodiments, one or more heating or cooling elements can be incorporated within the incubator (e.g., on an inner surface of the cabinet or door, and/or integrated within one or more of the walls and/or the base of the cabinet) for purposes of controlling the temperature within the incubator. In some embodiments, a heating element can be used for thawing liquids, for example, cell culture media or other reagents.
- In some embodiments, one or more air or oxygen sources, carbon filters, and/or one or more humidification or dehumidification systems are connected to the incubator and configured to control the level of oxygen, carbon dioxide, and/or humidity within the incubator (e.g., in response to signals from the one or more sensors in or attached to the incubator). In some embodiments, one or more controllers are attached to the sensors and other systems to control the internal environment of the incubator.
- In some embodiments, an incubator can include one or more light sources (e.g., an incandescent bulb, LED, UV or other light source). These can be placed within the incubator to illuminate regions within the cabinet. In some embodiments, the culture system operation is monitored using a camera or other light sensitive device that can be placed within or outside the incubator. In some embodiments, the light source is a sterilizing light source. For example, a UV lamp may be located within the transfer chamber and/or the interior chamber of the incubator.
- In some embodiments, the incubator includes a transparent object (e.g., window) that allows visible light or other light wavelengths from within the incubator to be detected by a camera or other light sensitive device placed outside the incubator. In some embodiments, the inner surface of the transparent object can be wiped (e.g., from the inside of the cabinet) to prevent or remove condensation droplets that may accumulate (e.g., due to the humid air inside the incubator) on the inner surface and interfere with the monitoring of the system. In some embodiments, the surface can be wiped by a wiper that is automatically controlled by a controller.
- In some embodiments, a culture cabinet includes windows, doors, or openings that when closed are sealed to preserve sterility after the incubator cabinet has been sterilized. In some embodiments, each seal of the incubator cabinet is air tight up to a threshold level of pressure (e.g., up to 1 atm). In some embodiments, a gasket is provide to ensure a desired level of sealing capacity. In general, a “gasket” is understood as a mechanical seal that fills the space between two objects, generally to prevent leakage between the two objects while under compression. Gaskets are commonly produced by cutting from sheet materials, such as gasket paper, rubber, silicone, metal, cork, felt, neoprene, nitrile rubber, fiberglass, or a plastic polymer (such as polychlorotrifluoro-ethylene). It is often desirable that a gasket be made from a material that provides some degree of yielding such that it is able to deform and tightly fills the space it is designed for, including any slight irregularities. In some embodiments, gaskets can be used with an application of sealant directly to the gasket surface to function properly. In some embodiments, a gasket material can include a closed-cell neoprene foam which is non-reactant with carbon dioxide or ozone.
- Incubators disclosed herein typically include one or more transfer devices for moving one or more items, e.g., from a first location to a second location, within the incubators. In some embodiments, the one or more items are one or more cell culture vessels. In other embodiments, the one or more items are useful for maintenance of one or more cell culture vessels and include, but are not limited to, pipettes, capillaries, liquids (e.g., cell culture medium), nutrients, and other materials. In some embodiments, a transfer device includes a robotic arm. In some embodiments, the robotic arm includes a platform within an incubator cabinet that may move along a rail or conveyor running in various directions along an inner surface (e.g., inner wall, base, etc.) of incubator cabinet. In some embodiments, an incubator cabinet may be configured with more than one (e.g., 2, 3, 4, or 5, or more) robotic arms to increase the throughput of the instrument and to provide redundancy in the event that one of the robotic arms fail.
- In some embodiments, a transfer device further includes a gripper assembly coupled to a robotic arm. In some embodiments, the gripper assembly includes one or more grippers mounted on the end of the robotic arm, each gripper having two or more (e.g., 3, 4, 5, or more) gripper fingers. In some embodiments, each of the gripper fingers on the robotic arm has a groove, friction plate, rubber pad, or other gripping surface. The gripping surface can allow the fingers to grip and transport various types of containers (e.g., culture vessels) within the cabinets. In some embodiments, the robotic arm may have an absolute encoder either coupled to the gripper assembly, or the platform, or a separate absolute encoder for each of the gripper assembly and/or the platform to determine whether the robotic arm is in a position where it may be safely homed (e.g., returned to a resting or storage configuration and/or location or origin of an operational coordinate system) without hitting an obstruction.
- In some embodiments, because it may be desirable in certain situations for the reach of the robotic arm not to extend to some areas of the incubator cabinet, the robotic arm may instead reach these locations by inserting a container into or removing a container from a shuttle or conveyor belt, located, for example, on the incubator cabinet floor or other surface that moves along an axis (e.g., x-axis, y-axis) and provides access to at least some of those locations to which the robotic arm cannot reach.
- In some embodiments, an incubator cabinet is designed to be used in conjunction with an external assay or laboratory automation system. For example, in some embodiments, the incubator cabinet may have a door having an opening large enough to allow the gripper arm to pivot outside of the incubator cabinet with a sufficient reach for the fingers to transport culture vessels or other containers or components from a transport line of the laboratory automation system into the incubator cabinet or transport external assay components into and/or out of the incubator cabinet.
- In some embodiments, a robotic arm is designed to carry, among other things, culture vessels, in which case movements of the robotic arm are controlled to prevent jerking or accelerations of such vessels or other movements which may cause the spilling of samples from the vessels. In some embodiments, a robotic arm is designed to carry, among other things, culture vessels, in which case movements of the robotic arm are controlled to prevent movement of such vessels in ways which cause newly plated cells to congregate/concentrate in specific areas of the culture vessel.
- In some embodiments, because a robotic arm transports vessels or other containers between specific positions in the incubator cabinet, the robotic arm or other components of the incubator can be designed to track precisely where the vessels or other containers are is located. In some cases, in an incubator cabinet with which a robotic arm may be used, there are likely to be areas, such as where other components of the incubator cabinet or walls of the incubator cabinet are located, and thus where certain movements of the robotic arm may be limited. In these cases, a homing mechanism can be used for each of various motors of the arms (e.g., x-motor, theta-motor and z-motor)to position properly the robotic arm to a known location after it is powered up or if a robotic arm collides with another object before resuming operation.
- In some embodiments, an uninterruptible power supply (“UPS”) is attached to or within the incubator cabinet, or contained with it, to allow for an orderly shut-down of incubator operations, including saving of various automation and sample information and the completion of any transport or transfer process that is underway (e.g., the transport of a container or vessel that is being carried by the robotic arm to its destination). The operator may be alerted to unauthorized opening of the incubator by an audible signal, a visual signal, an electronic signal (e.g., an email or a text message), or in some other manner.
- In some embodiments, a sensor or other feature is provided to detect when one or more doors of an incubator are opened (e.g., when an incubator cabinet door, such as an external or internal door, is opened). Such features are useful because they allow operators to keep track of or be warned of any unscheduled or unauthorized openings of the incubator (e.g., the incubator cabinet) that could jeopardize sterility, spoil a production, compromise an assay or experiment, etc.
- In some embodiments, a radiofrequency beacon or other signal source is located within the incubator (e.g., within the incubator cabinet) that can be used to determine the location of one or more devices within the incubator cabinet (e.g., devices having sensors that can detect the signal and use it to determine their location). In some embodiments, the devices could have signal sources and the sensor(s) could be located within one or more of the chambers of an incubator cabinet (e.g., located on an internal surface of an internal chamber).
- In some embodiments, light signals or lasers (e.g., a grid of laser signals) can be used to determine the location of one or more devices or components within the incubator cabinet. Such information can be communicated, e.g., wired or wirelessly, to an external computer or monitoring station. The information can be used to control operation of a transfer device, e.g., a robotic arm, within the incubator cabinet to ensure that the transfer device can grab, manipulate, or maneuver devices or items appropriately within the incubator cabinet.
- In some embodiments, before containers or vessels are brought into an incubator cabinet, a user can select an automation system protocol based on the particular containers, vessels, ingredients, or cells that are being inserted into the incubator cabinet. Relevant information related to the incubator and/or one or more incubator components, and the cells being grown can be entered into a data system. For example, one or more identifiers such as barcodes (e.g., 1D or 2D barcodes) can be placed on the container or vessel, and other significant information, such as, the type of container, the contents of the container, what assays or manipulations are to be performed on the sample in the container can be specified. In some embodiments, information related to the incubator system and/or cells can be contained in one or more barcodes, on a separate data system, or a combination thereof. The user may also enter information that identifies the dimensionality (e.g., height, diameter) of the vessel or other container or the system itself can be configured to determine the height or other dimensions of the vessel or other container. Using this information, the robotic arm may be requested to transport a particular container, such as when an analytical module is ready to perform an assay or other manipulation on cells grown in the vessels or has completed performing an assay or manipulation.
- The incubators provided herein include several components, including sensors, environmental control systems, robotics, etc. which may operate together at the direction of a computer, processor, microcontroller or other controller. The components may include, for example, a transfer device (e.g., robotic arm), a liquid handling devices, a delivery system for delivering culture vessels, a manipulator attached to the disclosed pipette tip, or other components to or from the incubator cabinet, an environmental control system for controlling the temperature and other environmental aspects of the incubator cabinet, a door operation system, an imaging or detection system, and a cell culture assay system.
- In some cases, operations such as controlling operations of a cell culture incubator and/or components provided therein or interfacing therewith may be implemented using hardware, software or a combination thereof. When implemented in software, the software code can be executed on any suitable processor or collection of processors, whether provided in a single component or distributed among multiple components. Such processors may be implemented as integrated circuits, with one or more processors in an integrated circuit component. A processor may be implemented using circuitry in any suitable format.
- A computer may be embodied in any of a number of forms, such as a rack-mounted computer, a desktop computer, a laptop computer, or a tablet computer. Additionally, a computer may be embedded in a device not generally regarded as a computer but with suitable processing capabilities, including a Personal Digital Assistant (PDA), a smart phone or any other suitable portable, mobile or fixed electronic device, including the incubator itself.
- In some cases, a computer may have one or more input and output devices. These devices can be used, among other things, to present a user interface. Examples of output devices that can be used to provide a user interface include printers or display screens for visual presentation of output and speakers or other sound generating devices for audible presentation of output. Examples of input devices that can be used for a user interface include keyboards, and pointing devices, such as mice, touch pads, and digitizing tablets. In other examples, a computer may receive input information through speech recognition or in other audible format, through visible gestures, through haptic input (e.g., including vibrations, tactile and/or other forces), or any combination thereof.
- One or more computers may be interconnected by one or more networks in any suitable form, including as a local area network or a wide area network, such as an enterprise network or the Internet. Such networks may be based on any suitable technology and may operate according to any suitable protocol and may include wireless networks, wired networks, or fiber optic networks.
- The various methods or processes outlined herein may be coded as software that is executable on one or more processors that employ any one of a variety of operating systems or platforms. Such software may be written using any of a number of suitable programming languages and/or programming or scripting tools, and may be compiled as executable machine language code or intermediate code that is executed on a framework or virtual machine.
- One or more algorithms for controlling methods or processes provided herein may be embodied as a readable storage medium (or multiple readable media) (e.g., a computer memory, one or more floppy discs, compact discs (CD), optical discs, digital video disks (DVD), magnetic tapes, flash memories, circuit configurations in Field Programmable Gate Arrays or other semiconductor devices, or other tangible storage medium) encoded with one or more programs that, when executed on one or more computers or other processors, perform methods that implement the various methods or processes described herein.
- In some embodiments, a computer readable storage medium may retain information for a sufficient time to provide computer-executable instructions in a non-transitory form. Such a computer readable storage medium or media can be transportable, such that the program or programs stored thereon can be loaded onto one or more different computers or other processors to implement various aspects of the methods or processes described herein. As used herein, the term “computer-readable storage medium” encompasses only a computer-readable medium that can be considered to be a manufacture (e.g., article of manufacture) or a machine. Alternatively or additionally, methods or processes described herein may be embodied as a computer readable medium other than a computer-readable storage medium, such as a propagating signal.
- The terms “program” or “software” are used herein in a generic sense to refer to any type of code or set of executable instructions that can be employed to program a computer or other processor to implement various aspects of the methods or processes described herein. Additionally, it should be appreciated that according to one aspect of this embodiment, one or more programs that when executed perform a method or process described herein need not reside on a single computer or processor, but may be distributed in a modular fashion amongst a number of different computers or processors to implement various procedures or operations.
- Executable instructions may be in many forms, such as program modules, executed by one or more computers or other devices. Generally, program modules include routines, programs, objects, components, data structures, etc. that perform particular tasks or implement particular abstract data types. Typically, the functionality of the program modules may be combined or distributed as desired in various embodiments.
- Also, data structures may be stored in computer-readable media in any suitable form. Non-limiting examples of data storage include structured, unstructured, localized, distributed, short-term and/or long term storage. Non-limiting examples of protocols that can be used for communicating data include proprietary and/or industry standard protocols (e.g., HTTP, HTML, XML, JSON, SQL, web services, text, spreadsheets, etc., or any combination thereof). For simplicity of illustration, data structures may be shown to have fields that are related through location in the data structure. Such relationships may likewise be achieved by assigning storage for the fields with locations in a computer-readable medium that conveys relationship between the fields. However, any suitable mechanism may be used to establish a relationship between information in fields of a data structure, including through the use of pointers, tags, or other mechanisms that establish relationship between data elements.
- In some embodiments, information related to the operation of the incubator (e.g., temperature, humidity, gas composition, images, cell culture conditions, etc., or any combination thereof) can be obtained from one or more sensors associated with the incubator (e.g., located within the incubator cabinet, or located within the incubator but outside the incubator cabinet), and can be stored in computer-readable media to provide information about conditions during a cell culture incubation. In some embodiments, the readable media comprises a database. In some embodiments, said database contains data from a single incubator. In some embodiments, said database contains data from a plurality of incubators.
- In some embodiments, data is stored in a manner that makes it tamper-proof. In some embodiments, all data generated by the instrument (e.g., an incubator) is stored. In some embodiments, a subset of data is stored.
- In some embodiments, the component (e.g., a computer) controls various processes performed inside the incubator. For example, a computer may direct control equipment (e.g., a manipulator, an imager, a fluid handling system, etc.). In some embodiments, the computer controls imaging of cell cultures, picking of cells, weeding of cells (e.g., removal of cell clumps), monitoring of cell culture conditions, adjustment of cell culture conditions, tracking of cell culture vessel movement within the incubator, and/or scheduling of any of the foregoing processes.
- In some embodiments, incubator cabinets provided herein are configured with a microscope or other imager or other device for purposes of monitoring cell growth, viability or other aspect of cells. In some embodiments, the microscope or imager is used in conjunction with an assay performed within the incubator cabinet, such as an image based phenotypic screen or assay.
- In certain embodiments, incubators provided herein are configured to permit one or more assays to be performed within an incubator cabinet or within a chamber operably connected to an incubator cabinet, e.g., a separate assay chamber that is part of the incubator. In some embodiments, incubators provided herein are configured to permit performance of a cell counting assay, a replication labeling assay, a cell membrane integrity assay, a cellular ATP-based viability assay, a mitochondrial reductase activity assay, a caspase activity assay, an Annexin V staining assay, a DNA content assay, a DNA degradation assay, a nuclear fragmentation assay, or a combination thereof. Other exemplary assays include BrdU, EdU, or H3-thymidine incorporation assays; DNA content assays using a nucleic acid dye, such as Hoechst Dye, DAPI, actinomycin D, 7-aminoactinomycin D, or propidium iodide; cellular metabolism assays such as AlamarBlue, MTT, XTT, and CellTitre Glo; nuclear fragmentation assays; cytoplasmic histone associated DNA fragmentation assays; PARP cleavage assays; and, TUNEL staining assays.
- In certain embodiments, incubators provided herein are configured to permit high-throughput screening (HTS) within an incubator cabinet. In some embodiments, HTS refers to testing of up to, for example, 100,000 compounds per day. In some embodiments, screening assays may be carried out in a multi-well format, for example, a 96-well, 384-well format, or 1,536-well format, and can be performed using automated protocols. In such high throughput assays, it is possible to screen several thousand different compounds or compositions in a single day. In particular, each well of a microtiter plate can be used to run a separate assay against a selected test compound, or, if concentration or incubation time effects are to be observed, a plurality of wells can contain test samples of a single compound. It is possible to assay many plates per day; assay screens for up to about 6,000, 20,000, 50,000, or more than 100,000 different compounds are possible using the assays. Typically, HTS implementations of the assays described herein involve the use of automation. In some embodiments, an integrated robot system that includes of one or more robotic arms transports assay microplates between multiple assay stations for compound, cell, and/or reagent addition, mixing, incubation, and finally readout or detection. In some aspects, an HTS assay may include preparing, incubating, and analyzing many plates simultaneously, further speeding the data-collection process.
- In some embodiments, assays can include test cells, control cells, and one or more test compounds, e.g., 10, 100, 1000, 10,000, or more test compounds. The cells and test agents can be arranged in one or more vessels in a manner suitable for assessing effect of the test compound(s) on the cells. These assays can be performed within one or more incubator cabinets of one or more incubators described herein. Typically, the vessels contain a suitable tissue culture medium, and the test compounds are present in the tissue culture medium and may be delivered to the culture medium within an incubator cabinet of an incubator provided herein in an automated fashion. A medium appropriate for culturing a particular cell type can be selected for use. In some embodiments, a medium is free or essentially free of serum or tissue extracts, while in other embodiments such a component is present. In some embodiments, cells are cultured on a plastic or glass surface.
- The above aspects and embodiments may be employed in any suitable combination, as the present invention is not limited in this respect.
- It should be understood that aspects of the invention are described herein with reference to certain illustrative embodiments and the figures. The illustrative embodiments described herein are not necessarily intended to show all aspects of the invention, but rather are used to describe a few illustrative embodiments. Thus, aspects of the invention are not intended to be construed narrowly in view of the illustrative embodiments. In addition, it should be understood that aspects of the invention may be used alone or in any suitable combination with other aspects of the invention.
- Having thus described several aspects of at least one embodiment of this invention, it is to be appreciated that various alterations, modifications, and improvements will readily occur to those skilled in the art. Such alterations, modifications, and improvements are intended to be part of this disclosure, and are intended to be within the spirit and scope of the invention. Accordingly, the foregoing description and drawings are by way of example only.
- While several embodiments of the present invention have been described and illustrated herein, those of ordinary skill in the art will readily envision a variety of other means and/or structures for performing the functions and/or obtaining the results and/or one or more of the advantages described herein, and each of such variations and/or modifications is deemed to be within the scope of the present invention. More generally, those skilled in the art will readily appreciate that all parameters, dimensions, materials, and configurations described herein are meant to be exemplary and that the actual parameters, dimensions, materials, and/or configurations will depend upon the specific application or applications for which the teachings of the present invention is/are used. Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. It is, therefore, to be understood that the foregoing embodiments are presented by way of example only and that, within the scope of the appended claims and equivalents thereto, the invention may be practiced otherwise than as specifically described and claimed. The present invention is directed to each individual feature, system, article, material, and/or method described herein. In addition, any combination of two or more such features, systems, articles, materials, and/or methods, if such features, systems, articles, materials, and/or methods are not mutually inconsistent, is included within the scope of the present invention.
- The indefinite articles “a” and “an,” as used herein in the specification and in the claims, unless clearly indicated to the contrary, should be understood to mean “at least one.”
- The phrase “and/or,” as used herein in the specification and in the claims, should be understood to mean “either or both” of the elements so conjoined, e.g., elements that are conjunctively present in some cases and disjunctively present in other cases. Other elements may optionally be present other than the elements specifically identified by the “and/or” clause, whether related or unrelated to those elements specifically identified unless clearly indicated to the contrary. Thus, as a non-limiting example, a reference to “A and/or B,” when used in conjunction with open-ended language such as “comprising” can refer, in one embodiment, to A without B (optionally including elements other than B); in another embodiment, to B without A (optionally including elements other than A); in yet another embodiment, to both A and B (optionally including other elements); etc.
- As used herein in the specification and in the claims, “or” should be understood to have the same meaning as “and/or” as defined above. For example, when separating items in a list, “or” or “and/or” shall be interpreted as being inclusive, e.g., the inclusion of at least one, but also including more than one, of a number or list of elements, and, optionally, additional unlisted items. Only terms clearly indicated to the contrary, such as “only one of” or “exactly one of,” or, when used in the claims, “consisting of,” will refer to the inclusion of exactly one element of a number or list of elements. In general, the term “or” as used herein shall only be interpreted as indicating exclusive alternatives (e.g. “one or the other but not both”) when preceded by terms of exclusivity, such as “either,” “one of,” “only one of,” or “exactly one of.” “Consisting essentially of,” when used in the claims, shall have its ordinary meaning as used in the field of patent law.
- As used herein in the specification and in the claims, the phrase “at least one,” in reference to a list of one or more elements, should be understood to mean at least one element selected from any one or more of the elements in the list of elements, but not necessarily including at least one of each and every element specifically listed within the list of elements and not excluding any combinations of elements in the list of elements. This definition also allows that elements may optionally be present other than the elements specifically identified within the list of elements to which the phrase “at least one” refers, whether related or unrelated to those elements specifically identified. Thus, as a non-limiting example, “at least one of A and B” (or, equivalently, “at least one of A or B,” or, equivalently “at least one of A and/or B”) can refer, in one embodiment, to at least one, optionally including more than one, A, with no B present (and optionally including elements other than B); in another embodiment, to at least one, optionally including more than one, B, with no A present (and optionally including elements other than A); in yet another embodiment, to at least one, optionally including more than one, A, and at least one, optionally including more than one, B (and optionally including other elements); etc.
- In the claims, as well as in the specification above, all transitional phrases such as “comprising,” “including,” “carrying,” “having,” “containing,” “involving,” “holding,” and the like are to be understood to be open-ended, e.g., to mean including but not limited to. Only the transitional phrases “consisting of” and “consisting essentially of” shall be closed or semi-closed transitional phrases, respectively, as set forth in the United States Patent Office Manual of Patent Examining Procedures, Section 2111.03.
- Use of ordinal terms such as “first,” “second,” “third,” etc., in the claims to modify a claim element does not by itself connote any priority, precedence, or order of one claim element over another or the temporal order in which acts of a method are performed, but are used merely as labels to distinguish one claim element having a certain name from another element having a same name (but for use of the ordinal term) to distinguish the claim elements.
- It should also be understood that, unless clearly indicated to the contrary, in any methods claimed herein that include more than one step or act, the order of the steps or acts of the method is not necessarily limited to the order in which the steps or acts of the method are recilted.
Claims (26)
1. A pipette tip comprising:
a body defining an inner volume and having first and second ends, the first end arranged to pass a liquid into and out of the pipette tip and the second end arranged for attachment to a pipette;
a bladder sealingly attached to the body, wherein the bladder includes a membranous sac in a collapsed configuration disposed in the inner volume; and
a pipette shell within the body of the pipette and receptive of the bladder in response to an applied pressure, wherein the pipette shell includes a pipette shell body into which the bladder is configured to be retracted in response to the applied pressure, and wherein the pipette shell is made of a rigid material.
2. The pipette tip of claim 1 , wherein the bladder is disposable in the inner volume of the body.
3. The pipette tip of claim 1 , wherein the bladder is arranged to cause a volume of liquid to be drawn into or expelled from the inner volume though the first end in response to a pressure gradient applied across the bladder.
4. The pipette tip of claim 1 , wherein the bladder is arranged to permit a volume of liquid to be drawn into the inner volume through the first end in response to a negative pressure gradient directed from the first end toward the second end and across the bladder, and wherein the bladder is arranged to permit a volume of liquid to be expelled from the inner volume through the first end in response to a positive pressure gradient directed from the first end toward the second end and across the bladder.
5. The pipette tip of claim 4 , wherein the bladder has a first side and a second side, wherein the first side faces the first end of the body, and wherein the negative pressure gradient is generated by drawing a vacuum on the second side.
6. The pipette tip of claim 1 , wherein the bladder is attached to the body at one of the first and second ends of the body.
7. The pipette tip of claim 1 , wherein the bladder is attached to the body at a location between the first and second ends of the body.
8. (canceled)
9. The pipette tip of claim 1 , wherein the pipette shell is removably attachable to the pipette tip.
10. The pipette tip of claim 1 , wherein the bladder is expandable to be at least partially disposed outside of the inner volume.
11. The pipette tip of claim 1 , wherein the pipette shell has a volume at least equal to a volume of the bladder.
12. The pipette tip of claim 1 , wherein the bladder provides a seal between a first compartment defined between a first side of the bladder and the first end of the body and a second compartment defined between a second side of the bladder and the pipette.
13. The pipette tip of claim 12 , wherein the bladder provides a seal while liquid is drawn into the first compartment.
14. The pipette tip of claim 1 , wherein the sac is permanently attached to the body at a periphery thereof.
15. The pipette tip of claim 1 , in combination with a second pipette tip, the second pipette tip comprising:
a second body defining a second inner volume and having third and fourth ends, the third end arranged to pass a liquid into and out of the second pipette tip and the fourth end arranged for attachment to a pipette; and
a second bladder sealingly attached to the second body;
wherein the first and second pipette tips are nestable.
16. The combination of claim 15 , wherein the second bladder is disposable in the second inner volume.
17. The combination of claim 15 , wherein the first pipette tip is nested on top of the second pipette tip.
18. The combination of claim 17 , wherein the second bladder is adjacent to the body of the first pipette tip when the first pipette tip is nested on top of the second pipette tip.
19-21. (canceled)
22. The pipette tip of claim 1 , wherein, in response to a first applied pressure, the bladder is arranged to move in a direction away from the first end of the body to draw a volume of liquid into the pipette tip.
23. The pipette tip of claim 22 , wherein, in response to a second applied pressure, the bladder is arranged to move in a direction toward the first end of the body to transfer a volume of liquid out of the pipette tip.
24. The pipette tip of claim 22 , wherein, in response to the first applied pressure, at least a portion of the bladder is arranged to accommodate a volume of liquid.
25. The liquid transfer device of claim 22 , wherein the volume of liquid drawn into the pipette tip is proportional to an amplitude of the first applied pressure.
26-33. (canceled)
34. A pipette tip comprising:
a body defining an inner volume and having first and second ends, the first end arranged to pass a liquid into and out of the pipette tip and the second end arranged for attachment to a pipette;
a bladder sealingly attached to the body, wherein the bladder includes a membranous sac in a collapsed configuration disposed in the inner volume and wherein the bladder and at least a portion of the inner volume are arranged to accommodate a volume of liquid; and
a pipette shell within the body of the pipette and receptive of the bladder in response to an applied pressure, wherein the pipette shell includes a pipette shell body into which the bladder is configured to be retracted in response to the applied pressure, and wherein the pipette shell is made of a rigid material.
35-72. (canceled)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18/333,495 US20230321647A1 (en) | 2017-05-19 | 2023-06-12 | Liquid transfer system |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762508883P | 2017-05-19 | 2017-05-19 | |
PCT/US2018/033350 WO2018213682A1 (en) | 2017-05-19 | 2018-05-18 | Liquid transfer system |
US201916614487A | 2019-11-18 | 2019-11-18 | |
US18/333,495 US20230321647A1 (en) | 2017-05-19 | 2023-06-12 | Liquid transfer system |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2018/033350 Continuation WO2018213682A1 (en) | 2017-05-19 | 2018-05-18 | Liquid transfer system |
US16/614,487 Continuation US11724254B2 (en) | 2017-05-19 | 2018-05-18 | Liquid transfer system |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230321647A1 true US20230321647A1 (en) | 2023-10-12 |
Family
ID=64274664
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/614,487 Active 2039-05-01 US11724254B2 (en) | 2017-05-19 | 2018-05-18 | Liquid transfer system |
US18/333,495 Pending US20230321647A1 (en) | 2017-05-19 | 2023-06-12 | Liquid transfer system |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/614,487 Active 2039-05-01 US11724254B2 (en) | 2017-05-19 | 2018-05-18 | Liquid transfer system |
Country Status (4)
Country | Link |
---|---|
US (2) | US11724254B2 (en) |
JP (1) | JP7338870B2 (en) |
CN (1) | CN110913990B (en) |
WO (1) | WO2018213682A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019042001A (en) * | 2017-08-31 | 2019-03-22 | キヤノン株式会社 | Acoustic wave reception device |
US20210237048A1 (en) * | 2020-02-03 | 2021-08-05 | Tecan Genomics, Inc. | Reagent storage system |
WO2023114546A2 (en) * | 2021-12-17 | 2023-06-22 | Advanced Solutions Life Sciences, Llc | End effector assemblies, systems, and methods of use |
CN114306799B (en) * | 2022-03-10 | 2022-07-12 | 济南鑫贝西生物技术有限公司 | Horizontal flow clean bench that dispenses |
WO2024086878A1 (en) * | 2022-10-24 | 2024-05-02 | Avicena Systems Limited | High-throughput analysis unit |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2225211B1 (en) | 1973-04-16 | 1979-02-16 | Oxford Lab | |
CN86200931U (en) * | 1986-02-14 | 1986-11-05 | 周朝相 | Pipette and airpocket with airpocket |
DE3635598A1 (en) * | 1986-10-20 | 1988-05-05 | Eppendorf Geraetebau Netheler | PIPETTING DEVICE WITH A CLIP-ON CONE FOR A PIPETTE TIP AND PIPETTE TIP FOR SUCH A PIPETTING DEVICE |
US4877585A (en) * | 1987-12-09 | 1989-10-31 | Brandeis University | Dilution pipette device |
JPH0445856A (en) | 1990-06-14 | 1992-02-14 | Toshimasa Akiyama | Structure of thin film fitted to pipet tip |
JPH08219956A (en) | 1995-02-17 | 1996-08-30 | Hitachi Koki Co Ltd | Pipet and using medhod thereof |
US6117394A (en) | 1996-04-10 | 2000-09-12 | Smith; James C. | Membrane filtered pipette tip |
DE19626234A1 (en) * | 1996-06-29 | 1998-01-02 | Innova Gmbh | Device for the contamination-free supply and removal of liquids |
US5779984A (en) * | 1996-12-04 | 1998-07-14 | Rainin Intstrumental Co., Inc. | Pipette tip rack and refill pack containing large maximized volume freely nestable pipette tips |
FI107026B (en) | 1998-08-26 | 2001-05-31 | Biohit Oyj | Suction device tip and method for dispensing fluid with a suction device |
US6475440B1 (en) * | 1998-09-16 | 2002-11-05 | Clontech Laboratories, Inc. | Applicator for use in deposition of fluid samples onto a substrate surface |
US6566145B2 (en) | 2000-02-09 | 2003-05-20 | William E Brewer | Disposable pipette extraction |
JP4271835B2 (en) | 2000-08-18 | 2009-06-03 | アークレイ株式会社 | Pipette device |
US6499362B1 (en) | 2001-12-03 | 2002-12-31 | Global Fia, Inc. | In-line filter probe for process analysis |
US7238520B2 (en) * | 2002-12-04 | 2007-07-03 | Smiths Detection Inc. | PCR sample preparation holder and method |
TWI415770B (en) * | 2006-01-13 | 2013-11-21 | Universal Bio Research Co Ltd | Variable form dispensing tube, deformation type dispensing device and deformation type dispensing processing method |
CN2868404Y (en) * | 2006-01-16 | 2007-02-14 | 河南农业大学 | Pipet |
DE102006046542A1 (en) * | 2006-09-27 | 2008-04-03 | Weber, Jürgen | Pipette with pipette holder for reception of volatile liquids, comprises an inserted closing element, which locks the pipette tip after filling, so that the pipette is transferred in drip-free manner |
US20080199361A1 (en) * | 2007-02-16 | 2008-08-21 | Francis Gomes | Hand-held pipetting device |
JP5268628B2 (en) | 2008-12-26 | 2013-08-21 | 川崎重工業株式会社 | Bulkhead unit for pipetter and pipette |
EP2512678A1 (en) * | 2009-12-18 | 2012-10-24 | Zafena Aktiebolag | Micropipette |
US9358538B2 (en) * | 2012-04-30 | 2016-06-07 | The Regents Of The University Of Michigan | High resolution pipette |
CH708562A2 (en) | 2013-09-13 | 2015-03-13 | Gyger Invest Ag | Dispenser for liquid substances. |
WO2015120371A2 (en) * | 2014-02-10 | 2015-08-13 | Kurt Koptis | Container and dispenser for flowable material and method |
ES2807510T3 (en) * | 2014-06-10 | 2021-02-23 | Siemens Healthcare Diagnostics Products Gmbh | Holder for a pipetting device for an automatic analysis apparatus |
CN105498877A (en) * | 2014-12-23 | 2016-04-20 | 马荣华 | Quantitative pipet |
CN204564168U (en) * | 2015-01-07 | 2015-08-19 | 山东科技大学 | A kind of pipette |
EP3308281A4 (en) * | 2015-03-31 | 2019-12-04 | Thrive Bioscience, Inc. | Cell culture incubators with integrated imaging systems |
US10137444B2 (en) * | 2016-05-11 | 2018-11-27 | Massachusetts Institute Of Technology | Nanoliter pipetting device |
CN106311369A (en) | 2016-10-13 | 2017-01-11 | 东南大学 | Anti-pollution pipette tip |
-
2018
- 2018-05-18 US US16/614,487 patent/US11724254B2/en active Active
- 2018-05-18 JP JP2019563598A patent/JP7338870B2/en active Active
- 2018-05-18 CN CN201880047623.0A patent/CN110913990B/en active Active
- 2018-05-18 WO PCT/US2018/033350 patent/WO2018213682A1/en active Application Filing
-
2023
- 2023-06-12 US US18/333,495 patent/US20230321647A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20200070144A1 (en) | 2020-03-05 |
CN110913990B (en) | 2022-08-26 |
CN110913990A (en) | 2020-03-24 |
JP2020520646A (en) | 2020-07-16 |
JP7338870B2 (en) | 2023-09-05 |
WO2018213682A1 (en) | 2018-11-22 |
US11724254B2 (en) | 2023-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11920122B2 (en) | Cell culture incubators with integrated cell manipulation systems | |
US11920121B2 (en) | Automated cell culture incubator | |
US11879120B2 (en) | Cell maintainer for autologous cell therapy production | |
US20210261899A1 (en) | Automated cell culture incubators comprising selectively permeable cell culture vessel storage compartments | |
US11034927B2 (en) | Cell culture incubators with integrated imaging systems | |
US20230321647A1 (en) | Liquid transfer system | |
US20220403314A1 (en) | Vessel for culturing cells | |
US20230303959A1 (en) | Automated apparatus and method for in vitro fertilization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: THRIVE BIOSCIENCE, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BLANCHARD, ALAN;REEL/FRAME:065484/0233 Effective date: 20220810 |